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Abstract 
The interaction of host-cell nucleic acid-binding proteins with the genomes of 
positive-stranded RNA viruses is known to play a role in the translation and 
replication of many viruses. To date, however, the characterisation of similar 
interactions with the genomes of members of the Caliciviridae family has been 
limited to in vitro binding analysis. In this study, feline calicivirus (FCV) and murine 
norovirus (MNV) have been used as model systems to identify and characterise the 
role of host-cell factors that interact with the viral RNA and RNA structures that 
regulate virus replication. It was demonstrated that RNA-binding proteins such as 
polypyrimidine tract-binding protein (PTB), poly(C)-binding proteins (PCBPs) and 
La protein interact with the extremities of MNV and FCV genomic and subgenomic 
RNAs. PTB acted as a negative-regulator in FCV translation and is possibly involved 
in the switch between translation and replication during the late stages of the 
infection, as PTB is exported from the nucleus to the cytoplasm, where calicivirus 
replication takes place. Furthermore, using the MNV reverse-genetics system, 
disruption of 5' end stem-loops reduced infectivity ~15-20 fold, while disruption of an 
RNA structure that is suspected to be part of the subgenomic RNA synthesis promoter 
and an RNA structure at the 3' end completely inhibited virus replication. Restoration 
of infectivity by repair mutations in the subgenomic promoter region and the recovery 
of viruses that contained repressor mutations within the disrupted structures, in both 
the subgenomic promoter region and the 3’ end, confirmed a functional role for these 
RNA secondary structures. Overall this study has yielded new insights into the role of 
RNA structures and RNA-protein interactions in the calicivirus life cycle. 
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Chapter 1. 
General Introduction  
                                   20
Gastroenteritis (GE) is one of the most common diseases in humans. More 
than 700 million cases per year are reported worldwide, resulting in approximately 3.5 
to 5 million deaths (mainly in developing countries) (reviewed by Atmar & Estes, 
2001). The causal agent for acute gastroenteritis can be bacterial, parasitic or viral. 
Bacterial GE is caused mostly by Salmonella and Campylobacter, parasitic GE 
mainly by Giardia and viral GE by caliciviruses, rotaviruses and astroviruses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 1.1. Phylogenetic relationship among caliciviruses Phylogenetic tree of 
caliciviruses based on the sequences of the capsid protein. Adapted from (Karst et al., 2003) 
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1.1. Caliciviridae 
Gastroenteritis caused by Norwalk virus (NV), a human calicivirus (HuCV) 
was first described in Norwalk, Ohio in 1968 (Adler & Zickl, 1969). The name 
calicivirus is derived from the Latin word calyx (=cup) because of the cup-like 
structures on their capsid. Since 1998 the Caliciviridae family has been divided into 
four genera (updated later for more formal nomenclature Büchen-Osmond, 2003) the 
Norovirus genus, comprising among others Norwalk virus and murine norovirus 
(MNV), the Sapovirus genus, with the Sapporo virus to be designated as the type 
species, Lagovirus genus, comprising mainly of rabbit hemorrhagic disease virus 
(RHDV) and the Vesivirus genus, containing swine vesicular exanthema virus 
(SVEV) and feline calicivirus (FCV). A phylogenetic tree showing the evolutionary 
interrelationships among the various genogroups of caliciviruses is presented in Fig. 
1.1.   
 
1.2. Disease and Epidemiology 
 
1.2.1. Human caliciviruses 
 
Caliciviruses which cause disease in humans (Human caliciviruses) can be 
found in both the Norovirus and Sapovirus genera. HuCV have been reported to be 
responsible for 75% of all gastroenteritis cases of viral aetiology and 60% of all 
gastroenteritis cases as estimated by CDC for the United States (Mead et al., 1999). 
HuCVs are commonly isolated during outbreaks of gastroenteritis in hospitals, 
restaurants, cruise ships, schools and other settings that combine food with large 
numbers of people. The transmission of HuCVs mainly follows the faeco-oral route, 
                                   22
but aerosolised vomit can become an alternative method of transmission (Graham et 
al., 1994). The symptoms of a HuCV infection last for 12 to 60 hours, and they 
include nausea, vomiting, abdominal cramps and diarrhoea. Children experience 
mainly vomiting, while in adults, diarrhoea is the most common symptom. Due to the 
vomiting caused by HuCVs and the seasonality, the disease is often referred as 
“winter vomiting disease”. The illness can be fatal when it leads to dehydration in 
susceptible persons. However, in the majority of cases in the developed world, the 
symptoms are mild and the infection is resolved within several days. 
 
The large number of people affected by HuCVs along with the required 
decontamination of the setting where an outbreak has occurred makes the HuCVs of 
high economic importance. The 35,000 hospitalisations in England and Wales and the 
283 episodes of infectious intestinal disease per 1000 person each year, support 
estimates of the profound economic effect of HuCV (reviewed by Lopman et al., 
2002). It was estimated that during 2003 and 2004, HuCV outbreaks in hospitals 
resulted in the loss of 3400 bed-days. The overall impact of outbreaks occurring in 
hospital environments alone, including the cost of replacing staff due to illness, has 
been estimated at ~70 million pounds Sterling per year (Lopman et al., 2004). 
 
1.2.2. Murine norovirus 
 
Another important member of the norovirus genus is murine norovirus 
(MNV). MNV (MNV-1) was first identified in transgenic mice lacking the 
recombination-activating gene 2 and the signal transducer activator of transcription 1 
(RAG2/STAT-1-/-). In these severely immunocompromised mice MNV-1 caused a 
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lethal infection that was associated with encephalitis, vasculitis of the cerebral 
vessels, meningitis, hepatitis, and pneumonia (Karst et al., 2003). STAT-1 is part of 
the signalling pathway responsible for innate immunity and is required for the 
clearance of the virus. The defect in STAT1 was the main determinant of the lethal 
phenotype as in STAT1-/- mice the mortality was high, while in RAG2-/- mice MNV-1 
showed only limited replication and lead to an asymptomatic infection, similar to that 
observed in immunocompetent mice (Karst et al., 2003). MNV-1 showed a clear 
tropism for murine dendritic cells and macrophages, while a macrophage cell line, 
(RAW 264.7), could support viral growth (Wobus et al., 2004). Recent studies have 
identified additional MNV strains (Hsu et al., 2006, Muller et al., 2007, Thackray et 
al., 2007), among them MNV-2, 3 and 4. In these cases the viruses were isolated from 
the mesenteric lymph nodes of persistently infected immunocompetent mice (Hsu et 
al., 2006). In a recent survey carried out in an animal facility, 67.5% of the laboratory 
kept mice were found positive for MNV (Muller et al., 2007). Thus, MNV is not only 
a good system for the study of the basic biology of noroviruses, but is also an 
important pathogen of research mice.  
 
1.2.3. Feline calicivirus 
 
Feline calicivirus (FCV), of the Vesivirus genus, causes an acute oral and 
upper respiratory system disease in domestic and wild cats. The disease is often called 
‘cat flu’ because of the similarities of the clinical signs to those caused by influenza 
virus in humans (TerWee et al., 1997). Recently, more virulent strains have become 
prevalent in the USA which cause a systemic infection. These highly virulent strains 
cause outbreaks of a systemic illness similar to the hemorrhagic disease caused by 
                                   24
RHDV in rabbits, which leads to the death or euthanasia of 50% of the infected cats 
(Pedersen et al., 2000).  To date, only one outbreak of highly virulent FCV has been 
reported in the UK (Coyne et al., 2006). In most cases the virus is shed in 
oropharyngeal secretions for about 30 days. However, a small part of the cat 
population remain as carriers (persistence) shedding virus for more than a month or 
even for the rest of their life (Radford et al., 2007). The prevalence of FCV ranges 
from 10% for domestic cats, to 25%-40% in feral cats or those living in large 
colonies. FCV is one of the very few caliciviruses which replicate efficiently in tissue 
culture, leading to the availability of a wide range of live-attenuated vaccines 
(reviewed by Radford et al., 2007). A report in 2006 presented a potential link 
between vesiviruses and undiagnosed human diseases. Using antigens from the San 
Miguel sea lion virus (SMSV) and the FCV vaccine strain F9 a high prevalence of 
anti-vesivirus antibodies was detected in individuals with undiagnosed hepatitis 
(Smith et al., 2006). Interestingly, ongoing viremia was detected in the 10% of these 
cases (Smith et al., 2006).   
 
Despite the advanced epidemiological knowledge on human caliciviruses, the 
molecular mechanisms that these viruses use for replication are still unknown. This is 
largely due to the fact that until very recently, cell lines or animal models that can be 
infected with HuCVs have not been available. Recent work by Asanaka et al. 
demonstrated limited evidence of Norwalk virus replication and packaging after 
transfection of cells with a full length clone (Asanaka et al., 2005). In 2006 an animal 
model for human caliciviruses was developed as HuCV demonstrated efficient 
infection in gnotobiotic pigs (Cheetham et al., 2006). In 2007 there was a report of a 
3-dimentional cell culture system that could support HuCV growth on an organoid 
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model of the human small intestinal epithelium (Straub et al., 2007). Despite these 
recent advances, FCV and MNV (Wobus et al., 2004) that can be propagated in cell 
culture are still the best readily available systems with which to study the basic 
mechanisms of viral genome translation and replication. MNV is the only norovirus 
that can replicate in a small animal model (mice) thereby boosting pathogenicity 
studies in noroviruses. Recently, a replicon system for Norwalk virus was developed, 
in which a self-replicating RNA representing the viral RNA was stably expressed in 
cells providing the first tool for the study of HuCV replication (Chang et al., 2006).  
 
1.3. Morphology and genome organisation 
 
 The particles (virions) of caliciviruses exhibit T=3 icosahedral symmetry 
and are 35-39nm in diameter (Prasad et al., 1999). Images taken by electron 
microscopy revealed small pits on the virus surface leading to the name calicivirus, 
from the Latin calyx (= cup) (Fig. 1.2a). However, the surface of Norwalk virus, in 
contrast to the other caliciviruses, seems to be less well defined by EM (Fig. 1.2b). X-
ray crystallography has also revealed the fine structure of the capsid from several 
        Figure 1.2. Calicivirus capsid morphology. (a.) Electron microscopy image of RHDV 
(microbes.otago.ac.nz) (b.) Electron microscopy image of Norwalk virus; bar = 50nm (www.epa.gov) 
(c.) X-ray crystallography structure of Norwalk virus  (Prasad et al., 1999). 
(a.)                                 (b.)                                   (c.) 
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members of the family as 180 copies of a single capsid protein, organised into 90 
dimers (Fig. 1.2c). In addition to the major capsid protein (VP1), two copies of the 
minor capsid protein (VP2) are present in each virion (Konig et al., 1998, Sosnovtsev 
& Green, 2000). More details about the capsid and receptor binding are discussed 
later in this chapter. 
 
       The capsid encloses the genome of the virus which is a positive sense RNA 
molecule of approximately 7.5 kb in length with a protein covalently linked to the 5’ 
end (VPg) and a poly(A) tail at the 3’ end. The genome is divided into three open 
reading frames (ORFs) flanked by two short untranslated regions (UTRs). The overall 
        Figure 1.3.  Graphic illustration of the coding region of representatives from the 
four calicivirus genera. The different open reading frames of all the viruses are presented; white for 
ORF1, grey for ORF2, blue for ORF3 and yellow for the additional ORF present in Manchester virus   
(reviewed by Atmar & Estes, 2001). In sapoviruses and lagoviruses ORF1 and ORF2 are fused but 
ORF2 is independent in the context of the subgenomic RNA. (* = potential ORF4 present in MNV) 
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structure of the genome is conserved in all the caliciviruses, with the only 
differentiation being the length of each ORF and the reading frame in which each 
ORF is encoded (Fig. 1.3). An additional ORF is predicted to exist in the Sapovirus 
genus (Manchester virus) and in the Norovirus genus (MNV), with the start codon 
very close to the N terminus of ORF2.  
 
 During the virus replication cycle, a subgenomic RNA is produced which 
encodes the major (VP1) and minor (VP2) capsid proteins (Fig. 1.4). This 
subgenomic RNA is 2.4 kb in length and shares the same 3’ UTR as the genomic 
RNA, from which it is produced. The sequences of the 5’ UTRs of the genomic and 
        Figure 1.4.  FCV and MNV Genomic and subgenomic RNAs. Graphic illustration of 
the genomic and subgenomic RNAs of FCV and MNV highlighting the proteins generated from the 
expression and processing of the three ORFs. Both RNAs in MNV and FCV have a VPg protein linked 
to the 5’ end of a short 5’UTR, while a poly(A) follows the 3’UTR. As the nomenclature in the 
bibliography is still obscure there are multiple designations for the different peptides. p5.6 – p76 is the 
nomenclature of FCV proteins (Sosnovtsev et al., 2002), 2B -3CD is the nomenclature according to the 
homology of the proteins in terms of function or genome position in picornaviruses and NS1-NS7 is the 
current nomenclature for the MNV proteins (Sosnovtsev et al., 2006). N-term = N-terminal peptide, Pro 
= protease, Pol= polymerase, VP1 = major capsid protein, VP2 =minor capsid protein, LC = premature 
leader-capsid  
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subgenomic RNAs are similar, signifying an involvement in a common mechanism. 
Similarly to the genomic RNA, the subgenomic RNA is covalently linked to VPg and 
has a poly(A) tail at the 3’ end. Encapsidation of the subgenomic RNA has been 
reported for RHDV (Meyers et al., 1991) and in a similar study on FCV, particles 
produced during a high multiplicity of infection, resulted in a subpopulation of lower 
density virions that were found to carry the 2.4 kb subgenomic RNA alone (Neill, 
2002). These findings suggest that encapsidation of the subgenomic RNA is a 
common phenomenon among caliciviruses. 
 
1.4. Viral proteins 
 
 Caliciviruses produce a large polyprotein from ORF1 that is processed by 
the viral protease to generate the mature non-structural proteins and a number of 
precursor proteins. For FCV the co-translational processing of the polyprotein yields 6 
proteins p5.6, p32, p39,p13, p30, p76 and a variety of precursor proteins (Sosnovtsev 
et al., 2002) (Fig. 1.4). For MNV, the processing of the polyprotein also yields 6 
proteins but with 2 main differences; p5.6 and p32 are merged to NS1-2, while p76 is 
split into NS6 and NS7 (Sosnovtsev et al., 2006). 
 
1.4.1. NS1 and NS2 
  
 The first non-structural peptides encoded in ORF1 of FCV are p5.6 and p32 
(NS1-2 for MNV). The RHDV 23-kDa protein is believed to be the analog of the 
FCV p32 protein and is predicted to have functional similarities with the 2B protein of 
picornaviruses. The picornavirus 2B protein contains hydrophobic membrane 
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association domains and is involved in the membrane rearrangements observed during 
infection. These rearrangements include vesicle formation and changes in the 
permeability of host cell membranes (Agirre et al., 2002). The FCV p32 protein has 
been found in the membranous replication complexes (Green et al., 2002), while the 
NV analog p48 interacts with VAP-A, a protein known to be involved in vesicle 
transport (Ettayebi & Hardy, 2003). Expression of p48 in cells disrupted vesicle 
transport and the Golgi apparatus (Ettayebi & Hardy, 2003, Fernandez-Vega et al., 
2004) 
 
1.4.2. NS3 (NTPase) 
 
 The FCV p39 protein (or MNV NS3) is predicted to possess an NTP-
binding domain similar to the conserved picornavirus 2C-NTPase. The 2C-like 
protein in RHDV and Southampton virus (Norovirus) has been shown to hydrolyse 
nucleoside triphosphates in vitro (Marin et al., 2000, Pfister & Wimmer, 2001). Co-
localisation of p39 with viral replication complexes is also indicative of a possible 
role in replication (reviewed by Sosnovtsev et al., 2002).  
 
1.4.3. NS4  
 
 The FCV p30 (MNV NS4) is predicted to have an amphipathic helix which 
may give membrane association properties (reviewed by Sosnovtsev et al., 2002). It is 
likely that p30 is functionally analogous to the 3A protein of picornaviruses, 
recruiting VPg to the membrane vesicles in the replication complexes (Green et al., 
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2002). In addition to its mature form, p30 is present as p30-VPg and p30-VPg-p76 
precursors during infection (Sosnovtsev et al., 2002).  
 
1.4.4. NS5 (VPg)  
 
 The FCV p13 or VPg protein is linked to the 5’ end of the genomic and 
subgenomic RNAs (Herbert et al., 1997). The linkage of VPg to the viral RNA is 
crucial for infectivity as treatment of the viral RNA with proteinase K leads renders 
the RNA non-infectious (Burroughs & Brown, 1978). In addition, mutations in VPg 
can result in a decrease or even complete loss of infectivity in the case of Tyr 24 
(Mitra et al., 2004). In vitro transcribed 5’ capped RNAs produced from a full length 
cDNA clone of FCV are  infectious when transfected into cells (Sosnovtsev & Green, 
1995). These observations led to the speculation that VPg might be involved in the 
initiation of the translation in caliciviruses. The translation initiation factor eIF3 has 
been demonstrated to interact with the Norwalk virus VPg protein using the yeast 
two-hybrid system and in vitro binding assays (Daughenbaugh et al., 2003). 
Furthermore, the translation initiation factor eIF4E interacts with the Lordsdale virus 
(HuCV) and FCV VPg proteins. Inhibition of eIF4E activity was found to impede 
FCV translation in vitro confirming a functional role for the VPg:eIF4E interaction 
(Goodfellow et al., 2005). MNV-1 VPg also interacts with eIF4E, although 
sequestration of eIF4E did not inhibit in vitro translation of MNV VPg-linked RNA 
(Chaudhry et al., 2006). It has been speculated that eIF3 bridges the interaction of 
eIF4G with MNV VPg, as the domain of eIF4G which interacts with eIF4E is not 
required in MNV translation (Chaudhry et al., 2006).  
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1.4.5. NS6 and NS7 (Protease and Polymerase) 
 
 The p76 protein is the homolog of the picornaviral 3CD protein and has two 
distinct regions relative to their function. The first half has been characterised as a 
trypsin-like serine protease and is related to the picornaviral 3C protease (and as such 
is named 3C-like protease). The second half is the viral RNA-dependent RNA 
polymerase (RdRp) related to the picornaviral 3D polymerase. In contrast to the FCV 
protein, in RHDV (Martin Alonso et al., 1996), NV (Blakeney et al., 2003) and MNV 
(Sosnovtsev et al., 2006) the protease-polymerase protein is further processed and the 
two functions are separated into two distinct proteins (NS6 and NS7). 
 
 The 3C-like protease has been characterised in NV, RHDV and FCV. In NV 
the protein has been characterised in vitro as both a cis and trans acting protease 
(Blakeney et al., 2003) with high substrate specificity (Someya et al., 2000). In 
RHDV and FCV, mutagenesis of the cleavage sites demonstrated a high substrate 
specificity and that the 3C-like protease is the only protease required for complete 
processing of the polyprotein (reviewed by Clarke & Lambden, 1997, Sosnovtsev et 
al., 2002). The 3C-like protein, in addition to the processing of the polyprotein, is 
thought to inhibit cap-dependant protein synthesis by cleavage of the eukaryotic 
initiation factor eIF4G (Willcocks et al., 2004) and poly(A)-binding protein 
(Kuyumcu-Martinez et al., 2004).  
 
 The p76 protein (3CD) also possesses RNA-dependent RNA polymerase 
(RdRp) activity in the 3D-like domain of the protein. The RdRp activity, as 
mentioned above, is separated from the protease activity in RHDV and NV during 
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polyprotein processing. However, in FCV, despite the existence of minor cleavage 
sites between protease and polymerase, the active form of the RdRp and the only form 
found during the infection, is full-length p76 (Wei et al., 2001). In noroviruses the 
separated polymerase moiety retains the RdRp activity (Belliot et al., 2005). 
Norovirus and Sapovirus RdRp have been shown to act in a primer independent 
manner and are capable of de novo initiation (Fukushi et al., 2004, Fullerton et al., 
2007). Crystal structures are now available for a number of the calicivirus RdRp’s and 
that they look similar to other RdRps (Ng et al., 2002).  
 
1.4.6. VP1 (major capsid protein)  
 
 The second ORF (ORF2) codes for the major capsid protein (VP1) and is 
thought to be produced from the subgenomic RNA alone. However, in lagoviruses 
and sapoviruses a portion of capsid is produced from the genomic RNA as ORF2 is 
fused to ORF1 giving a polyprotein that contains non-structural proteins and the 
major capsid protein (Clarke & Lambden, 1997). The capsid protein, as mentioned 
above, forms dimers that can be assembled to form the viral particle (90 dimers) in the 
absence of either RNA or other viral proteins (Bertolotti-Ciarlet et al., 2002). In FCV 
only, the capsid protein contains a leader peptide (leader of the capsid or LC) at its N 
terminus that is cleaved by p76 to give the mature capsid protein. The structure of the 
capsid protein, as determined using VLP’s, demonstrates that VP1 can be divided into 
two domains, S and P (Prasad et al., 1999). The S domains interact with each other to 
form the major contacts between the subunits, while the P domains protrude from the 
surface forming cup like structures on the surface of the virion. The two domains are 
separated by a flexible hinge (Prasad et al., 1999). The P domain is further divided 
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into P1 and P2, while P2 is the most variable region of the capsid and the determinant 
of the species-specific binding to the respective receptor (Tan et al., 2004).  
 
1.4.7. VP2 (minor capsid protein)  
 
 The third ORF (ORF3) of FCV codes for a small protein (VP2) of unknown 
function. The protein is basic leading to the speculation that it may interact with 
nucleic acids. This hypothesis, along with the observation that the inner surface of the 
virion is rather acidic, has led to the idea that VP2 may contribute to the encapsidation 
of the viral RNA (reviewed by Glass et al., 2000), however no direct evidence for 
such a role has been reported as yet. The VP2 protein of Norwalk virus, expressed 
from baculovirus in insect cells, exists in two forms, both phosphorylated (35 kDa) 
and non-phosphorylated (23 kDa). Only 1 or 2 copies of the protein are present in 
each particle (Glass et al., 2000, Glass et al., 2003). VP2 protein has been shown to 
stabilise VLPs when VP1 and VP2 are co-expressed in the baculovirus system, while 
VP2 also protects VLPs from proteolytic degradation (Bertolotti-Ciarlet et al., 2003). 
A two hybrid screen also confirmed an interaction between VP2 and VP1 (Kaiser et 
al., 2006). Finally, VP2 protein is required for the production of infectious FCV 
particles and for virus replication (Sosnovtsev et al., 2005). 
 
1.5. Virus life cycle 
 
 Very little is currently known about the life cycle of caliciviruses and most 
of our knowledge is inferred from our current understanding of other related positive 
strand RNA viruses, such as picornaviruses. The virus life cycle begins with the 
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attachment of the particle to specific receptors, which in some cases is a carbohydrate 
moiety, on the membrane of the host cells. NV infection has been associated with 
ABO histo-blood group type (Hennessy et al., 2003) as Norwalk virus can bind the 
human ABO, Lewis and secretor histo-blood group antigens (Huang et al., 2003). 
During experimental human infections a proportion of individuals were found to be 
resistant to NV infection (Lindesmith et al., 2003). This resistance was later attributed 
to a mutation in α(1,2)-fucosyltranferase (FUT2) gene (Thorven et al., 2005), which 
regulates the expression of ABH antigens in saliva, mucosal tissues and secretions. 
Feline junctional adhesion molecule 1 (JAM-1) was recently identified as a receptor 
for FCV (Makino et al., 2006). Expression of JAM-1 in non permissive hamster lung 
cells led to infection by a variety of FCV strains (Makino et al., 2006). Studies also 
suggest that α2,6-linked sialic acid may play a role in virus binding (Stuart & Brown, 
2007). 
 
 After the attachment to the cell surface, the viral RNA is released in the 
cytoplasm where it is recognised by the translation system of the cell. VPg acts as a 
cis-acting translation element that by interaction with translation initiation factors 
leads to the recruitment of the ribosome. This leads to the translation of the first ORF 
(ORF1) of the genomic RNA. ORF1 codes for the viral polyprotein which, in the case 
of Sapporo virus and RHDV includes, at its C terminus, the capsid protein. However, 
in the case of FCV, the ORF1 polyprotein stops at the end of the RdRp. The 
polyprotein is subsequently cleaved by the 3C-like protease of the virus first in cis, as 
it is part of the polyprotein, and then in trans producing the mature viral proteins 
(Sosnovtsev et al., 2002). 
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        Figure 1.5. Virus induced 
vesicles. Vesicles (arrow) produced 
during replication of FCV in CRFK 
cells (Green et al., 2002)  
 The non-structural proteins cause 
rearrangements in the cellular membranes that 
lead to the formation of vesicles, similar to 
those observed during poliovirus infection (Fig. 
1.5). The replication complexes are formed on 
these vesicles and produce, via a negative strand 
RNA intermediate, new positive strand RNAs. 
All the viral proteins, structural and non-
structural, and their precursors have been 
detected in these replication complexes. In 
addition to the newly synthesised genomic RNA, subgenomic RNA is also formed 
during genome replication. Both have negative sense RNA intermediates as two 
species of negative sense RNA can be detected by Northern blot in purified FCV 
replication complexes (one at ~8 kb and the other at ~2.5 kb) (Green et al., 2002). 
 
 The mechanism which caliciviruses use for subgenomic RNA synthesis is 
not known, however two mechanisms have been proposed. The first one implicates 
premature termination of the negative sense RNA synthesis that then serves as a 
template for the subgenomic RNA synthesis. The second is based on an internal 
initiation mechanism that utilizes a full length antisense genomic RNA and a cis-
acting RNA element that is recognised by RdRp. The initiation of positive sense 
subgenomic RNA synthesis would occur in the region upstream of the ORF2 
initiation codon. Deletion analysis has shown that the RHDV RdRp requires 50 bases 
upstream of the start of subgenomic RNA sequence in order to produce RNA with the 
same size as the subgenomic RNA in vitro. The above result infers the existence of a 
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cis-acting RNA element that initiates the subgenomic RNA synthesis on the negative 
sense genomic RNA (Morales et al., 2004).  
 
 The replication of the subgenomic RNA is followed by its translation, again 
through VPg-dependent translation initiation. ORF2 is translated to produce the 
capsid protein with the leader peptide attached to the N terminus in the case of FCV. 
This leader peptide is subsequently removed by the viral protease to produce the 
mature capsid protein. A termination reinitiation mechanism has been proposed for 
the translation of ORF3 (VP2) in RHDV, as the stop codon of ORF2 is required for 
the efficient initiation of ORF3 translation (Meyers, 2003). Also, some sequence 
elements upstream of ORF3 (in ORF2) are required for ORF3 translation as any RNA 
with less than 100 nt preceding ORF3 can not express ORF3 (Meyers, 2003). 
Subsequent analysis of the synthesis of VP2 in FCV revealed an identical termination 
reinitiation mechanism (Luttermann & Meyers, 2007). Furthermore, two sequence 
motifs, referred to as TURBSs (termination upstream ribosomal binding sites)  
essential for reinitiation were identified upstream of ORF3 one of which is conserved 
among caliciviruses and is complementary to part of the 18S rRNA (Luttermann & 
Meyers, 2007) Fig. 1.6. 
 
 
  
 
 
 
 
 caugggaau           uga 
                    aug 
ORF3 
51nts
ORF2 
guacccuua 
18s rRNA   
Figure 1.6. Termination reinitiation for translation of ORF3. The junction region between 
ORF2 and ORF3 of FCV, where the termination reinitiating takes place. ORF2 stop codon and  the 
ORF3 start codon as well as the sequence complementary to the 18s rRNA are highlighted (Luttermann 
& Meyers, 2007). 
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 The last step of the virus life cycle is the production of new virus particles. 
The genomic RNA, and in some cases the subgenomic, is encapsidated possibly with 
the help of VP2 (Glass et al., 2000). Progeny FCV viruses have been reported to arise 
as early as 30 minutes post infection (reviewed by Green et al., 2002). It is thought 
that the newly assembled particles are then released during the virus induced cell 
lysis.   
 
1.6. RNA as a functional molecule 
 
 
Until twenty years ago the view of an RNA was that of a passive information 
carrying molecule (mRNA) or part of the protein-synthesis machinery, either 
transferring the amino-acids (tRNA), or providing a scaffold for the ribosomal 
proteins (rRNA). During the 1980s, revolutionary discoveries in the biology of RNA 
pointed towards a new era where RNA was found to play a central role in the 
regulation of all cellular mechanisms due to its ability to form functional complex 
structures. Findings such as the autocatalytic excision of an intervening sequence in 
Tetrahymena’s 26S rRNA (Kruger et al., 1982) , and the ribozyme activity of RNase 
P (Guerrier-Takada et al., 1983) were some of the first discoveries in this new era for 
the RNA. The propensity of RNA to form complex higher order structures can be 
only compared with the folding ability of proteins (Storz et al., 2005). Since the 
discovery of the first functional RNA structures a cascade of identifications of new 
functional RNA molecules took place. siRNAs (small interfering RNAs) (Fire et al., 
1998), miRNAs (micro RNAs) (Lai, 2002), snRNAs (small nuclear RNAs) and 
snoRNAs (small nucleolar RNAs) (Storz et al., 2005) were found to regulate gene 
expression and alternative splicing. The peptidyltransferase activity of ribosomes was 
                                   38
found to be situated in the RNA moiety (Nissen et al., 2000) placing the ribosome in 
the growing list of enzymaticaly active RNAs, the ribozymes. 
 
Most of the RNAs described above have evolved their structures in order to 
interact with proteins and in most cases the function of these RNAs is only apparent 
as part of a specific ribonucleoprotein complex (RNP). An obvious transition towards 
more complicated RNPs is the evolution of RNase P. The RNase P RNP complex 
consists of an RNA molecule and an increasing, on the evolutionary ladder, number 
of proteins: 1 in bacteria, 4 in archaea, 9 in yeast, and 10 in mammalian RNase P. The 
most important finding though is the relative dependence of the enzymatic activity on 
the protein moiety. The RNA moiety in bacteria is active in the absence of protein, 
while its activity in archea is reduced and drops dramatically in eukaryotic RNase P 
(Kikovska et al., 2007).  
 
 Higher life forms have developed more complex networks for regulating gene 
expression. A big part of this transition resides in the increase of functional RNA 
molecules (Mattick, 2001). Genes in eukaryotic organisms contain more of, what 
were thought to be, “junk” sequences (Mattick, 2004). Recently it was made obvious 
that these sequences are part of a regulatory interaction network that acts, in part, at 
the RNA-protein interaction level. These sequences code for small functional RNAs 
(Lai, 2002) or alternative splicing regulators (Singh, 2002) and untranslated regions 
(UTRs) in the mRNAs that regulate the export from the nucleus, localization in the 
cytoplasm and translational control (Jansen, 2001, Kozak, 2005). 
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 The sequences flanking the coding region of a eukaryotic mRNA (and to a 
lesser extent of the prokaryotic) contain regulatory structures recognized by a variety 
of proteins or even by other RNAs (Staton et al., 2000, Jansen, 2001, Kozak, 2005, 
Ciesla, 2006). The presence of these regulatory structures on every mRNA signifies 
their important role in the regulation of gene expression. Some of the best studied 
functional RNA elements are the AU-rich elements (ARE) and the iron responsive 
element (IRE) that are present in a variety of mRNAs.  
 
1.6.1 AU-rich elements (AREs) 
  
AU-rich elements were first identified in the 3’ UTR of tumour necrosis factor 
(TNF) mRNA (Caput et al., 1986). The AU rich sequence (UUAUUUAU) was 
conserved between human and murine TNF mRNAs while it was present in variety of 
others including the mRNA for human and mouse interleukin 1, human and rat 
fibronectin, and most of the sequenced human and mouse interferons (Caput et al., 
1986). Since then, the list of mRNAs containing AREs has grown enormously and it 
is now estimated that 5–8% of human mRNAs contain AREs (reviewed by Barreau et 
al., 2005).  AREs are usually 50–150 nts in length and regulate the stability of an 
mRNA. When the ARE motif of the 3' UTR of human granulocyte-macrophage-
colony-stimulating factor (GM-CSF) mRNA was inserted into the 3' UTR of β-globin 
mRNA the later was destabilized, despite the fact that it is naturally a very stable 
mRNA (Shaw & Kamen, 1986). The regulation of mRNA stability by AREs is 
mediated by the control of length of the 3’ poly(A) tail. Shortening of the poly(A) tail 
of c-fos mRNA, rapidly increased its degradation, leading to reduced protein 
production (Chen & Shyu, 1994). AREs are binding targets for a variety of RNA-
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binding proteins with one of the best studied examples being the mRNA stability 
regulation by the proteins Hu and AUF1 (or hnRNPD). HuR (member of Hu family) 
increased the stability of p21 mRNA by binding to its ARE (Wang et al., 2000), while 
binding of  AUF1 to mRNAs triggered their degradation (DeMaria & Brewer, 1996). 
Amongst the proteins that have been identified to interact with AREs are 
polypyrimidine tract binding protein (PTB or hnRNPI) and hnRNPC (Hamilton et al., 
1993), T cell intracellular antigen-1 (TIA-1) with its related protein TIAR (Piecyk et 
al., 2000), and a number of RNA-binding metabolic enzymes such as glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH) and enoyl-CoA 
hydratase (reviewed by Ciesla, 2006). The wide distribution of AREs in the 
transcriptome and the regulation of high importance aspects of the cell biology by 
ARE-binding proteins signify the importance of these elements.    
 
1.6.2. Iron response elements (IREs) 
 
 Some of the most conserved RNA structures in eukaryotic cells are the iron 
response elements (IREs). IREs are hairpin structures located at the 5’ or 3’ end of 
mRNAs involved in the iron homeostasis of the cell, regulating their expression 
(Thomson et al., 1999). The loop of the hairpin, usually consisting of 5-6 nucleotides 
(CAGYGX)1, and a single nucleotide cytosine bulge at the 5’ part of the stem are the 
most conserved parts of the structure. Regulation via IREs is mediated by the 
interaction of the RNA element with the iron regulatory proteins 1 and 2, (IRP1 and 
IRP2) in responce to the levels of iron in the cell. Binding of IRPs to the IRE is 
induced under low intracellular iron concentration while high levels of iron inhibit the 
                                                 
1  Y = C or U and X any nucleotide expect for G 
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interaction (Thomson et al., 1999) (Figure 1.7). When the IRE is situated at the 5’ 
UTR of an mRNA, like the mRNAs for H (heavy) and L (light) ferritin subunits, the 
interaction of the IRE with IRP1 or 2 with the IRE prevents the formation of the 43s 
translation initiation complex (Goessling et al., 1998) (Figure 1.7). The inhibition is 
thought to involve sterical blocking of access to the 5’ cap by the translation initiation 
cap-binding complex eIF4F (Muckenthaler et al., 1998). A different effect is observed 
when the IREs are situated at the 3’UTR of the mRNA. The 3’UTR of transferrin 
receptor (TfR1) mRNA encompasses 5 IREs able of binding IRP1/2 (Erlitzki et al., 
2002).  In this instance binding of IRPs prevents degradation of the mRNA by an 
endonuclease, increasing the half-life of the mRNA and thus its translation efficiency 
(Erlitzki et al., 2002, Rouault, 2006) (Figure 1.7). 
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Figure 1.7. Iron responsive elements. The role of  IREs in the regulation of ferritin and 
transferrin receptor mRNA translation depending on the intracellular levels of iron (Fe2+)  (Rouault, 
2006) 
                                   42
 The regulation of important processes, such as those described above, by RNA 
structures and RNA-binding proteins, as well as the variety of genetic diseases 
associated with specific RNA protein interactions (Bakheet et al., 2001, Hollams et 
al., 2002, Rouault, 2006) signify their central role in the regulation of post 
transcriptional gene expression.  
 
1.7. RNA structures in (+) sense RNA viruses 
 
1.7.1. IRESs 
  
It is well established that at the initial stages of infection the genomes of 
positive sense RNA viruses must be recognised by the host cell translational 
machinery in order to generate the proteins essential for virus replication. Different 
positive strand RNA viruses have evolved a variety of mechanisms to exploit the 
translation machinery of the cell. Some viruses have become adapted to the use of 
normal cap-dependent translation of the host cell e.g. rotaviruses (Vende et al., 2000) 
and some flaviviruses (West Nile virus; Ray et al., 2006), while others have 
developed alternative methods such as the VPg-dependent translation of caliciviruses 
(Chaudhry et al., 2006) and the internal ribosomal entry site (IRES) dependent 
translation of picornaviruses and hepatitis C virus (HCV) (Jang, 2006). 
 
 IRESs are RNA structures present in the 5’ UTRs of a number of viral and 
cellular mRNAs which lead to the placement of the 40s ribosomal subunit at the 
correct site to allow protein synthesis initiation (Baird et al., 2006). The recruitment of 
the 40s ribosomal subunit to the IRES is accomplished through the direct interaction 
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of the IRES with several canonical translation initiation factors including eIF2, eIF3, 
eIF4A, eIF4B, eIF4E and eIF4G,  often with the assistance of non-canonical 
translation factors or IRES trans-acting factors (ITAFs) (reviewed by Jackson, 2005). 
The only known IRES to differ from this norm is the Cricket paralysis virus (CrPV) 
IRES which is able to bind the ribosome directly via a t-RNA like domain and 
promote an initiation factors independent translation initiation (Jan & Sarnow, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8.  Structures of picornaviral IRESs. Graphical illustration of the two main types of 
internal ribosomal entry sites (IRESs) found in picornaviruses. The nomenclature of structural domain 
is presented above each stem-loop. I – VI for type I and A – L for type II. AUG is the initiation codon 
and poly(C) is the poly-cytosine stretch present in type II IRESs. (Adapted from Jang, 2006) 
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The encephalomyocarditis virus (EMCV) IRES was the first to be discovered 
and characterised using the dicistronic translation assay where two reporter genes are 
expressed from the same mRNA, the first under cap-dependent translation and the 
second under IRES-dependent translation (Pelletier & Sonenberg, 1988). Soon after it 
became obvious that all picornaviruses contain an IRES element in their 5’ UTRs 
(Jackson, 2005). Using phylogenetic and biochemical analysis picornavirus IRESs 
can be divided into two groups: type I IRESs, which  includes the enterovirus and 
rhinovirus IRESs (Fig. 1.8) and type II, which includes the cardiovirus (e.g. EMCV), 
aphthovirus (e.g. foot and mouth disease virus or FMDV), and hepatovirus IRESs 
(e.g. HAV) (Fig. 1.8) (Jang, 2006).   
 
 
Several stem loop elements of the picornaviral IRESs have been shown to 
interact with the canonical and non canonical translation factors. For example, eIF4G 
and eIF4B interact with stem loop V of the poliovirus IRES (Fig. 1.8) (Ochs et al., 
2002). Disruption of the interaction between stem loop V and eIF4G by a mutation in 
the IRES of Sabin type 1 poliovirus vaccine strain resulted in impaired translation 
efficiency, that conferred the attenuated phenotype of the strain (Ochs et al., 2003). 
Similar requirements have been demonstrated for the type II IRESs. The J/K elements 
of EMCV IRES recruit eIF4A (Kolupaeva et al., 1998), while  the interaction of 
eIF4A with eIF4G increases the affinity of eIF4G for the EMCV IRES (Lomakin et 
al., 2000) A structural rearrangement of the downstream RNA structures induced by 
eIF4G/eIF4A binding is thought to be required for the efficient recruitment of the 
ribosome (Kolupaeva et al., 2003).  
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 The picornavirus IRESs which have been extensively studied, all interact with 
a variety of non-canonical translation factors (or IRES trans-acting factors, ITAFs). 
ITAFs are usually members of the heterogeneous nuclear ribonucleoprotein (hnRNP) 
family of RNA binding proteins involved in post transcriptional control of mRNAs 
(discussed in more detailed later). Initial studies using RRLs to study IRES function 
indicated that additional supplementary factors were required for efficient translation 
initiation in enteroviruses and rhinoviruses ( Dorner et al., 1984, Borman et al., 1993). 
The stimulatory ITAFs, include the polypyrimidine tract binding protein (PTB), 
poly(rC) binding protein (PCBP), the Lupus autoantigen (La) and the upstream of N-
ras protein (unr). PTB has been shown to bind the EMCV, poliovirus, FMDV and 
rhinovirus IRESs (Kaminski et al., 1995, Hunt & Jackson, 1999, Back et al., 2002a).  
Poliovirus IRES activity is greatly dependent on PTB and proteolytic cleavage of the 
protein, as occurs late in the infection, reduces significantly the translation efficiency 
(Back et al., 2002a). Interestingly the attenuation of the poliovirus type 3 Sabin 
vaccine strain has been attributed to the reduced affinity of its IRES for the neuronal 
variant of PTB (nPTB) (Guest et al., 2004). PTB was shown to be required for the 
translation initiation from the FMDV IRES as it was found to bind simultaneously to 
the H and the J/K/L stem loop elements using different RNA binding domains (Song 
et al., 2005). A rather complicated situation has been described with regards to the 
role of PTB binding to the EMCV IRES. Initially, it was thought that PTB was 
required for the translation initiation from the EMCV IRES  as its activity in the 
established dicistonic reporter system was dependent on PTB (Kaminski et al., 1995). 
However, further studies revealed that the sequences downstream of the IRES were 
determining the requirement for PTB and that in its natural context, the IRES was 
rather PTB independent (Kaminski & Jackson, 1998). The importance of the size of 
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an oligo-adenine RNA bulge was raised by the authors and that the maintenance of a 
higher order RNA structure was found to determine the requirement for PTB. Both 
findings pointed towards an RNA chaperone activity of PTB on the IRES function.  
 
 Further work on ITAFs demonstrated that the La protein was required for 
efficient translation from the poliovirus IRES as addition of La to in vitro translation 
systems resulted in stimulation of IRES activity and reduced production of aberrant 
translation initiation products (Meerovitch et al., 1993). The poliovirus IRES 
demonstrated a requirement for PCBP (Walter et al., 2002), while the unr protein was 
found to be required for the translation initiation from type I IRESs but not type II 
IRESs (Boussadia et al., 2003). Another factor called ITAF45 or ebp1 is required for 
the efficient translation initiation from the FMDV IRES (Pilipenko et al., 2000). 
Despite the fact that ITAF45 displayed similar affinities for both the EMCV and 
FMDV IRESs, siRNA mediated knockdown had no effect on the EMCV IRES 
(Monie et al., 2007). 
  
An important common structural element of the picornavirus IRESs is the 20-
nucleotide long polypyrimidine (Yn) tract downstream of the structural elements 
which bind the canonical translation initiation factors (stem loop V for type I IRESs 
and stem loops J, K and L for type II IRESs) (Fig. 1.8). The length of this Yn track 
and the nucleotides between Yn and the start codon have been shown to be important 
for the function of the IRES (Jang & Wimmer, 1990, Pilipenko et al., 1992). 
 
 Another IRES element is present in the hepatitis C virus (HCV) 5’UTR which 
is substantially different from that found in picornavirus IRESs. Only porcine 
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teschovirus IRES, a newly identified picornavirus, has a remarkably similar structure 
to HCV and is speculated that it was the result of an interspecies recombination event 
(Pisarev et al., 2004). HCV IRES is closely related structurally and functionally to the 
pestivirus IRES (Pestova et al., 1998, Fletcher & Jackson, 2002). In contrast to 
picornavirus IRESs, the HCV IRES is independent of the eIF4 factors. Cryo electron 
microscopy reconstruction of HCV IRES with the 40s ribosomal subunit confirmed a 
direct interaction (Spahn et al., 2004). However, it is believed that interaction of the 
HCV IRES with eIF3 enhances the formation of the initiation complex (Spahn et al., 
2001).  Interestingly most of the ITAFs found to interact with picornaviral IRESs also 
interact with the HCV IRES (Lu et al., 2004). The La protein enhances HCV 
translation by binding to the initiation codon and neighbouring sequences (Ali & 
Siddiqui, 1997, Costa-Mattioli et al., 2004). The role of PTB in HCV translation is 
rather unclear. Early experiments on HCV IRES activity showed that 
immunodepletion of PTB from rabbit reticulocyte lysates resulted in a reduction in 
translation efficiency from the HCV IRES (Ali & Siddiqui, 1995). However, addition 
of recombinant PTB failed to reverse the effect of depletion, signifying that factors 
associated with PTB may be responsible for the reduction of translation efficiency 
(Ali & Siddiqui, 1995). Further experiments using RNA aptamers designed against 
PTB showed a reduction in HCV IRES driven translation, recovered by addition of 
recombinant PTB (Anwar et al., 2000). Importantly, in the same publication the 
authors supported the in vitro results by in vivo data. Recently, however, the situation 
has become more complicated as results using different approaches contradicted the 
initial view of the PTB requirement in HCV translation. Overexpression of PTB in 
cells inhibited the translation from the HCV IRES, while expression of the antisense 
RNA for PTB gene reduced the levels of PTB and stimulated HCV translation 
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(Tischendorf et al., 2004). The different results produced using different constructs 
demonstrated the need of a natural context in which HCV IRES activity can be 
assessed. Also, the above studies revealed the potential involvement of more RNA 
elements in the regulatory mechanism of HCV translation such as the X region of the 
3’ UTR that is discussed in more details later. 
 
 
 
. 
 
 
 
 
 
 
 
1.7.2. Other structures involved in viral translation 
 
A feature common among mRNAs and viral RNAs is the existence of specific 
RNA elements, usually at the 3’ end of the RNA, which function as cis-acting 
regulators of translation. A well known example is the so called “X” region situated at 
the 3’end of the HCV genome which stimulates IRES driven translation (Ito et al., 
1998). This region is comprised of 98 nucleotides, is highly conserved among HCV 
strains and forms 3 stem loop structures which interact with a variety of proteins 
(Tsuchihara et al., 1997). Addition of this element to the 3’end of constructs 
Coding region 
5’ 
3’ 
 U/C      SL1   
 
 
         SL2 
 
       SL3 IRES 
X region 
                     III 
 
               II 
 
 
 
       I 
Figure 1.9.  Structures of hepatitis C virus genomic RNA. Graphic representation of the 
HCV genomic RNA highlighting the IRES and the 3’ end X region.  Structural domains of the 5’ end 
I, II and III as well as the three 3’ stem loops SL1, SL2 and SL3 are represented.  U/C = 
polypyrimidine tract 
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expressing a reporter under the control of the HCV or EMCV IRES, stimulated 
translation (Ito et al., 1998). In the same report, deletion of the PTB binding site in the 
X region hampered its stimulatory role  (Ito et al., 1998). Recent studies have added a 
further level of complexity to the role of PTB in HCV translation; a pyrimidine rich 
stretch in the core-coding region of HCV, with high affinity for PTB, was shown to 
inhibit HCV translation while addition of the X region to the 3’ end of the transcripts 
restored the translation efficiency (Ito & Lai, 1999). Subsequent reports using 
different systems also produced contradicting results. Whilst some groups agreed that 
the X region stimulated the HCV IRES mediated translation (Michel et al., 2001, 
McCaffrey et al., 2002) others argued that the X region had no effect (Fang & Moyer, 
2000, Friebe & Bartenschlager, 2002). There was even a report claiming that the X 
region (or rather the SL3 part of it) had an inhibitory effect on HCV translation 
(Murakami et al., 2001). However, recently, an extensive analysis using a variety of 
methods and constructs concluded that the result varied with different approaches. A 
precise 3’ terminus was a key factor for the effect observed, while the U/C rich stretch 
before just before X region and the 1st stem loop were mostly responsible for 
stimulation (Song et al., 2006). A remarkable result came from the in vivo 
experiments included in the same report as they observed that stimulation of HCV 
IRES-dependent translation by the 3’ UTR was only obvious in hepatoma cell lines 
such as Huh-7 and HepG2 cells, indicating a role for a cell specific factor (Song et al., 
2006). This observation adds to the accumulated evidence towards the importance of 
RNA-protein interactions in viral tropism. However, the role of PTB is still obscure 
while the protein required to bridge the interaction between 5’ and 3’ UTRs is 
unknown. 
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1.7.3. RNA structures involved in viral replication 
 
 A crucial step in the life cycle of positive stranded RNA viruses is the 
switch from translation to replication. This transition is very important as translation 
proceeds in a 5’ to 3’ direction while the synthesis of the negative strand RNA 
proceeds in 3’ to 5’ direction. This conflict, which favours the more robust ribosome, 
inhibits replication (Gamarnik & Andino, 1998, Barton et al., 1999). Poliovirus, 
which is arguably the best studied positive stranded RNA virus, has provided the best 
example of such regulation. The poliovirus 3CD protein, a homologue of the FCV 
p76 protein, was found to participate in the formation of a ribonuleoprotein (RNP) 
complex on the cloverleaf structure of the poliovirus 5’UTR. In addition to 3CD, this 
RNP complex was found to contain a 36 kDa cellular protein (Fig. 1.6) (Andino et al., 
1993) which was subsequently identified as the PCBP2 protein (Parsley et al., 1997). 
The interaction of 3CD with the 5’cloverleaf (5’CL) was found to increase the affinity 
of PCBP2 for the 5’ CL (Walter et al., 2002). The proposed hypothesis is that 
increasing amounts of 3CD produced by viral RNA translation trigger the 
displacement of PCBP2 from the IRES (Perera et al., 2007). 3CD assists binding of 
PCBP2 to the 5’CL where it promotes the interaction between the 5’CL and the 
3’UTR through a 3CD/PCBP-3CD/PABP protein bridge (Barton et al., 2001, Herold 
& Andino, 2001). This interaction induces the negative strand RNA synthesis after the 
3’UTR bound 3CD is cleaved to 3Dpol which is the active polymerase (Gohara et al., 
2000). This interaction was also shown to be required for VPg uridylation thereby 
providing the protein primer for the negative strand RNA synthesis (Lyons et al., 
2001), while evidence suggest that the same complex decreases the sensitivity of the 
RNA to RNases (Barton et al., 2001).  
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 There is currently limited data on the transition from translation to 
replication in other animal positive-strand RNA viruses. A similar end to end 
interaction through a protein bridge has been suggested to be a possible trigger of the 
switch in HCV (Song et al., 2006). Down-regulation of HCV translation by the core 
and/or NS5A protein may also be part of the mechanism (Zhang et al., 2002, 
Kalliampakou et al., 2005). 
 
 
 
 
 
 
 
 
 
 
1.8. Host RNA-binding proteins 
  
 The recruitment of host cell proteins is a general observation in all studied 
RNA viruses and is believed to occur mainly due to the evolutionary need of these 
viruses to keep the size of their genome small. PTB, PCBP and La, as mentioned in 
the previous section, have been extensively studied as they have been found to 
interact with a number of viral RNAs (Hellen et al., 1993b, Ali & Siddiqui, 1995, 
Gamarnik & Andino, 1998). 
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                                                         3CD 
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Figure 1.10.  End to end interaction of poliovirus RNA. Graphic representation of the 
3CD/PCBP-3CD/PABP protein bridge between 5’ and 3’ UTRs that triggers the initiation of the 
negatives strand RNA synthesis in polioviruses (Barton et al., 2001, Herold & Andino, 2001)  
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1.8.1 Polypyrimidine tract binding protein (PTB) 
 
 Polypyrimidine Tract Binding protein (PTB), also known as hnRNP-I, has 
four RNA recognition motifs (RRMs) and four variants; PTB-1,-2,-4 (Fig. 1.11) and 
neuronal PTB (nPTB). The major physiological role of PTB is to regulate the 
alternative mRNA splicing of a variety of mRNAs. PTB acts as a splicing repressor 
by excluding selected 3’ splice sites during mRNA maturation (Valcarcel & Gebauer, 
1997). PTB negatively regulates the splicing of a plethora of mRNAs, such as γ2 
subunit of the GABAA receptor (Ashiya & Grabowski, 1997), α-actinin (Southby et 
al., 1999), Fas (Izquierdo et al., 2005) and FosB (Marinescu et al., 2007). This exon 
exclusion is mediated by the competition of PTB with other splicing regulating 
proteins. For example, during the regulation of Fas mRNA splicing, TIA-1 protein 
recruits the U1 snRNP that induces the exon exclusion, while competition of TIA-1 
binding on the RNA by PTB inhibits the splicing (Izquierdo et al., 2005). However, in 
the case of calcitonin and calcitonin gene-related peptide mRNAs, PTB has been 
shown to act as a positive regulator of the exclusion of a 3’-terminal exon (Lou et al., 
1999). Involvement of PTB in the regulation of RNA polyadenylation (Lou et al., 
1999), localisation (Cote et al., 1999) and stability (Pautz et al., 2006) have also been 
reported. The localisation of PTB is mainly nuclear, concentrated in the perinucleolar 
compartment, but under certain circumstances it may appear in the cytoplasm 
shuttling between cytosol and the nucleus (Kamath et al., 2001). Alteration of the 
nuclear pore permeability and composition during poliovirus (Gustin & Sarnow, 
2001) and rhinovirus (Gustin & Sarnow, 2002) infection has been shown to induce the 
flow of nuclear proteins to the cytoplasm, while protein kinase A (PKA) 
phosphorylation of PTB at Ser-16 results in the redistribution of PTB to both nucleus 
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Figure 1.11.  Polypyrimidine tract binding protein alternative splicing variants. The 
main PTB variants PTB1, 2 and 4. The 4 RNA recognition motifs (RRMs) and the nuclear 
localisation signal (NLS) are depicted (Wagner & Garcia-Blanco, 2001)  
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and cytoplasm (Xie et al., 2003). The phosphorylation state of PTB is very likely to 
play a role in the cytoplasmic function of PTB as phosphorylated PTB has been found 
to be associated with HCV replication complexes (Chang & Luo, 2006). PTB binds 
short, single strand polypyrimidine motifs such as UCUU, UCUUC, UUCUCU or 
CUCUCU and it is believed to have a chaperone activity, stabilising a functional 
RNA conformation (reviewed by Simpson et al, 2004). Binding of PTB and PCBP1 to 
the IRES present in Bag-1 mRNA results in a conformational change in the IRES 
which induces ribosome recruitment (Pickering et al., 2004).  
 
 
 
 
 
 
 
 
 
 PTB protein has been found to interact with the RNA of a variety of positive 
strand-RNA viruses. The interaction of PTB with the 5’ UTR of poliovirus and 
encephalomyocarditis virus (EMCV) is required for the efficient translation of the 
RNA (Hellen et al., 1993a). As mentioned before, the attenuation of the poliovirus 
vaccine strain Sabin type 3 has been attributed to the reduced affinity of the viral 
IRES to the neuronal variant of PTB (nPTB) (Guest et al., 2004). In foot-and-mouth 
disease virus (FMDV) PTB protein was found in the translation complexes bound on 
the IRES, while mutations in the major binding site had a direct effect on translation 
                                   54
efficiency of FMDV RNA. Rabbit reticulocyte lysates depleted of the PTB 
demonstrated a reduced translation from the FMDV IRES, while addition of 
recombinant PTB restored the original translation levels (Niepmann et al., 1997). In 
vivo experiments with transient overexpression of the PTB demonstrated increased 
translation under several picornaviral and flaviviral IRESs (Gosert et al., 2000). In 
mouse hepatitis virus (MHV), a coronavirus, PTB has been shown to bind to the 
leader sequence of its RNAs on specific UCUAA repeats. Deletion of these repeats 
led to impairment of transcription (Li et al., 1999).  In the same virus PTB was also 
found to interact with the 3’ UTR altering the secondary structure of the RNA, 
opening up a double-stranded region that may expose important sequences for the 
regulation of subgenomic RNA synthesis (Huang & Lai, 1999). In vitro binding 
assays have shown that PTB is binding the 5’ and 3’ extremities of Norwalk virus 
genome (Gutierrez-Escolano et al., 2000, Gutierrez-Escolano et al., 2003). The PTB 
binding site has been roughly located into the first 110 nucleotides of the Norwalk 
virus genomic RNA (Gutierrez-Escolano et al., 2000), a region that has been 
predicted to form a stem-loop structure (Jiang et al., 1993).  
 
1.8.2 Lupus autoantigen (La) 
 
 La (Lupus autoantigen) protein has also been shown to interact with the 
RNA of many positive sense RNA viruses. La, a 52-kDa protein, has been 
characterised as an autoantigen in patients with systemic lupus erythematosus and 
Sjogren's syndrome (Buyon, 1989). La is comprised of an RNA binding La motif 
(present as well in other non-related proteins) an RRM and an NLS at the C-terminus 
(Fig. 1.12). A potential second RRM (maybe residual) has been proposed for the La 
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protein of vertebrates (Birney et al., 1993) and Drosophila melanogaster (Wolin & 
Cedervall, 2002) (Fig. 1.12). La is an abundant protein with mainly nucleoplasmic 
and nucleolar localisation (Graus et al., 1985). However, as in the case of PTB, La 
seems to shuttle between the nucleus and cytoplasm under certain circumstances, such 
as poliovirus (Meerovitch et al., 1993) and dengue virus (Yocupicio-Monroy et al., 
2007) infection, apoptosis (Ayukawa et al., 2000), and treatment with metabolic 
inhibitors (Bachmann et al., 1989) either due to alteration in phosphorylation state, 
cleavage or modification of the permeability of nucleopores.  
 
 
 
 
 
 
  
 Extensive study of La has revealed that the physiological role of the protein 
is to stabilise and protect the 3’ends of small nascent RNA transcripts (Wolin & 
Cedervall, 2002). This protective role has been shown to be required for t-RNA 
maturation as binding of La to the 3’ end of the pre-t-RNAs inhibits the 
exonucleolytic 3’Æ 5’ degradation of the RNA while facilitating an endonucleolytic 
removal of the 3’ extension (Yoo & Wolin, 1997). Furthermore, La protein seems to 
stabilise a functional t-RNA structure, as certain mutations that inhibit either the 
maturation or the aminoacylation by disrupting the t-RNA conformation are 
compensated by La (Wolin & Cedervall, 2002). The spliceosomal U1, U2, U4, U5 
RNAs and the small nucleolar RNA U3 RNA are another group of La targets. Binding 
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M
Figure 1.11.  The functional domains of La protein. The RNA-binding region encompasses 
the La motif and the well characterised RNA recognition motif (RRM1). pRRM2 is the predicted 
second RRM in the La protein of some organisms. The small basic motif (SBM) as well as the nuclear 
localisation signal (NLS) is depicted (Wolin & Cedervall, 2002). 
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of La aids the maturation as it blocks the exonucleolytic degradation when it reaches a 
poly(U) stretch (Chanfreau et al., 1997, Xue et al., 2000). Other RNA targets that La 
has been demonstrated to bind are the 5S pre-rRNA, RNase P RNA, rodent 4.5SI and 
4.5SII RNAs, Y RNAs, the mitochondrial RNA processing (MRP) complex RNA and 
the Epstein Barr virus (EBV) EBERs (Wolin & Cedervall, 2002).  
 
 During poliovirus infection the La protein relocates to the replication sites in 
the cytoplasm where it aids viral translation by minimising the production of aberrant 
peptides (Meerovitch et al, 1993; Svitkin et al, 1994). The role of La in IRES-
dependent translation has also been demonstrated in the case of Hepatitis C virus (Ali 
& Siddiqui, 1997, Costa-Mattioli et al., 2004). In caliciviruses La protein has been 
shown to bind on the 5’ and 3’ extremities of the NV genomic RNA in the same 110 
nts where PTB appears to bind (Gutierrez-Escolano et al., 2000, Gutierrez-Escolano et 
al., 2003). 
 
 In addition to its regulatory role in the organisation and biogenesis of the 
translation machinery, the La protein regulates directly the translation of several 
proteins by interacting with their mRNAs. A dominant negative form of La 
selectively inhibited the translation under the X-linked inhibitor of apoptosis (XIAP) 
IRES element (Holcik & Korneluk, 2000), while translation of the protein chaperone 
BiP mRNA was enhanced in the presence of La (Kim et al., 2001). A different 
mechanism of translation regulation has been observed for the peptidylglycine alpha-
amidating monooxygenase (PAM) mRNA. Binding of La to the 3’ UTR of the mRNA 
induced the nuclear retention of the mRNA, while addition of La protein lacking its 
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own nuclear retention element resulted to the export of the mRNA from the nucleus 
(Brenet et al., 2005).   
  
1.8.3 Poly(C) binding protein (PCBP) 
 
 Another protein that has been extensively studied for its RNA-binding 
activity is poly(rC) binding protein (PCBP). The best studied PCBPs are those 
belonging in the group of the α-complex proteins (α-CPs) and are known as α-CP1, α-
CP2, α-CP3 and α-CP4 or most commonly known as PCBP1, PCBP2, PCBP3 and 
PCBP4. In contrast to the three different PTBs, PCBPs are not the result of alternative 
spliced mRNAs, but they exist in the genome as four different genes. Moreover, a 
variety of alternative splicing products have been identified for PCBP1 and PCBP4 
(Makeyev & Liebhaber, 2002). All four PCBPs are comprised of three hnRNP K-
homology (KH) domains (Fig. 1.13) that have the ability to bind single stranded RNA 
individually (Dejgaard & Leffers, 1996). However, a more complicated collaboration 
of all three KH domains results in the high affinity of hnRNP K for poly(C) (Siomi et 
al., 1994).   
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Figure 1.13. Poly(C) binding proteins. The domain layout of the four major PCBPs. The three 
hnRNP K-homology (KH) domains are depicted (Makeyev & Liebhaber, 2002) 
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 PCBPs are involved in the translation of several mRNAs by regulating their 
stability. Formation of an RNP complex between PCBP1 or PCBP2 and a pyrimidine 
rich element at the 3’ UTR of α-globin mRNA leads to increased mRNA stability 
(Chkheidze et al., 1999, Kong et al., 2003), while interruption of the pyrimidine rich 
element results in reduced mRNA stability (Weiss & Liebhaber, 1995). Similar 
regulatory roles of PCBPs have been observed for the mRNAs of β-globin (Yu & 
Russell, 2001) and collagen α1 (I) (Stefanovic et al., 1997) suggesting the 
involvement of PCBPs in a general mechanism of mRNA stabilisation by interaction 
with the 3’ UTR. Inhibition of mRNA translation is another aspect of PCBPs’ 
function. PCBP1, PCBP2 and hnRNP K interact with a CU-rich element at the 3’ 
UTR of 1,5-lipoxygenase (LOX) mRNA leading to translational silencing (Ostareck 
et al., 1997). This inhibition is achieved by blockage of the 40S ribosomal subunit 
accessibility to the 60S subunit at the initiation complex of the 5’ end (Ostareck et al., 
2001). The involvement of PCBPs in the regulation of picornavirus translation and 
replication has already been discussed in the section dedicated to IRESs. Another 
level of regulation that PCBPs are involved in is transcriptional as several PCBPs 
have been shown to interact with pyrimidine rich single stranded DNA elements. 
PCBPs have been shown to activate the transcription of human c-myc (Tomonaga & 
Levens, 1996), the neuronal nicotinic acetylcholine receptor (Du et al., 1998) and µ-
opioid receptor gene (Kim et al., 2005)  
 
 In caliciviruses, PCBP2 has been found to interact with the 5’extremity of 
the NV genomic RNA in supershift mobility assays, while the binding seems to take 
place in the first 110 nt of the 5’extrermity, the same region in which PTB and La 
have been found to bind (Gutierrez-Escolano et al., 2000). A strong binding of PCBP2 
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to the 3’UTR of the NV genomic RNA has also been observed, in the region where a 
predicted stem-loop structure is located (Gutierrez-Escolano et al., 2003). 
 
1.8.4 Other host cell RNA binding proteins 
 
 In addition to PTB, La and PCBP there are several other host cell proteins 
that have been reported to bind on the RNA of positive stand RNA viruses. The 
upstream of n-Ras protein (Unr) has been shown to bind to the poliovirus and 
rhinovirus IRES (Boussadia et al., 2003). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was been found to interact with the 5’ UTR of Hepatitis A virus, hnRNP 
A1 interacts with the 5’ leader of both positive and negative sense RNA in mouse 
hepatitis virus, Sam68 and EF-1α bind to poliovirus RNA, while the latter has been 
demonstrated also to interact with the 3’ UTR of Dengue 4 virus (reviewed by Lai, 
1998). In addition, in NV, the hnRNP L protein has been found to participate in the 
formation of an RNP complex at the 5’ extremity of the genomic RNA (Gutierrez-
Escolano et al., 2000). Finally, poly(A) binding protein (PABP) has been shown to 
interact with the poly(A) tail of positive strand RNA viruses genomes, often 
participating in the formation of a protein bridge between the 5’ and 3’ UTRs (Herold 
& Andino, 2001). 
 
1.9. Aim of the study 
 
 The aim of this project was to identify host cell RNA-binding proteins that 
interact with the extremities of the genomic and subgenomic RNA of caliciviruses, 
forming the viral ribonucleoprotein complexes (RNPs). As no functional data exists 
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up to date for any RNA-protein interaction involved in calicivirus life cycle the role of 
PTB in FCV translation and replication was examined. For this purpose in vitro and in 
vivo translation studies were used in conjunction with replication studies in the FCV 
tissue culture infection system. Furthermore, using the MNV reverse genetics system 
that became available in the 3rd year of this project, an attempt was made to identify 
functional cis-acting RNA elements in the MNV genome. Such elements could be 
possibly involved in the regulation of the translation and replication of MNV. The 
long term goal for this second part of my study was to identify potential binding sites 
of host cell and viral RNA-binding proteins on the viral RNA. The characterisation of 
the RNA-protein interactions that regulate calicivirus replication can shed light on the 
mechanism of calicivirus replication and may reveal potential targets for the synthesis 
of drugs or the production of attenuated calicivirus strains that can be used as vaccines 
against caliciviruses. 
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2.1. Antisera 
 
Antiserum to the FCV RdRp (p76) was generated by immunization of New 
Zealand white rabbits with recombinant p76 previously purified in the lab. Goat 
antiserum to hnRNP I (PTB) (Cat# sc-16547), used for the western blots, was 
purchased from Santa Cruse Biotechnology, while mouse monoclonal DH3, DH7 and 
DH17 antisera to PTB were kindly provided by Eckard Wimmer (Stony Brook 
University, New York, USA). Antiserum to GAPDH (Cat# AM4300) was purchased 
from Ambion. Antiserum to FCV Urbana capsid was kindly provided by Stanislav 
Sosnovtsev (National Institutes of Health, Bethesda, Maryland, USA). 
 
 
2.2. Viruses and Cell lines 
  
FCV was propagated in Crandel Reese feline kidney (CRFK) cells at 37 oC 10 
% CO2. CRFK cells were maintained in Dulbecco MEM (DMEM) with 10 % foetal 
calf serum (FCS) at 37 oC with 10% CO2. MNV was propagated in the murine 
leukaemia macrophage cell line RAW 264.7 cells using DMEM at 37 oC 10 % CO2. 
Baby-hamster kidney cells (BHK-21) expressing T7 DNA polymerase (BSRT7 cells) 
used during reverse genetics recovery of MNV from the cDNA clones were cultured 
in DMEM containing 1mg/ml G418  at 37 oC 10 % CO2.  
 
 
2.3. Western blot 
  
For western blot analysis, cells were lysed in radioimmunoprecipitation 
(RIPA) buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100 and 0.1% SDS). The protein concentration was determined using the BCA protein 
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assay (Pierce) and equal quantities of protein from each lysate in reducing SDS-
PAGE sample buffer were separated by SDS-PAGE. The proteins were transferred to 
a polyvinylidene fluoride (PVDF) Immobilon-P transfer membrane (Millipore) by 
semi-dry blotting according to the manufacturer’s instructions (Biorad). The 
membrane was blocked with 5% milk powder in PBST (0.1% Tween 20 / PBS), 
subjected to the primary antibody for 2 h and subsequently washed 3 times. The 
secondary, horseradish peroxidase (HRPO) conjugated, antibody was applied for 1 h 
and the membrane was washed twice in PBST and twice in PBS. For the final 
visualisation, ECL detection substrate (Amersham-Biosciences) was used according 
to manufacturer’s instructions. 
 
 
2.4. Northern blot 
  
Total RNA was extracted from cells using the GenElute Total RNA isolation 
kit (Sigma) following the protocol described by the manufacturer. The concentration 
of RNA was determined by measuring the absorbance at 260 nm (A260) in a 
spectrophotometer. RNA was mixed with an equal volume of 2x glyoxal RNA 
loading buffer (Ambion) and incubated at 55 oC for 30 minutes. Equal amounts of 
RNA (10 μg) were separated on a 0.7% agarose gel. Electrophoresis was performed in 
0.5xTBE buffer. The RNAs were transferred to a positively charged nylon membrane 
Hybond N+ (Amersham Biosciences), using capillary transfer under mildly alkaline 
conditions to partially hydrolyse the RNA as described (Sambrook, 2001). The 
membrane was pre-hybridised for 1 h with Rapid-Hyb solution (Amersham 
Biosciences) at 70 oC and the RNA probe was added in tube. Hybridisation was 
performed at 70 oC for 2 h, after which the membrane was washed in 2x SSC 
(300mM NaCl, 30 mM Na-Citrate pH 7.0), 0.1% SDS at room temperature for 10 
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minutes, then in 1x SSC (150 mM NaCl, 15 mM Na-Citrate pH 7.0), 0.1 % SDS at 65 
oC for 20 minutes. Exposure of membrane to a phosphor imager screen allowed its 
visualisation.  
 
 
2.5. Reverse transcription (RT) and Polymerase chain reaction 
(PCR)  
 
 RT reactions were performed on 5μg of total RNA from infected cells using 
SuperScript II Reverse transcriptase (Invitrogen) according to the manufacturer. For 
PCR amplifications, Triple Master Taq polymerase (Eppendorf) or KOD Hot start 
(Novagen) was used according to the manufacturer’s protocol in an Eppendorf 
thermal cycler. For mutagenic extension PCRs 500 ng of the first PCR product, after 
purification with GFX PCR DNA and Gel Band Purification Kit (GE Healthcare), 
was used as the forward primer in a subsequent PCR reaction containing a reverse 
primer downstream on the template (Fig. 2.1). The primers used for amplification of 
FCV sequences from the FCV full-length cDNA clone, pQ14, are listed in Table 2.1. 
The primers used for the sequencing of MNV and amplifications from the MNV full-
length cDNA clone, pT7:MNV 3’Rz and mutant derivatives are listed in Tables 2.2 
and 2.3. 
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oligo oligo sequence 5’ Æ 3’ Pol Description 
IGRDG13 TAATACGACTCACTATAGGGGTAAAAGAAATTTGAG F 5’G1-x PCR 
IGRDG157 TAATACGACTCACTATAGGGCTGAGCTTCGTGCTTAAAAC F 5’G32-245 PCR 
IGRDG158 TAATACGACTCACTATAGGGTATCTTTATAACAAGCTTTCTCGC F 5’G118-245 PCR 
IGRDG159 TAATACGACTCACTATAGGGACAAGCTTTCTCGCCCTATAAG F 5’G128-245 PCR 
IGRDG18 GGATCTGTCCTTTGGAAG R 5’Gx-245 PCR 
IGRDG14 TAATACGACTCACTATAGGGAGTCCTTACGGACACTGTG R 5’G72-245 PCR 
IGRDG15 TAATACGACTCACTATAGGGTCGCGCCTCCGTTGAAGCG  5’G111-245 PCR 
IGRDG16 TAATACGACTCACTATAGGGACAAGCTTCTGCCCTTATAG R 5’G164-245 PCR 
IGRDG17 TAATACGACTCACTATAGGGTGTGCAGTTAGGACAAAC R 5’G202-245 PCR 
IGIC3 GCTTGTTATAAAGATACTGCAAGTCGCGCCTCCGTTCAAGCG R mBS1 Syn PCR 
IGIC4 GCTTGTTATAAAGATACTTTTTTTCGCGCCTCCGTTCAAGCG R mBS1 F(A) PCR 
IGIC48 GGGCGAGAAAGCTTGTTATACAAGTACTGAAGATCGCGCCTCCG R mBS2 Syn PCR 
IGIC49 GGGCGAGAAAGCTTGTTATTTTTTTACTGAAGATCGCGCCTCCG R mBS2 F(A) PCR 
IGRDG135 TGTGCAGTTAGGACAAACGTCATAACTGGCACTTTTTTTTCAAGCTTCTGCCCTTATAG R mBS3 F(A) PCR 
IGRDG137 TGTGCAGTTAGGACAAACGTCATAACTGGCACAACTTGGACAAGCTTCTGCCCTTATAG R mBS3 Syn PCR 
IGIC67 GGGCGAGAAAGCTTGTTATACAAGTACTGCAAGTCGCGCCTCCGTTGAAGCG R 
mBS1+mBS2 Syn 
PCR 
IGRDG19 TAATACGACTCACTATAGGGGTGTTCGAAGTTTGAGCATG F 
IGRDG28 TTGGCCAGAGCTCCATTCCAGTGCATTGGAGGG R 5’SG1-285 PCR 
IGRDG26 TAATACGACTCACTATAGGGAAGGGTACAAGGCCCCCTCC F 
IGRDG22 CCCTGGGGTTAGGCGCAAATG R 
3’ extremity 7493-
7683 PCR 
IGRDG54 GCGGGATCCTTATTCTTCAGCAAAGCTAAC R 
p76-coding region 
specific for RNase H 
digestion of the 
genomic RNA 
M13/Puc R ACACAGGAAACAGCTATGACCA R M13/Puc pGemT reverse primer 
 
 
 
 
 
5’                                                         3’ 
3’                                                         5’ 
3’                                                                                                                                5’ 
 
F
R1
R2
1st PCR 
 
 
 
2nd PCR 
Figure 2.1. Mutagenesis by extension PCR. The extension PCR used a mutagenic 1st PCR 
amplification by a forward (F) and a mutagenic reverse primer (R1) as forward primer in conjunction 
with a second reverse primer (R2) further downstream. X is the mutation introduced. 
x 
x
x
5’ 3’x 
3’                                                                                                                                5’ 
 
5’                                                                                                                                3’ 
 
x 
x
Final 
product 
Table 2.1. FCV oligonucleotides  
† The primers used on the FCV full length cDNA clone, pQ14, or cDNA from cells infected with FCV 
‡ The underlined nucleotides highlight the T7 RNA polymerase promoter sequence 
§  Polarity: F and R represent forward and reverse primer respectively. 
¶ x = nucleotide between 1 and 245 Syn = synonymous mutations, F(A) = full adenosine substitution  
†        ‡                         §                                ¶ 
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oligo oligo sequence  5’ Æ 3’ Pol Position in MNV genome 
1F GTGAAATGAGGATGGCAACGCCATCTTCTGCGCCC F 1 
404F GGAGCCTGTGATCGGCTCTATCTTGGAGCAGG F 404 
491R GCCTGGCAGACCGCAGCACTGGGGTTGTTGACC R 491 
922F GCATTGTCAATGCCCTGATCTTGCTTGCTGAGC F 922 
1139R GGCGAACTTGCCCATCTCTTGGGCGGCCTTGAGAGCC R 1139 
1540F GCTTTTGCCAAAACCTAGCCAAGAGGATTGCTG F 1540 
1540R CAGCAATCCTCTTGGCTAGGTTTTGGCAAAAGC R 1540 
1954F GGCCCGATTACAGCCACATCAATTTCATCTTGG F 1954 
1954R CCAAGATGAAATTGATGTGGCTGTAATCGGGCC R 1954 
2392F GTGTCAGAAGGATAAAGGAGGCCCGCCTCCGCTGC F 2392 
2392R GCAGCGGAGGCGGGCCTCCTTTATCCTTCTGACAC R 2392 
2616R GCCCCCGGCCCTTCTTGTTCTTGCCCTTCTTTCC R 2616 
2902F GCAAGCCGATCGACTGGAATGTGGTTGGCC F 2902 
2902R GGCCAACCACATTCCAGTCGATCGGCTTGC R 2902 
3394F CGGGCGACTGTGGCTGTCCCTATGTTTATAAGAAGGGTAAC F 3394 
3394R GTTACCCTTCTTATAAACATAGGGACAGCCACAGTCGCCCG R 3394 
3734F GCGAGATCAGCTTAAGCCCTATTCAGAACCACGCG F 3734 
3734R CGCGTGGTTCTGAATAGGGCTTAAGCTGATCTCGC R 3734 
4450F GCCCTTGCACCACACAGCTGAATAGTTTGG F 4450 
4450R CCAAACTATTCAGCTGTGTGGTGCAAGGGC R 4450 
4839R GCAGGGCCATTAGTTGGGAGGGTCTCTGAGCATGTCC R 4839 
5052F GTGAATGAGGATGAGTGATGGCGCAGCGCCAAAAGCCAATGGC F 5052 
5332R GTTCCCAACCCAGCCGGTGTACATGGCTGAGAGGTGGGC R 5332 
5722R CACGGGCAAGTCGACCATCCGGTAGATGGTTCTCTC R 5722 
6034F GGTTACCCCGATTTCTCTGGGCAACTGGAGATCGAGGTCC F 6034 
6034R GGACCTCGATCTCCAGTTGCCCAGAGAAATCGGGGTAACC R 6034 
6427F GTCTCCTGGTTCGCGTCTAACGCGTTCACCGTGCAGTCC F 6427 
6427R GGACTGCACGGTGAACGCGTTAGACGCGAACCAGGAGAC R 6427 
6733F GCAATTCCATCTCAAATGTTCAAAACCTTCAGGCAAAC F 6733 
6733R GTTTGCCTGAAGGTTTTGAACATTTGAGATGGAATTGC R 6733 
7155F GTGGACACATCCCCTCTACCGATCTCGGGTGGACGCTTGCC F 7155 
7400R TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTAAAATGCATCTAACTACCACAAAG R 7400 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2. MNV sequencing oligonucleotides  
                                  §  † 
† The primers used on the MNV full length cDNA clone, pT7:MNV 3’Rz and mutant derivatives or  
   cDNA from cells infected with MNV 
§ Polarity: F and R represent forward and reverse primer respectively. 
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oligo oligo sequence  5’ Æ 3’ Pol Description  
IGIC50 GAGCTCACTAGTTAATACGACTCACTATAGTGAAATGAGGATGGCAACACCCAGTAGTGCGCCCTCTGTGCGCAACA F 
m50 mutagenic 
primer 
IGIC51 GAGCTCACTAGTTAATACGACTCACTATAGTGAAATGAGGATGGCAACGCCATCTTCTGCGCCTTCGGTACGCAACACAGAGAAACGCA F 
m51 mutagenic 
primer 
IGIC52 GCCGGCGCTAGCTTTTTTTTTTTTTTTTTTTTTTTTTTAAAATGCATCTAACTACCACTTACGCAGTAAGCAGAAATCATTTTCAC R 
m52 mutagenic 
primer 
IGIC53 CAAAGACTGCTGAGCGTTCCTGCGGGGTTTCGGCGTCCATTGTTCCAAAGCGCACCC R 
m53 mutagenic 
primer 
IGIC54 GCCGGCGCTAGCTTTTTTTTTTTTTTTTTTTTTTTTTTAAAATGCACGAAACTGTCATAAAGAAAAGAAAGCAGTAAGC R 
m54 mutagenic 
primer 
IGIC16 TAATACGACTCACTATAGGGGTGAAATGAGGATGGCAACGC F 5’G1-x PCR 
IGIC17 AGCACGCGTGCATCACTACGCG R 5’Gx-250 PCR 
IGIC143 GCCTTCTTGTTTTTGCGTTTC R 5’G1-73 PCR 
IGIC144 TTTCGTCTTCGCTCTCCG R 5’G1-138 PCR 
IGIC145 TGAGCTTCCTGCTCAGGAGGG R 5’G1-172 and 5’G73-
172 PCRs 
IGIC146 TAATACGACTCACTATAGGGTTCGTCTAAAGCTAGTGTCTCC F 5’G73-250 and 5’G73-
172 PCRs 
IGIC147 TAATACGACTCACTATAGGGACATGACCCCTCCTGAGCAGG F 5’G138-250 PCR 
IGIC148 TAATACGACTCACTATAGGGAGCCCGGCGCCCTTGCGGCCC F 5’G172-250 PCR 
IGIC18 TAATACGACTCACTATAGGGGTGAATGAGGATGAGTGATGGC F 
IGIC19 CACCAAGGGGGCACTGGAC R 5’SG1-200 PCR 
IGIC127 TAATACGACTCACTATAGGGACATCCCCTCTACCGATCTCGG F 
IGIC128 TTTTTTTTTTTTTTTAAAATGC R 
3’extremity nts 
7161-7382 + (A)15 
IGIC161 GGAACAATGGACGCCGAAACCCCGCAGGAACGTTCGGCGGTCTTTGTGAATG F 
IGIC162 CATTCACAAAGACCGCCGAACGTTCCTGCGGGGTTTCGGCGTCCATTGTTCC R 
m53R mutagenic 
primer 
 
 
 
 
 
 
2.6. Viral RNA immunoprecipitation  
 
 For the immunoprecipitation of viral RNP complexes, 2 x 107 CRFK cells 
were infected for 16 h with FCV (m.o.i of 0.1). The cells were harvested in 2 ml of 
polysome lysis buffer (100 mM KCl, 5 mM Mg2Cl, 10 mM HEPES pH 7.0, 0.5 % 
Nonidet P-40, 1mM DTT, 100 U/ml RNasin RNase inhibitor (Promega), 1x complete 
EDTA free protease inhibitor (Roche Applied Sience)). Cell lysis was assisted by 
passing the lysates through a blunt end 23G needle (20x). The lysates were 
centrifuged at 16,000 g for 15 min in a 4 oC centrifuge. The supernatant was 
† The primers used on the MNV full length cDNA clone, pT7:MNV 3’Rz and mutant derivatives 
‡ The underlined nucleotides highlight the T7 RNA polymerase promoter sequence 
§ Polarity: F and R represent forward and reverse primer respectively. 
¶ x = nucleotide between 1 and 250, (A)15 = poly(A) tail of 15 adenines. 
         ‡                             §                            ¶† 
Table 2.3. MNV oligonucleotides  
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supplemented with polysome lysis buffer up to a final volume of 5 ml was precleared 
using 200 μl of protein-A agarose beads (50 % slurry) for 2 h at 4 oC with rotation in 
a 15 ml tube. In parallel, 10 μl of antibody (400 ng for α-GAPDH) was incubated with 
40 μl of protein-A agarose (50 % slurry) equilibrated in polysome lysis buffer for 2 h 
at 4 oC. The excess antibody was removed by 4x wash in 1 ml of polysome lysis 
buffer and 1 ml of precleared lysates was added to the beads. The antibody carrying 
beads and the precleared lysates were incubated at 4 oC overnight (~16 h) with 
rotation. The beads were washed with 1 ml of polysome lysis buffer (4x) and with 1 
ml of polysome lysis buffer containing 1 M urea at 4 °C for 5 min for each wash. The 
beads were resuspended in 100 μl of polysome lysis buffer with 0.1 % SDS and 30 μg 
proteinase K (Promega). The reaction was incubated at 50 °C for 30 min, the RNA 
was extracted with phenol–chloroform and precipitated using ethanol with 1 μg of 
glycogen as a carrier. After precipitation, the pellet was resuspended in 20 μl of 
ddH2O and cDNA was synthesised using d(N)6 random primers (Promega). The 
detection of viral cDNA was performed by PCR amplification of the 5’G1-245 region 
(Table 2.1) of the viral genome and the PCR products were analysed on a 2 % 
agarose gel. 
 
2.7. T7 transcription  
  
For the preparation of RNA probes for northern blot analysis, T7 transcription 
reactions contained 40 mM Tris (pH 8.0), 40 mM DTT, 6 mM MgCl2, 2 mM 
spermidine, 0.5 mM ATP, CTP, GTP, 10 μM UTP, 4 μl αP32UTP (10 μCi/μl, 3000 
mCi/mmol) (at a 1:15 proportion hot:cold), 300 ng of PCR product and 0.5 μg/μl T7 
polymerase. The reaction was incubated at 37 oC for 2 h and DNase I treated (2 U) for 
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15 min at 30 oC. The riboprobes were purified using a G50 column and the purified 
probe was mixed with 1 ml of Rapid-Hyb buffer (Amersham Biosciences).  
 
RNA probes for the electrophoretic mobility shift assay (EMSA), competitor 
RNAs and RNAs for the RNA affinity columns were synthesised by in vitro T7 
transcription after PCR amplification of the respective regions from pQ14. 
Radioactive probes were synthesised using Megashortscript T7 (Ambion) with α-32P 
UTP according to manufacturer’s protocol. Transcription reactions contained 40 mM 
Tris, 32 mM MgOAc, 40 mM DTT, 2 mM spermidine, 7.5 mM NTPs, 0.7 μg/μl T7 
RNA polymerase and high concentration of template DNA. The radioactive probes 
were purified by electrophoresis in a 6% acrylamide, 7M urea gel and overnight 
diffusion in 0.1% SDS, 10 mM Tris, 1 mM EDTA solution. The RNAs were phenol-
chloroform extracted, ethanol precipitated and resuspended in 50 μl of ddH2O. The 
concentration of each probe was determined by spectrometry quantification at 260 
nm.  
 
The 5’cap-CAT-FMDV IRES-LUC bicistronic RNA was produced using the 
Megashortscript kit (Ambion) using 210 ng of XhoI linearised 
pGEMCATLUC:FMDV IRES plasmid according to the manufacturer with the 
addition of 6 mM of Ribo m7G cap analog (Promega). 
 
2.8. RNA affinity columns 
 
0.75 g of activated CNBr-sepharose 4B beads was washed once with 50 mls of 
1mM HCl and twice with 10 mls of double distilled water. 250 µl of CnBr-Sepharose 
(Pharmacia) (bead volume) was added to 750 μl of 0.2 M MES pH 6.0 containing 200 
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µg of RNA.  The reactions were incubated for 2 h at 4 oC with rotation. The 
absorption at 260 nm was measured for each column after coupling to ensure that 
equal amounts of RNA were coupled to the column. The beads were washed with 100 
mM Tris pH 8.0 and incubated in 100 mM Tris pH 8.0 for 1 h at 4 oC to block the 
non-reacted groups. The beads were washed three times in S10 dilution buffer (50 
mM HEPES pH 8.0, 120 mM potassium acetate, 5.5 mM magnesium acetate, 10 mM 
KCl, 6 mM DTT) prior to use. 100 μl of RNA beads (bed volume) were incubated 
with 100 μl of HeLa S10 extracts, prepared previously in the lab, for 1 h at 4 oC.  
Finally the beads were washed 4 times with S10 dilution buffer and the bound 
proteins were eluted with 100 μl of reducing SDS PAGE loading buffer. The final 
elutions were separated by 12.5% acrylamide SDS PAGE and stained using silver 
stain (Biorad). 
 
2.9. Protein purification 
 
2.9.1 GST-PTB 
 
DH5α E. coli cells were transformed with the pGEX6P-1 PTB plasmid, 
provided by Richard Jackson (University of Cambridge, UK). Cells from a single 
colony were grown in LB at 37 oC up to an OD600 of 0.6. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was added at a final concentration of 0.1 mM and the 
protein expression was induced for 2 hours. The cells were lysed using a French press 
under high pressure (1000 bar) in PBS containing 0.5 mM DTT, 10 mM EDTA, 3 
μg/ml leupeptine and pepstatin, 1% Triton X-100, 1 mM PMSF. The clarified lysate 
was passed through a glutathione-sepharose column and washed with PBS containing 
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0.5 mM DTT, 10 mM EDTA and 1% Triton X-100. A second wash with 50 mM Tris 
pH 8.0, 150 mM NaCl and 0.5 mM DTT followed. The protein was then eluted in 10 
mM reduced glutathione, 50 mM Tris pH 8.0, 150 mM NaCl and 0.5 mM DTT and 
dialysed against 50 mM HEPES pH 7.6, 1 mM DTT, 1 mM MgCl2 and 20 % 
glycerol.  
 
2.9.2 His-PTB, His-PCBP1 and His-PCBP2 
 
SG13009 E. coli cells were transformed with the pQE9 PTBI1 plasmid for 
His-PTB and JM109 E. coli cells were transformed with the pQE30:PCBP1 and 
pQE:PCBP2 plasmid for His-PCBP1 and His-PCBP2 respectively. Cells from a single 
colony were grown in LB at 37 oC up to an OD600 of 0.6. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was added at a final concentration of 0.1 mM and the 
protein expression was induced for 2 hours. For His-PTB, the cells were lysed using a 
French press under high pressure (1000 bar) in PBS containing 0.5 mM DTT, 10 mM 
EDTA, 3 μg/ml leupeptine and pepstatin, 1% Triton X-100, 1 mM PMSF. For His-
PCBP1 and His-PCBP2, the cells were pelleted and resuspended in lysis buffer (50 
mM Tris pH 8.0, 20% glycerol, 500 mM NaCl) containing lysozyme (1 mg/ml). The 
cells were incubated on ice for 30 min and sonicated for complete lysis. The protein 
purification was performed using Ni-NTA (Qiagen) according to the manufacturer. 
His-PTB was dialysed against 50 mM HEPES pH 7.6, 1 mM DTT, 1 mM MgCl2 and 
20 % glycerol. His-PCBP1 and His-PCBP2 preparations were dialysed against 5 mM 
Tris pH 7.5, 100 mM KCl, 1 mM DTT, 0.05 mM EDTA and 5 % glycerol.  
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2.10. Electrophoretic mobility shift assays (EMSAs) 
 
The 7.5 μl EMSA reactions contained 85 nM radioactive probe, GST-PTB at 
varying concentrations, 0.67 μg/μl yeast t-RNA, 5 mM HEPES pH 7.6, 25 mM KCl, 
2.5 mM MgCl2, 1 mM DTT and 4% glycerol. For the competition assays containing 
5’G1-245 RNA probes, 0.5 μg of GST-PTB or 0.75 μg of La protein was used per 
reaction. For the competition assays which contained the FCV 5’SG1-285 RNA probes, 
0.5 μg of GST-PTB was used per reaction. For the competition assays that contained 
the MNV 5’G1-250 RNA probe 1 μg of GST-PTB was used per reaction. For the 
competition assays that contained the MNV 3’extremity RNA probe (nts 7133-7382) 
0.125 μg of GST-PTB was used per reaction. Competitor RNAs were used at 850nM 
and 8.5 μM, while the non-specific competitor RNAs only at 8.5 μM. All reactions 
were incubated for 10 min at 30 oC and for all but three probes the reactions were 
analysed using a 4 % acrylamide gel (acrylamide:bis-acrylamide 19:1) containing 5 % 
glycerol. EMSAs containing FCV nts 1-111, 118-245 and 128-245 were analysed on a 
5 % acrylamide gel (acrylamide:bis-acrylamide 19:1) containing 5 % glycerol. The 
EMSA gels were dried and visualised on a phosphor imager screen. Band 
quantification was performed using the ImageQuant 5.0 software package (Molecular 
Dynamics). 
 
2.11. VPg-linked viral RNA purification 
 
FCV VPg-linked RNA was extracted from viral replication complexes in 
infected CRFK cells (Green et al., 2002). Four T175 flasks of CRFK cells were 
infected for 6 hours with FCV (m.o.i. of 10) at 37 oC. The cells were harvested and 
pelleted at 500 g for 5min. The pellets were washed in 10 ml of PBS and the aliquots 
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combined into a 50 ml Falcon tube. The cells were pelleted at 500g for 5 min and 
resuspended in ice cold TN buffer (10mM Tris pH 7.8, 10mM NaCl), in which they 
were incubated for 15 min to swell. Lysis was performed in a dounce homogeniser 
(60x), the lysate was aliquoted in 1.5 ml tubes and centrifuged at 800g for 5 min 4 oC 
to pellet the nuclei and the unlysed cells. The supernatant was subsequently 
centrifuged at 13,000 rpm on a desk-top centrifuge for 20 min at 4 oC to pellet the 
replication complexes. The pellets were resuspended in 120 μl TN buffer containing 
15 % glycerol and combined. The RNA from the replication complexes was purified 
using the GenElute Total RNA isolation kit (Sigma) following the protocol described 
by the manufacturer. 
 
2.12. In vitro translation 
 
 
For in vitro translation assays, FCV RNA purified from replication complexes 
and in vitro synthesised bicistronic 5’cap-CAT-FMDV IRES-Luc RNA were 
translated using the Flexi rabbit reticulocyte lysates (RRLs) (Promega). Each 12.5 μl 
translation reaction included 6.25 μl of RRL, 20 μM amino acid mixture minus 
methionine, 100 mM KCl, 2 mM DTT, 0.5 mM MgOAc, 5μCi 35S methionine (1000 
Ci/mmol) (GE Healthcare) and 312.5 ng of preparation containing FCV VPg-linked 
RNA or bicistronic RNA. Translation reactions occasionally contained 1 μl of His-
PTB or buffer at various concentrations, and 5’G1-245 RNA transcripts at various 
concentrations. The reactions were incubated at 30 oC for 1.5 h. However, for the 
assessment of the role of temperature in the inhibition of FCV translation by His-PTB, 
the reactions were incubated at a range of temperatures. For the translation of the 
RNase H treated FCV RNA 3.5 μl of the RNase H reaction was added in the 
translation reactions.  
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 The translation reactions were mixed with equal volume of 2x reducing SDS-
PAGE sample buffer and 5 μl of each reaction were separated in a 12.5% acrylamide 
gel. The gel was fixed using fixation solution (10 % ethanol and 10 % glacial acetic 
acid in ddH2O) and dried. The dried gels were visualised on a phosphor imager 
screen. Band quantification was performed using the ImageQuant 5.0 software 
package (Molecular Dynamics). 
 
2.13. RNase H treatment of FCV RNA 
 
The specific digestion of the FCV genomic RNA in the viral RNA preparation 
from infected cells was carried out by using RNase H and the IGRDG54 
oligonucleotide that is complementary to p76 coding region or the non-specific 
M13/Puc R primer. RNase H reactions contained 1.26 μg of VPg-linked RNA 
preparation, 25 pmol of IGRDG54, 10 U RNAsin (Promega), 37.5 mM KCl, 25 mM 
Tris-HCl pH 8.3, 1.5 mM MgCl2, 5 mM DTT and 50 U of RNase H (Ambion). The 
reaction was incubated at 37 oC for 20 min.  
 
2.14. Bioinformatics tools 
 
 Alignments of MNV and FCV sequences were performed with the ClustalW 
online software (www.ebi.ac.uk/Tools/clustalw/index.html) using sequences 
submitted in GenBank (www.ncbi.nlm.nih.gov/Genbank/index.html) or obtained by 
sequencing of PCR products by the MRC Sequencing Service (Imperial College, 
UK). The FCV and MNV GenBank strains used in the present study are listed in 
Table 2.4.  
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Strain Accession Number Strain 
Accession 
Number 
Urbana L40021 CR6 EU004676 
DD/2006/GE DQ424892 CR7 EU004677 
USDA AY560118 CR10 EU004678 
UTCVM-H1 AY560116 CR11 EU004679 
UTCVM-H2 AY560117 CR13 EU004680 
UTCVM-NH1 AY560113 CR15 EU004681 
UTCVM-NH2 AY560114 CR17 EU004682 
UTCVM-NH3 AY560115 CR18 EU004683 
FCV2024 AF479590 WU11 EU004663 
F4 D31836 WU12 EU004664 
F9 M86379 WU20 EU004665 
F65 AF109465 WU21 EU004666 
CFI/68 U13992 WU22 EU004667 
MNV1 DQ285629 WU23 EU004668 
MNV2 DQ223041 WU24 EU004669 
MNV3 DQ223042 WU25 EU004670 
MNV4 DQ223043 WU26 EU004671 
CR1 EU004672 MNV1/2002/USA AY228235 
CR3 EU004673 Berlin/04/06 DQ911368 
CR4 EU004674 Berlin/05/06 EF531290 
CR5 EU004675 Berlin/06/06 EF531291 
 
 
For the thermodynamic prediction of RNA structures three online software 
packages were used. Single sequence based thermodynamic predictions were 
performed using mfold (frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/RNA-
form1.cgi)  (Zuker, 2003). Alignment based thermodynamic predictions were 
performed using pfold (www.daimi.au.dk/~compbio/RNAfold/) (Knudsen & Hein, 
2003). Single sequence based thermodynamic predictions for RNA structures that 
included pseudoknots were performed using Kinefold (http://kinefold.curie.fr/) 
(Xayaphoummine et al., 2005).  
 
 
Table 2.4. GenBank accession numbers of FCV and MNV strains 
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2.14. MNV and FCV reverse genetics 
 
 
Synonymous mutations in the RNA structures present at the 5’ end of the 
MNV genomic RNA were introduced by PCR amplification using the 5’ mutagenic 
primer IGIC50 to generate m50 and IGIC51 to generate m51, in combination with the 
3’ primer 1139R. The resultant PCR products were digested with SpeI and FseI and 
cloned into the MNV infectious clone pT7:MNV G3’Rz. Synonymous changes were 
introduced into the stem loop immediately upstream of the initiation site for 
subgenomic RNA synthesis at the NS/S junction by PCR amplification of the region 
using primers IGIC53 and 4450F. The resultant PCR product was digested with BipI 
and NsiI and cloned into the MNV transfer vector pSL301:MNV AfeI-SacII. The 
mutated region was then transferred to the MNV infectious clone pT7:MNV G 3’Rz 
by digestion with AfeI and SacII to generate the mutated derivative m53. Mutations 
for the RNA structures present in the 3’ UTR of MNV (m52, m54) were generated by 
PCR amplification of the 3’ end of the MNV genome using the 5’ mutagenic primer 
IGIC52 or IGIC54 (for m52 and m54 respectively) in combination with 6427F. The 
resultant product was digested with NheI and BstAPI before insertion into a transfer 
vector containing the MNV subgenomic RNA (pSL301:MNV SG 3’Rz). The mutated 
fragment was subsequently transferred to the MNV infectious clone pT7:MNV G 
3’Rz using the SacII and NheI restriction sites. The region that included the mutations 
in m53RevA was PCR amplified using primers 4450F and 5332R. The resultant PCR 
product was digested with BipI and NsiI and cloned into the MNV transfer vector 
pSL301:MNV AfeI-SacII. The mutated region was then transferred to the MNV 
infectious clone pT7:MNV G 3’Rz by digestion with AfeI and SacII to generate the 
mutated derivative m53RevA. Compensatory mutations for the m53 MNV mutant 
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were introduced by overlap PCR2. For m53R mutagenic PCR, the IGIC161 and 
IGIC162 complementary mutagenic primers were used in combination with primers 
3394F and 6034R as distal vector primers (Fig. 2.2). The restriction sites used to 
clone this mutagenised region back into the m53 clone were HindIII and SacII. In all 
cases, the insertion of the correct mutations was subsequently confirmed by 
sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
BSRT7 cells were plated in 6-well plates at a density of 7.5 x 105 cells/well in 
antibiotic free DMEM with 10 % FCS and incubated overnight at 37 oC 5 % CO2. The 
cells were incubated for 1 h with a fowlpox virus expressing T7 RNA polymerase at 
an m.o.i. (based on the virus titre in chick embryo fibroblasts) of 0.5 p.f.u. per cell in 
700 μl of antibiotics free DMEM (10 % FCS). Antibiotics free DMEM (10 % FCS) 
                                                 
2 m53R cloning was performed by Dalan Bailey.  
5’                                                         3’ 
3’                                                         5’ 
F1
R1
R2
1st PCRs 
 
 
 
 
 
 
 
 
2nd PCR 
 
Figure 2.2. Overlapping mutagenesis PCR. A set of initial PCR reactions was carried out using 
primer pairs F1-R1 and F2-R2. R1 and F2 are the mutagenic primers and are complementry to each 
other. The resulted PCR products were annealed at the region of the mutagenic primers and were 
extended. A second PCR was performed using primers F1 and R2 to amplify the mutated product.  
x 
x
x
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media were subsequently supplemented up to a final volume of 2 ml. 1 µg of each 
MNV cDNA construct was transfected using Lipofectamine 2000. To analyse protein 
expression, cells were harvested 24 h post-transfection for Western blot analysis. To 
examine the presence of infectious norovirus, cells were harvested 24 h post-
transfection, virus was released by two freeze–thaw cycles and the titres of virus were 
determined as TCID50/ml in RAW 264.7 cells, using microscopic visualization for 
the appearance of cytopathic effect.  
 
FCV, strain Urbana, and FCV mutants were recovered using the FCV full 
length infectious cDNA clone pQ14 and mutant derivatives (Sosnovtsev & Green, 
1995) after transfection of 1 μg of plasmid into CRFK cells infected with a Vaccinia 
poxvirus expressing T7 RNA polymerase (MVAT7).  
 
2.15. Determination of viral titre (TCID50/ml) 
 
 The titre of FCV and MNV was determined by serial dilutions of the virus 
containing media in a 96 well plate with dilutions spanning from 10-1 to 10-8. The 
fraction (%) of the infected wells in a number of repeats for each dilution was 
determined by the cytopathic effect of the virus on the cells. The viral titre was 
calculated using the following formulas: 
 
                
 
 
 
Σ 
  8 
 
      
i =1 
xi  y = 1 - × 100
-1 + 0.5   × 20 
xi = % infected wells per dilution, i = dilution as 10-i 
TCID50/ml = 10
 y
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2.16. MNV plaque assays 
 
Plaque morphology of the recovered MNVs was examined by plaque assay 
(Wobus et al., 2004). RAW 264.7 cells, maintained in media (MEM with 10% low-
endo FCS, 10mM HEPES pH7.6, 1% Penicillin/Streptomycin, 1% Glutamate), were 
seeded into 6 well plates (3.5 cm diameter) at a density of 3 x 106 cells per well and 
left overnight to reach a 80-90 % confluency. 1.5 ml 10-fold dilutions in complete 
DMEM media of virus inoculum were applied to the cell monolayer for 1 h at room 
temperature. The inoculum was aspirated and 1.5 ml 3 % low melting point 
SeaPlaque agarose (42 oC) (Lonza, Switzerland) mixed with 1.5ml 2x overlay MEM 
(37 oC) (Invitrogen) was added over the monolayer. After the agarose was solidified 
at room temperature the plates were incubated upside-down at 37 oC. Three days later 
methylene blue solution (1:1:1 of 1 % ethylene blue in ethanol: 1x PBS: Formalin [35-
40 % formaldehyde in solution]) was applied to the agarose and the cells were stained for 
3-4 h. The agarose plug was removed, the stained monolayer was washed in water and 
the plate was dried.  
 
2.17. DNA and RNA and siRNA transfection 
 
Cells were transfected with 1 μg of plasmid or RNA using 4 μl of 
Lipofectamine 2000 (Invitrogen) according to the manufacturer. For siRNA 
transfection, CRFK cells were plated at 4 x 105 cells per well in a 6-well dish. After 2 
h, the cells were transfected with 220 pmol/well of PTB P1 siRNAs (Domitrovich et 
al., 2005) using 4 μl of Lipofectamine 2000 following manufacturers protocol. After 
overnight incubation at 37 oC 5% CO2, the cells were split using trypsin into two 
                                   80
wells of a 6-well dish. A second transfection with 55 pmol/well of siRNAs followed 
and the cells were incubated overnight at 37 oC 5% CO2. The media was replaced and 
the cells were grown for a further 3 days. To control for non-specific effect of siRNAs 
cells were treated following the same procedure with siRNAs against GFP. 
 
2.18. Plasmid preparation  
 
DH5α cells were incubated on ice with 1μg of plasmid or 2 of ligation for 30 
minutes. The cells were heat shocked at 42 oC for 30 seconds and incubated for 1 h in 
SOC media (Invitrogen). The plasmid DNA was extracted from 1 ml of bacterial 
culture using alkaline lysis, phenol chloroform extraction and ethanol precipitation 
(Sambrook, 2001) Plasmid DNA from 100 ml cultures was extracted using Wizard 
Plus Midipreps DNA Purification System (Promega) according to the manufacturer. 
 
2.19. Luciferase assay 
 
The luciferase assay in cell lysates was performed using 100 μl of luciferase 
reagent (Promega) onto 5 μg of total protein from each cell lysate and the luciferase 
activity was measured in a luminometer.  
 
2.20. Confocal microscopy 
 
 CRFK cells were plated on round glass cover slips and infected with FCV 
(m.o.i of 0.5) for 9 h at 37 oC or for 16 h at 32 oC. The glass cover slips were washed 
with chilled PBS and fixed in 4 % paraformaldehyde solution containing 250 mM 
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HEPES pH 7.4 for 10 min on ice. An 8 % paraformaldehyde solution containing 250 
mM HEPES pH 7.4 was applied for 20 min at room temperature and the cells were 
subsequently washed 3x with PBS. 50 mM ammonium chloride was applied for 10 
min at room temperature and the cells were washed 3x with PBS. Permeabilisation of 
the cells was performed using 0.2 % Triton-X 100 in PBS for 10 min at room 
temperature and block buffer (1 % bovine serum albumin in PBS) was applied for 5 
min (3x).  
 
 Staining of cells for p76 and PTB was performed using a rabbit polyclonal 
antibody for p76 and a mouse monoclonal antibody for PTB (DH17). Image-iT FX 
signal enhancer was used according to the manufacturer (Invitrogen). The antibodies 
were diluted 1:200 in block buffer and applied on cells for 1 h. The excess antibody 
wash removed by 3x wash with block buffer for 5 min and the secondary antibodies 
were applied at an 1:500 dilution for 1h. Alexa Fluor 488 α-rabbit (Cat# A11030) 
(Invitrogen) was used as a secondary antibody for p76 and Alexa Fluor 546 α-mouse 
(Cat# A31628) was used as a secondary antibody for PTB. The cells were washed 3x 
with PBS for 5 min and instantly in ddH2O. The glass cover slips were mounted on a 
glass slide with 40 μl of Mowiol 4-88 (Calbiochem) containing 1 μg/ml of 4',6-
diamidino-2-phenylindole (DAPI). The cells were viewed with a Zeiss LSM 510 Meta 
confocal microscope, and the images were processed with Zeiss Meta 510 software 
(Carl Zeiss). For the quantification of staining intensity in specific areas of the 
confocal images Image Quant 5.0 software (Molecular Dynamics) was used as 
described previously  (Henics & Zimmer, 2006). 
 
 
                                   82
 
 
 
 
 
 
 
 
                                                
            
 
 
 
 
 
 
 
 
 
 
Chapter 3. 
Analysis of the role of PTB 
in the calicivirus life cycle 
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3.1. Introduction 
  
A large number of cellular proteins have been identified which interact with 
the 5’ and 3’ ends of cellular mRNAs (Erlitzki et al., 2002, Thomson et al., 2005) as 
well as the 5’ and 3’ ends of many viral RNAs (Gamarnik & Andino, 2000, Guest et 
al., 2004, Lu et al., 2004). As detailed in Chapter 1, these interactions often play a 
central role in genome translation and replication for many positive strand RNA 
viruses. A variety of techniques have been developed for the identification of host cell 
factors that interact with specific RNA structures, for example electrophoretic 
mobility shift assays (EMSAs) and functional analysis using fractions of cell extracts 
prepared by traditional chromatographic fractionation procedures, have previously 
been used to demonstrate the importance of PTB and unr for rhinovirus IRES activity 
(Borman et al., 1993, Hunt et al., 1999). In contrast, components of human telomerase 
were identified using a yeast three hybrid system in which the RNA component of the 
enzyme was used to screen a library of cellular proteins (Le et al., 2000). 
Northwestern analysis of EMSA complexes formed between iron response elements 
(IREs) and cellular extracts has been used to identify a wider variety of IRE 
regulatory proteins (IRPs) (Popovic & Templeton, 2005). More sophisticated methods 
which combine RNA affinity chromatography and mass spectrometry, have also been 
used for the identification of proteins which interact with the poliovirus (Blyn et al., 
1996) and HCV IRESs (Lu et al., 2004). The aim of the work presented in this chapter 
was to characterise the interaction between PTB and the calicivirus RNA and assess 
the role of the protein in the calicivirus life cycle. Although FCV and MNV data is 
presented side by side, MNV was only available during the latter part the project, 
hence, the studies on MNV were less developed.  
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3.2. PTB interacts with the 5' extremities of the calicivirus genomic 
and subgenomic RNAs in vitro. 
 
RNA affinity columns were generated in order to identify proteins which 
interact with the 5’ extremities of calicivirus genomic and subgenomic RNAs. These 
regions of the viral genomes were chosen as bioinformatics analysis indicated that 
they are predicted to contain a high degree of RNA structure (data not shown). In 
addition, RNA structures required for the translation and replication of positive strand 
RNA viruses are generally located at the extremities of the viral genome. RNA 
affinity columns were generated by coupling in vitro transcribed RNAs corresponding 
to the 5’ extremities of the FCV or MNV3 genomic and subgenomic RNAs to 
cyanogen bromide activated sepharose. The RNAs used in this study represented the 
first 245 nts of the FCV genomic RNA (5’G1-245), the first 285 nts of the FCV 
subgenomic RNA (5’SG1-285), the first 250 nts of the MNV genomic RNA (5’G1-250) 
and the first 200 nts of the MNV subgenomic RNA (5’SG1-200). Cytoplasmic extracts 
from HeLa cells, which are permissive to calicivirus replication, were applied to the 
RNA affinity columns. After extensive washing, proteins retained on the columns 
were analysed by SDS-PAGE. Silver staining revealed the proteins that were 
selectively retained by the RNA on the column (Fig. 3.1a). Western blot analysis 
using specific antisera was used as an initial approach to identify proteins which 
bound the calicivirus RNAs. A small number of proteins are regularly found in RNPs 
formed on the 5’ extremity of positive stranded RNA viral genomes, often playing 
crucial roles in translation or replication. As highlighted in chapter 1, one such protein 
is PTB, which has been found to interact not only with genomes of HCV, 
                                                 
3 MNV columns were made by Yasmin Chaudhry 
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coronaviruses and picornaviruses, but has also been reported to interact with the 
Norwalk virus genome, the prototype human calicivirus. PTB consensus binding 
sequences (Yx-UCUU-Yz)4 were identified in the FCV genomic and subgenomic 
RNA 5’ extremities. The thermodynamic predictions of the FCV 5’G1-245 and the 
MNV 5’G1-250 RNA secondary structures are presented in Figures 3.1c and 3.2 
respectively, with the potential PTB binding sequences highlighted. To determine if 
PTB was specifically retained by the calicivirus RNA sequences coupled to the 
affinity columns, elutions were analysed by Western blot for the presence of PTB 
(Fig. 3.1b). PTB was selectively retained by both the 5’ genomic and 5’ subgenomic 
extremities of FCV and MNV. The levels of PTB retained on the column containing 
non-specific control RNA (E. coli 5S ribosomal RNA) were similar to the background 
levels of protein retained by the beads alone, indicating that the retention of PTB was 
specific for the calicivirus RNA sequences. 
 
A drawback of using RNA affinity columns is that they do not always 
demonstrate a direct binding of the identified proteins to the RNA target as proteins 
may be retained indirectly via interactions with other proteins which interact directly 
with the target. In order to address the direct nature of the interaction, recombinant 
GST-tagged PTB was used in EMSAs in which the selected viral RNA transcripts 
were used as radiolabeled probes (Fig. 3.3 and 3.4). In order to limit non-specific 
RNA-protein interactions, the reactions contained a 280 fold excess of non-specific 
yeast t-RNA. Increasing concentrations of PTB were incubated in EMSA reactions  
 
 
                                                 
4 Y=pyrimidine x,z=random numbers  
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        Figure 3.1. Riboproteomic and bioinformatic analysis of PTB binding on FCV 
and MNV RNA. (a.) Proteins retained by the RNA affinity columns containing the 5’ genomic and 
5’ subgenomic RNAs analysed on a 12.5% polyacrylamide gel. The 5S ribosomal RNA and sepharose 
beads without RNA (-) were used as controls (b.) The thermodynamically predicted secondary structure 
of FCV 5’G1-245. The coloured bases show the sites of co-variation in some of the FCV strains that 
verify evolutionally the conservation of the secondary structure. The polypyrimidine stretches 
conserved among the different FCV strains are highlighted with a black line. Alignments of all the 
different strains of FCV for the polypyrimidine stretches are presented in the boxes and the numbers 
next to sequences show the number of strains in which a specific altered sequence is found (c.) Western 
blot for PTB of the proteins isolated on RNA affinity columns containing the FCV and MNV 5’G and 
5’SG RNAs. Columns containing the 5S ribosomal RNA or without RNA (-) were used as controls. 
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containing the FCV 5’G1-245 and 5’SG1-285 RNA probes and the amount of protein 
required to retard the mobility of approximately 40 – 50 % of the probe was 
determined (Fig. 3.3a). The optimum amount of PTB (0.5 μg) was subsequently used 
in competition EMSAs in order to address the specificity of the interaction. The 
formation of the PTB:5’G1-245-RNA complex was inhibited by the addition of 
unlabelled 5’G1-245 and 5’SG1-285 RNA transcripts (Fig. 3.3b). The same procedure 
was repeated using the FCV 5’SG1-285 RNA as radiolabeled probe (Fig. 3.2c) 
demonstrating the specific interaction of PTB with these important regions of the 
FCV genome. In both cases an RNA transcript representing the poliovirus 2C cis-
acting replication element (2C Cre) was used as a non-specific competitor RNA and  
did not inhibit complex formation. The band that was observed to have the same 
mobility as the complex, but which formed in the absence of recombinant protein  
 
 
 
 
 
 
 
 
 
Figure 3.2. Bioinformatics analysis of the 5’ end of the MNV genomic RNA. The 
thermodynamically predicted secondary structure of MNV 5’G1-250. The polypyrimidine stretches 
conserved among the different MNV strains are highlighted with a black line (BS1-5). 
BS2 
BS3 
BS4 
BS5 
BS1 
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(highlighted by an asterisk in the PA lane in Figure 3.3b), was likely to represent 
either an alternative fold of the RNA probe or a probe duplex. This complex was 
removed in most of the subsequent EMSAs by denaturing and reannealing the RNA 
probe prior to use.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 3.3. PTB binds specifically to the FCV 5’ genomic and 5’ subgenomic 
RNA extremities (a.) EMSA analysis examining the ability of PTB to interact with the 5’ extremity 
of the FCV genome (5’G1-245). RNA probes encompassing nts 1-245 of the FCV genome were 
incubated with increasing concentrations of protein and the reactions separated on an 4 % native 
acrylamide gel. (b., c.) EMSAs demonstrating successful inhibition of complex formation, between 
recombinant PTB and labelled FCV 5’ genomic (5’G1-245, b.) and 5’ subgenomic (5’SG1-250, c.) RNA 
probe upon addition of non-labelled 5’ genomic (5’G) and 5’ subgenomic RNA (5’SG). (PA = probe 
alone, N = no competitor RNA, NS = non specific RNA, CI = complex I, CII = complex II CIII = 
complex III and P= probe *=alternative structure of the RNA probe or probe dimer) 
PA          0.125 0.25 0.375    0.5   0.75   1.5     3.0 
μg GST-PTB 
CIII 
 
CII 
CI 
 
P 
PA  N   NS      5’G            5’SG PA  N   NS      5’G          5’SG 
0.5 μg GST-PTB                                      0.5 μg GST-PTB 
 FCV          FCV                                        FCV            FCV 
 
              (a.)                     
 
 
 
 
 
 
 
 
 
 
 
 
(b.)                                                           (c.) 
 
FCV 5’G1-245 
FCV 5’G1-245 FCV 5’SG1-285 
*
CIII 
 
CII 
CI 
 
P 
                                   89
PA  0.125 0.25   0.5   1.0     2.0    4.0  
μg GST-PTB 
CIII 
 
CII  
CI 
 
P 
† 
 
‡ 
PA   0.125 0.25   0.5   1.0     2.0    4.0  
μg GST-PTB 
CIII 
 
CII 
CI 
 
P 
        Figure 3.4. PTB binds specifically to the MNV 5’ genomic and 5’ subgenomic 
RNA extremities  (a., b.) EMSA analysis examining the ability of PTB to interact with  the 5’ 
extremity of the MNV genome (5’G1-250). RNA probes encompassing nts 1-250 of the MNV genomic 
RNA and nts 1-200 of MNV subgenomic RNA were incubated with increasing concentrations of 
protein and the reactions separated on an 4 % native acrylamide gel. (c.) EMSAs demonstrating 
successful inhibition of complex formation, between recombinant PTB and labelled 5’ G1-250 RNA 
probe, by non-labelled MNV 5’G1-250 (5’G) and 5’SG1-200 RNA (5’SG). (PA = probe alone, N = no 
competitor RNA, NS = non specific RNA, CI = complex I, CII = complex II CIII = complex III and P= 
probe, † and ‡ are alternative RNA conformations or probe multimers)  
    (a.)                    (b.) 
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Similar EMSAs were performed for the MNV 5’genomic and 5’ subgenomic 
extremities (Fig. 3.4a,b). In agreement with my previous data using RNA affinity 
columns, PTB bound less well to the MNV 5’genomic extremity than on the MNV 5’ 
subgenomic end in the EMSA experiments. The specificity of the interaction was also 
demonstrated using competition assays (Fig. 3.4c).  
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3.3. PTB interacts with the FCV RNA in infected cells. 
 
Although the in vitro data demonstrated PTB binding to the FCV and MNV 
genomes, it was important to demonstrate that this interaction also occurred during 
infection. To address this question, immunoprecipitation combined with RT-PCR (IP-
RT-PCR) was used to determine if PTB was associated with the viral genome during 
replication. Antibodies to PTB were first assayed for their ability to efficiently 
immunoprecipitate PTB from cell extracts (Fig. 3.5a). Two monoclonal antibodies 
(DH7 and DH17) to PTB were able to immunoprecipitate PTB efficiently from cell 
extracts (Fig. 3.5a) and were also able co-precipitate the FCV RNA from infected 
cells (Fig. 3.5b). One monoclonal (α-PTB DH3) and two polyclonal antibodies 
(mouse α-PTB St Cruz and guinea pig α-PTB) to PTB were either unable or not  
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        Figure 3.5. PTB interacts with the viral RNA in vivo. (a.) Western blot for PTB 
showing the ability of a variety of antibodies to immunoprecipitate PTB. (b.) RT-PCR for the 5’G1-245 
of the vRNA pulled down during the immunoprecipitation of PTB and p76 (protease-polymerase) from 
infected feline kidney cell cytoplasmic lysates. RT-PCR of the RNA extracted from the 
immunoprecipitation of GAPDH from infected cytoplasmic lysates and the α-PTB DH17 RNA (-RT) 
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efficient enough in PTB immunoprecipitation and thus they were not used for RNA 
immunoprecipitation (Fig. 3.5a). The viral RNA was detected by RT-PCR using 
primers which amplified the 5’G1-245 region of the FCV genomic RNA (Fig. 3.5b). 
Antisera to the viral RdRp, p76, was used as a positive control in the assay as it is in 
direct contact with the viral RNA during genome replication, while an α-GAPDH 
antibody was used as negative control in both PTB and FCV RNA 
immunoprecipitation (Fig. 3.5a,b). 
 
3.4. FCV replication is not affected by overexpression of PTB 
  
To begin to elucidate a role for the interaction of PTB with the viral RNA, PTB1 was 
overexpressed in CRFK cells and the effect on virus replication monitored (Fig. 3.6a). 
The hypothesis was that if PTB regulated calicivirus life cycle its overexpression 
could stimulate or repress viral replication. Transient expression of PTB1 in CRFK 
cells resulted in a 90% increase of PTB1 levels. To assess the effect of PTB 
overexpression on calicivirus replication, CRFK cells overexpressing PTB1 and 
control cells were infected with FCV at a multiplicity of infection (m.o.i.) of 4. The 
one step growth curve of FCV showed that the viral titre was unaffected by the 
increased PTB levels (Fig. 3.6b). The lack of effect of PTB overexpression on viral 
replication was further confirmed by northern blot detection of the genomic and 
subgenomic RNA levels, as well as the detection of the viral polymerase, p76 by 
western blot (Fig. 3.6c). 
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3.5. RNAi-mediated knockdown of PTB 
 
 An approach that has been increasingly used for the study of the role of 
proteins in cells is RNAi mediated knockdown of protein expression. When siRNAs, 
small RNA sequences specific for the target mRNA, are transfected into cells, they 
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        Figure 3.6. Calicivirus replication is not affected by overexpression of PTB1  
(a.) Western blot for PTB demonstrating increased levels of PTB1 after transient expression in CRFK 
cells. (b.) One step growth curve of FCV (m.o.i. of 4) in cells overexpressing PTB and control cells. (c.) 
Western blot analysis of the expression of the viral polymerase, p76, in cells overexpressing PTB and 
control cells at various time points post infection (p.i.) and northern blot detection of genomic (G) and 
subgenomic (SG) RNAs at the same time points. 
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     Figure 3.7. RNAi-mediated 
PTB knockdown has a dramatic 
effect on poliovirus translation  
(a.) Western blot analysis of PTB 
demonstrating decreased levels of all 
PTB isoforms after transfection of 
CRFK cells with PTB and GFP (control) 
specific siRNAs. (b.) Luciferase 
production driven by the poliovirus 
IRES in CRFK cells treated with PTB 
and GFP specific siRNAs. 
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si RNA
activate the RNA induced silencing system of 
the cell, leading to specific degradation of the 
target mRNA (Elbashir et al., 2001). siRNA 
mediated knockdown of PTB has been shown 
to effectively impede HCV replication 
(Domitrovich et al., 2005) and poliovirus 
translation (Florez et al., 2005). PTB siRNAs 
(Domitrovich et al., 2005) were used to 
reduce PTB expression in CRFK cells. 
Western blot analysis demonstrated that the 
levels of PTB were decreased by 80% (Fig. 
3.7a). Since the knockdown was not 
complete, very common in RNAi 
experiments, the effect of the PTB reduction  
on translation of the PTB dependent IRES of 
poliovirus (Toyoda et al., 1994) was 
examined (Fig. 3.7b). An RNA construct 
expressing luciferase under the control of the poliovirus IRES was transfected into 
CRFK cells which had been previously transfected with the PTB specific siRNAs. 
The luciferase signal from the cells underexpressing PTB was reduced by 99.5 % 
compared to the cells transfected with the control green fluorescence protein (GFP) 
specific siRNAs (Fig. 3.7b). The almost complete inhibition of the poliovirus IRES 
function demonstrated that the levels of PTB knockdown were sufficient to 
demonstrate a role of PTB in cells. 
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3.6. FCV replication is affected by RNAi-mediated knockdown of 
PTB in a temperature dependent manner 
 
 As the levels of PTB knockdown were sufficient to inhibit poliovirus 
translation, the ability of FCV to grow under reduced PTB levels was investigated. 
CRFK cells transfected with either PTB or control GFP siRNAs, were infected with 
FCV at an m.o.i of 4 and the growth kinetics of the virus was examined (Fig. 3.8a). 
The growth curve demonstrated only a small decrease in virus production of not more 
than 40 % at 6 hours post infection (p.i.), while the titre at 3 and 9 hours post infection 
was essentially unaffected (Fig. 3.8a). Western blot analysis demonstrated that PTB 
knockdown had a limited effect on the production of the viral polymerase, p76. Band 
quantification using a densitometry scanner demonstrated a reduction of p76 
expression of approximately 30 % at 3 h p.i., 35 % at 6 h p.i., and 25 % at 9 h p.i. 
(Fig. 3.8b). Such a limited effect on the viral protein expression may explain the 
insignificant effect of PTB knockdown on the overall virus yield.  
 
A major parameter affecting RNA conformation and consequently its 
interactions with RNA binding proteins is temperature (Moulton et al., 2000). At 
lower temperatures unfavourable base pairing can be stabilised, while at higher 
temperatures base paring essential for the functionality may be disrupted. CRFK cells 
transfected with PTB and control (GFP) siRNAs were infected in suspension and 
subsequently incubated on a PCR block in order to achieve an accurate (±0.1 oC) and 
constant temperature. Infection of cells at a range of temperatures (32-39 oC) with 
FCV (m.o.i. of 4), showed a differential effect of PTB knockdown on viral 
polymerase (p76) production 6 hours p.i. (Fig. 3.9). The effect was more apparent at 
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extreme temperatures (32 and 39 oC) where the viral polymerase levels (p76) were 
approximately 20 % of the levels observed in the control cells at the same 
temperature. In contrast, at 37 oC the levels of p76 were 65 % of the control (Fig. 3.9), 
verifying the limited effect discussed in the previous paragraph.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 3.8. Limited effect of RNAi-mediated knockdown of PTB on FCV 
replication at 37 ºC (a.) One step growth curve of FCV (m.o.i of 4) in cells treated with PTB and 
control GFP specific siRNAs. (b.) Western blot for viral polymerase (p76), PTB and GAPDH (control) 
during the FCV infection in the PTB and GFP siRNA treated cells. (p.i. = post infection) 
0       3       6       9       0       3       6       9 
 
GFP siRNAs             PTB siRNAs 
 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
p76 
 
PTB 
 
 
GAPDH 
Hours p.i. 
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In order to determine the effect of PTB knockdown on calicivirus replication 
at a temperature in which this effect was apparent, FCV (m.o.i of 4) was used for the 
infection of PTB and control siRNA treated cells at 32 oC. 32 oC was chosen for 
further analysis as the virus replication, even in the control cells, was severely 
inhibited at 39 oC.  During the course of the infection, virus yield was measured at 3, 
6, 9, and 18 hours p.i. (Fig. 3.10). At 6 hours p.i. a 99 % reduction of virus production 
was observed and at the consecutive time points, 9 and 18 hours p.i., virus yield was 
reduced by 95 % and 93 % respectively in PTB siRNA transfected cells compared to 
control transfected cells (Fig. 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 3.10. FCV yield is reduced by RNAi-mediated knockdown of PTB at 32 
ºC. FCV growth kinetics after infection of CRFK cells treated with PTB and GFP (control) siRNA cells 
at a multiplicity of infection of 4.   
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3 6 9 18 3 6 9 18
PTB siRNA
GAPDH
PTB
Capsid
GFP siRNA
p76
Hours p.i.
       Figure 3.11. FCV protein expression is inhibited by PTB knockdown at 32 ºC. (a.) 
FCV polymerase (p76) and major capsid protein were detected by western blot during infection of PTB 
siRNA transfected and control (GFP siRNAs) cells. (b.) The levels of both proteins are plotted as 
percentage of the respective protein production in control cells at 18 hours p. i.. 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
Calicivirus non-structural proteins, such as the polymerase p76, are produced 
by translation of the genomic RNA, while the major (VP1) and minor (VP2) capsid 
proteins are produced by the translation of the subgenomic RNA. The levels of the 
viral polymerase (p76) and major capsid protein were determined by western blot for 
all the time points p.i. (Fig. 3.11a). The production of both proteins was severely 
affected demonstrating a similar response to the PTB knockdown. At 6 hours post  
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infection protein production was reduced by 90 %, by 79 % at 9 h and by 60 % at 18 h 
p.i. (Fig. 3.11b). RNA production was also affected by PTB knockdown, as shown by 
northern blot analysis for genomic and subgenomic RNAs (Fig. 3.12a). The  
production of both RNAs was equally inhibited with the inhibition ranging from 60% 
at 6 h p.i. to 30 % at 18 h p.i. (Fig. 3.12b,c). Such a profound effect on the viral 
replication signified a role of PTB in the viral life cycle. The fact that translation and 
replication are highly interdependent during a normal virus infection meant that no 
specific role for PTB in one or the other stage could be attributed as part of this study; 
but an attempt to address this is described later in this chapter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G
SG
3 6 9 18 3 6 9 18
GFP siRNA PTB siRNA
Hours p.i.
       Figure 3.12. Calicivirus RNA production is inhibited by PTB knockdown at 32 
ºC. (a.)  Genomic (G) and subgenomic (SG) RNA from calicivirus infected cells underexpressing PTB 
(PTB siRNA) or control (GFP siRNA) cells was detected by Northern blot analysis of RNA from cells 
infected at 32oC. The levels of (b.) genomic and (c.) subgenomic RNA were plotted as percentage to the 
levels of genomic RNA production at 18 hours p.i. in the control GFP siRNA transfected cells. 
                       (a.) 
 
 
 
 
 
 
 
 
 
(b.)               (c.) 
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3.7. PTB binds at least on two sites of FCV genomic RNA 5’ end in 
a synergistic manner. 
  
 To further characterise the interaction between PTB and the FCV genomic 
RNA 5’G1-245, truncations of the region were used as radiolabeled probes for EMSA 
analysis. The predicted PTB consensus binding sequences (Fig. 3.13a) were taken 
into consideration during the design of the truncations in order to analyse different 
combinations of the potential binding sites. The secondary structure of the region was 
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                                           ORF START
245
163
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223
32 
118
128
S1 
SL1 
S2 
SL3 SL4 
SL2 
SL6
SL5 
 
            BS1                            BS3 
                         
                     BS2
        
 
 
                                       BS4 
 
 
Figure 3.13. Mapping of the PTB binding site(s) on the FCV 5’G1-245. (a.) The secondary 
structure of nucleotides 1-245 of the FCV genomic RNA (5’G1-245) as predicted thermodynamically. 
The four potential binding sites of PTB are highlighted with red letters and the structural elements 
(stems,S and stem-loops,SL) are annotated in italics. The continuous arrows indicate the nucleotide 
positions which represent the 3’ end of RNA transcripts that start from 1st nucleotide of the 5’G1-245 
(3’end truncations), while the dashed arrows indicate the nucleotide positions that represent the 5’ end 
of RNA transcripts that terminate at  nucleotide 245 of the 5’G1-245 (5’end truncations) (b.) Alignment 
of the synonymous mutations (mt) with the wild-type (wt) sequence of FCV in three of the potential 
binding sites that were used in the mutational analysis of PTB binding on the FCV 5’G1-245. Underneath 
each alignment the full-adenine substitutions for each potential biding site are presented 
    R  R  D  L  Q  Y  
mt AGGCGCGACTTGCAGTAT 
wt AGGCGCGATCTTCAGTAT 
   ********  * ****** 
FA AGGCGCGAAAAAAAGTAT 
    L  Q  Y  L  Y  N 
mt CTTCAGTACTTGTATAAC 
wt CTTCAGTATCTTTATAAC 
   ********    ****** 
FA CTTCAGTAAAAAAATAAC 
 
    A  C  P  S  C  A  
mt GCTTGTCCAAGTTGTGCC 
wt GCTTGTCCTTCTTGTGCC 
   ********   ******* 
FA GCTTGTAAAAAAAGTGCC 
 
BS1                                   BS2                                 BS3 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
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also taken also into account in order to reduce, where possible, the effect of 
truncations on the native RNA conformation (Fig. 3.13a). As no biochemical data 
existed on the structure of the FCV 5’ end, free energy minimisation algorithms and 
evolutional co-variation were used to predict the RNA secondary structure presented 
in Figures 3.1 and 3.13a. 
 
Two sets of truncations were tested for their ability to form a complex with 
PTB. The FCV 5’G1-245 was truncated at the 3’ end producing RNA transcripts 
encompassing nucleotides (nts) 1-111, 1-163, 1-202 and 1-223. Nts 1-111 did not 
contain any of the PTB consensus sequences, 1-163 encompassed the BS1 and BS2 
potential binding sites and 1-223 sequence contained the BS1, BS2 and BS3 
consensus sequences (Fig. 3.13a). The FCV 5’G1-245 was also truncated at its 5’ end 
producing transcripts that encompassed nts 32-245, 118-245 and 128-245 RNAs. Nts 
32-245 contained all predicted PTB consensus sequences, but lacked the first stem 
loop of the original 5’G1-245, 118-245 encompassed  BS2, BS3 and BS4 potential 
binding sites and nts 128-245 contained  BS3 and BS4 consensus sequences (Fig. 
3.13a). As the only purpose of this series of EMSAs was to crudely identify the PTB 
binding site(s), the affinities are expressed using a rather arbitrary scale in which the 
affinity of PTB for the RNA probe representing the 5’G1-245 RNA sequence is 
represented as: “++++” (Fig. 3.14). Also, the fact that the preparation of PTB used in 
these experiments had a small quantity of truncated products made difficult the 
accurate calculation of affinities. Titration of PTB on the 1-111 sequence 
demonstrated that it has no ability to interact with PTB, not unexpected since there is 
no pyrimidine rich stretch in this region. Addition of the first two potential binding  
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Figure 3.14. Mapping of the PTB binding site(s) on the FCV 5’G1-245. (a.) Titration of 
PTB on RNA probes that represent the 3’ and 5’ end truncation of the 5’G1-245 RNA. (b.) Graphic 
illustration of the different RNA transcripts used to evaluate the contribution of the different potential 
binding sites (    ) in PTB binding (PA = probe alone, ++++ = 5’G1-245 affinity for PTB, - = absence of or 
residual affinity to PTB, nts = nucleotides) 
111 
              1-111                                         1-164                                       1-202  
                 32-245                                     118-245                                    128-245   
PA                                              PA                                          PA 
  
 
 
 
 
 
 
 
 
PA                                            PA                                            PA 
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1-245 
 
128-245 
 
118-245 
 
32-245 
 
1-202 
 
1-164 
 
1-111 
 
++++ 
- 
+ 
++++
++++ 
++ 
- 
μg GST-PTB 
PA 4.0   2.0   1.0   0.5  0.25 0.125 
      
                               (a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  (b.) 
 
 
 
 
 
 
 
 
GST-PTB                                   GST-PTB                                 GST-PTB 
 
 
 
 
 
 
 
 
 
GST-PTB                                GST-PTB                                  GST-PTB 
 
1-245
               relative  
  nts                                       affinity 
                                   103
sites and stem loop 4 (SL4) (1-164) dramatically increased the affinity of the RNA for 
PTB. The further addition of BS3 and SL5 (1-202) restored the affinity of the RNA 
for PTB to the 5’G1-245 level. The deletion analysis demonstrated that BS4 and 
sequences downstream of nucleotide 202 did not contribute to PTB binding. Indeed, 
BS4 was not conserved in FCV sequences that became available later (Fig. 3.1c). 
Deletion analysis from the 5’ end of the 5’G1-245 RNA demonstrated that deletion of 
the nucleotides 1-127, containing BS1 and BS2 (128-245), led to the abolishment of 
PTB binding, while addition (to this probe) of BS2 (118-245) partially restored PTB 
binding. Interestingly, deletion of nucleotides 1-31 increased the binding of PTB on 
the RNA, possibly because disruption of stem 1 (S1) made the BS2 region single 
stranded (Fig. 13a). Finally, deletion of nts 1-31 and 118-245, producing an RNA that 
encompassed BS1 only, was not able to form a complex with PTB. The above 
deletion analysis showed that the most critical potential binding site was BS2 as all 
RNA probes containing BS2 were able to bind PTB, while probes lacking this region 
demonstrated minimal or no PTB binding activity. 
 
     The deletion analysis was followed by mutational analysis of the potential 
PTB binding sites (Fig. 3.15). However, as all the potential binding sites were located 
in the protein-coding region, the mutations had to preserve the original amino-acid 
sequence (synonymous nucleotide changes) while changing the pyrimidine rich 
sequence. This was not as important for the in vitro binding assays as it was for the 
assessment of the effect of these mutations in virus replication. A synonymous mutant 
RNA produced for BS2 was tested in EMSAs and demonstrated wild-type levels of 
PTB binding (Fig. 3.13b). Synonymous mutations were introduced in the other  
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Figure 3.15. Mutational analysis of PTB binding sites on the FCV 5’G1-202 by 
electrophoretic mobility shift assays. (a.) EMSAs in which increasing amounts of PTB are 
incubated with wild-type (wt) and mutated (mBS2+3) FCV 5’G1-202 RNA probes. (b.) The fraction (%) of 
the probe in complex under increasing amounts of GST-PTB for EMSAs that contain 5’G1-202 probes with 
different combinations of the mutations in the PTB potential binding sites BS1, BS2 and BS3. (c.) 
Graphic illustration of the different RNA transcripts used to evaluate the contribution of the different 
potential binding sites (     ) in PTB binding after the mutational analysis. The blue stars highlight the 
potential binding sites that were mutated in each RNA probe. (PA= probe alone, ++++ = wt affinity of 
5’G1-202 for PTB) 
 
μg GST-PTB                        μg GST-PTB 
 PA                                      PA  
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potential binding sites (Fig. 3.13b) and as for BS2, demonstrated wild-type affinity 
for PTB (Fig. 3.15). A second set of mutant RNAs was constructed in which 
synonymous mutations in the potential binding sites of PTB were introduced in all 
possible combination (BS1+BS2, BS1+BS3, BS2+BS3 and BS1+BS2+BS3). The 
triple RNA mutant showed a dramatic reduction in PTB binding while the only 
double mutant that demonstrated a defect in PTB binding was BS2+BS3 (Fig. 3.15). 
As the PTB binding curve for the BS2+BS3 mutant RNA was the same as the triple 
mutant it was considered as the minimum combination of mutations required for the 
reduction in PTB binding.   
 
Even if in vitro PTB binding was significantly reduced in the mutated RNAs, 
some residual binding activity remained. This signified that at least one additional 
region, which did not correspond to any of the evolutionally conserved pyrimidine 
rich tracts, contributed the observed lower binding affinity of the RNA to PTB. All 
the above mutational analysis was repeated using RNAs in which the polypyrimidine 
tract had been fully substituted by adenines (full(A) substitutions). PTB binding of the 
full(A) mutant RNAs was exactly the same as with the synonymous mutations, 
showing that the binding that was observed for the synonymous mutant RNAs was 
not due to the remaining pyrimidines in the potential binding sites (data not shown). 
 
3.8. Viruses with reduced affinity for PTB have the same growth 
kinetics as the wild-type virus in tissue culture 
 
The main reason for the identification of the PTB binding site was to 
investigate a potential defect of a virus with a reduced ability to bind PTB. The 
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synonymous mutations that reduced PTB binding at the 5’ genomic extremity were 
cloned into the FCV full length clone, pQ14, either individually (m14:BS2, m26:BS3) 
or in combination (m2:BS2+BS3)5. The viruses were produced through transfection 
of the mutated FCV infectious clones into BSRT7 cells infected with a modified 
strain of Vaccinia virus expressing T7 polymerase (Fig. 3.16a). This Vaccinia virus 
strain although unable to go through a full replication cycle in BSRT7 cells shows 
limited expression, which produces recombinant T7 polymerase. The T7 polymerase, 
using the promoter upstream of the viral cDNA, creates a large number of transcripts 
that express the viral proteins, while a minority of them are able to replicate and 
produce infectious virus. The recovered viruses were amplified, their sequence 
confirmed and their growth kinetics compared to the wild-type virus (Fig. 3.16b). All 
three mutant viruses were able to replicate at rates similar to the wild-type indicating 
that the introduced mutations did not confer any significant attenuation to the virus in 
CRFK cells. No increase in temperature sensitivity of virus replication was observed 
at 32 or 39 oC for all three mutant viruses while they also demonstrated the same 
response to PTB knockdown as wild-type virus (data not shown).  
 
 
 
 
 
 
 
 
                                                 
5 FCV mutant clones were made by Stanislav Sosnovtsev (NIH, Maryland, USA) 
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NS1/2 NS3 NS4 NS5 NS6 NS7 VP2
VP1
T7                         cDNA clone 
Vaccinia T7 BSRT7 
cells 
ORF2 
ORF1                                                              ORF3 Recovered 
calicivirus 
 
mBS2 
 
mBS3 
 
mBS2+3 
 
wt 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
 
Figure 3.16. Recovery of genetically defined FCV which contain mutations in the 
PTB binding sites. (a.) Schematic representation of the procedure followed during the reverse 
genetics recovery of the mutant viruses. Briefly, the viral cDNA infectious clone was transfected into 
BSRT7 cells infected with Vaccinia virus T7 and the recovered viruses were harvested amplified and 
retitred. The sequence was confirmed prior to use in growth curves (b.) Growth kinetics of the infection 
in CRFK cells for the mutant FCVs (m14 = mBS2, m26 = mBS3 and m2 = mBS2+3) at 37 oC and at a 
multiplicity of infection of 0.4.
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3.9. PTB inhibits FCV in vitro translation  
 
In order to define the stage of the virus life cycle at which PTB might be 
involved, isolation of the two main processes, translation and replication, was 
required. The lack of a replicon system for FCV made the study of a translation 
independent FCV replication almost impossible. Additionally, the unique mechanism 
of calicivirus translation made the investigation of FCV translation in cells rather 
difficult. As explained thoroughly in the general introduction, FCV and the vast 
majority of caliciviruses require the interaction of the translation machinery with the 
VPg protein linked to the 5’ end of the viral RNA. Transfection of an in vitro 
synthesised RNA would require the prior attachment of VPg to its 5’ end in order to 
be translated, but such a method is not yet available. However, an in vitro translation 
system was recently developed (Goodfellow et al., 2005), thereby allowing the 
investigation of the requirements of the calicivirus translation machinery. As PTB is a 
well known regulator of picornavirus translation (Niepmann et al., 1997) its effect on 
FCV translation was assessed by titration of recombinant his-PTB in a rabbit 
reticulocyte lysate (RRL) FCV in vitro translation assay (Fig. 3.17). Addition of 
increasing amounts of PTB was followed by declining production of in vitro 
synthesised FCV proteins (Fig. 3.17). In order to verify that the inhibition of FCV 
translation by PTB was specific, in vitro synthesised 5’G1-245 RNA was titrated into 
the reactions containing exogenous PTB (Fig. 3.17). Results indicated that addition of 
the FCV 5’G1-245 RNA restored FCV translation back to normal levels (Fig. 3.17).  
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A capped and polyadenylated bicistronic RNA expressing the CAT enzyme 
from the 5’ cap structure and firefly luciferase from the FMDV IRES (5’cap-CAT 
FMDV-IRES-Luciferase 3’ poly(A)tail) was used  to assess the effects of PTB (or the 
impurities regularly found with purified proteins) on the general cap-dependent and 
IRES-dependent translation (Fig. 3.18). Upon addition of low amounts of PTB into 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
 
               0ng      70ng    140ng    280ng   0.5μg    1.0μg    1.5μg   
280ng 3CD 
+1.5 μg 5’G
280ng PTB  
+ 5’G    PTB 
              0ng      70ng     140ng   280ng    0.5μg    1.0μg     1.5μg   280ng 3CD
+1.5 μg 5’G 
LC 
p76 
 
C  
 
 
p39 
p32, p30 
 
 
 
Figure 3.17. Inhibition of FCV in vitro translation by PTB. (a.) Effect of addition of his-
PTB on FCV in vitro translation that demonstrates the reduced expression of FCV proteins that are 
produced by the translation of ORF1 (from the genomic RNA) and ORF2 (from the subgenomic RNA). 
The 35S methionine labelled FCV proteins were analysed by SDS-PAGE. Addition of increasing 
amounts of 5’G1-245 RNA on top of PTB led to the recovery of the FCV translation. (b.) Bar chart 
illustrating the efficiency of FCV translation as % of the control (0ng PTB) as measured by phosphor-
imager densitometry quantification. LC = leader peptide + capsid, C = capsid p76, p39, p32 and p30 are 
various other proteins of FCV. 3CD is the poliovirus protease-polymerase and 5’G is the FCV 5’G1-245. 
Error bars represent the standard deviation from three different experiments 
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the translation reactions cap dependent translation was not affected, while FMDV 
translation demonstrated a rather insignificant increase (Fig. 3.18). Under the same 
conditions FCV translation was reduced by 40 and 60 % at 70ng and 140ng of PTB 
respectively (Fig. 3.17). This fact along with the rescue of FCV translation by 5’G1-245 
signified that the inhibitory effect of PTB is caused specifically by its interaction with 
the FCV RNA. Only at the highest concentration of PTB were both FMDV and cap 
dependent translation affected (Fig. 3.18). In contrast to FCV translation, titration of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               0ng      70ng    140ng    280ng   0.5μg    1.0μg    1.5μg   
280ng PTB  
+ 5’G    PTB 
FMDV IRES 
cap 
FMDV IRES -
firefly 
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cap -CAT 
 
 
 
Figure 3.18. Effect of PTB on cap-dependent and FMDV-IRES dependent in vitro 
translation. (a.) Increasing amounts of his-PTB and 5’G1-245 in the in vitro translation of a bicistronic 
RNA construct that expressed the CAT enzyme under the cap structure and firefly luciferase under the 
FMDV IRES. Increasing amounts of FCV 5’G1-245 RNA on top of PTB were used to asses the 
specificity of the effect of PTB on translation. The 35S methionine labelled CAT and firefly luciferase 
were analysed by SDS-PAGE. (b.) Bar chart that illustrates the efficiency of cap- and FMDV IRES-
dependent translation as % of the control (0ng PTB) as measured by phosphor-imager densitometry 
quantification. Error bars represent the standard deviation from three different experiments 
his-PTB        0ng       70ng    140ng     280ng    280ng   280ng    280ng 
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Figure 3.19. The inhibition of FCV in vitro translation by PTB is temperature 
dependent. (a.) Addition of 140ng of his-PTB in the FCV in vitro translation under different 
incubation temperatures. The proteins expressed from the FCV genomic and subgenomic RNA labelled 
with 35S methionine were analysed by SDS-PAGE in 12.5 % polyacrylamide gel. (b.) Illustration of the 
efficiency of FCV translation before and after addition of his-PTB. The raw data in phosphor imager 
arbitrary units is presented as a bar chart by the Y1 axis for every incubation temperature, while the line 
(Y2 axis) represents the relative inhibition (as % of the –PTB control) of FCV translation upon addition 
of his-PTB at every incubation temperature.  LC = leader peptide + capsid, C = capsid 
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the FCV RNA. Only at the highest concentration of PTB were both FMDV and cap 
dependent translation affected (Fig. 3.18). In contrast to FCV translation, titration of 
5’G1-245 RNA transcript did not restore the levels of either cap-dependent or IRES-
dependent translation, leading to the assumption that some other factor(s) co-purified 
with PTB, rather than PTB itself, may have been responsible for the inhibitory effect.  
 
3.10. Inhibition of FCV in vitro translation is temperature 
dependent 
 
 The analysis of the effect of PTB knockdown using siRNAs showed a 
temperature dependent effect on the virus growth that led to the hypothesis of a 
potential involvement of the well documented RNA chaperone activity of PTB. 
Therefore, in vitro translation assays were incubated at various temperatures to assess 
the temperature dependence of the PTB inhibitory effect on FCV translation. Indeed, 
at 30 oC, which is the optimum in vitro translation temperature, the inhibitory effect of 
PTB was less apparent than it was at temperatures lower or higher (Fig. 3.19).  
 
3.11. FCV translation is enhanced by RNAi-mediated knockdown 
of PTB 
  
As stated above the requirement of VPg protein at the 5’end of the FCV RNA 
for its translation excluded the possibility of experiments on calicivirus translation in 
tissue culture using in vitro transcribed RNA. During virus replication a subgenomic 
RNA (sgRNA) is produced from the 3’ half of the viral genomic RNA, which 
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similarly to the genomic RNA is translated using the VPg protein. However, the 
sgRNA does not produce the viral polymerase as it codes only for the major (VP1) 
and minor (VP2) proteins. Thus, if the sgRNA was present in cells without the 
genomic RNA it would be able to produce the capsid proteins, but lacking the 
polymerase it wouldn’t be able replicate. An attempt to separate the two major 
processes of calicivirus life cycle, translation and replication, in tissue culture was 
made by specifically digesting the genomic RNA with RNase H. A DNA 
oligonucleotide complementary to the coding region of the RdRp (p76) was annealed 
to the viral RNA preparation and the complex was digested by the DNA:RNA hybrid 
specific RNase H. The efficiency of RNase H in removing the genomic RNA was 
assessed by in vitro translation of the digestion reaction in RRLs (Fig. 3.20a). The 
viral RNA treated with a non-specific oligonucleotide produced a normal FCV protein 
profile, while the RdRp specific oligonucleotide resulted in the elimination of all the 
genomic RNA produced proteins. The FCV major capsid protein is produced as a 
premature protein (LC) attached to a leader peptide that is subsequently removed by 
the viral protease that is fused to the RdRp in p76 protein. The absence of p76 in the 
protein profile is not only apparent directly but also indirectly by the fact that the LC 
remained uncleaved. The identity of the bands corresponding to the LC and the capsid 
in the FCV in vitro translation were verified by immunoprecipitation using an α-
capsid antibody (Fig. 3.20a). The RdRp specific RNase H digested viral RNA that 
contained only the sgRNA was transfected into CRFK cells treated with PTB and 
GFP specific siRNAs to assess the effect of PTB knockdown in the viral translation. 
As shown by western blot for the major capsid protein, the production of protein from 
the subgenomic RNA was highly induced in the absence of PTB. This fact signified 
that siRNA-mediated knockdown of PTB reduced the inhibition in FCV translation 
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caused by the presence of PTB (Fig. 3.20b).  However, the protein that was detected 
had a similar molecular weight to the mature major capsid protein that is present in 
infected cells and virions (Fig. 3.20b), while the premature LC precursor protein, 
produced by the subgenomic RNA in the absence of p76, could not be detected. The 
LC protein produced during transfection of subgenomic RNA construct was used as a 
control in the assay. The pT7SG+R plasmid that expressed subgenomic RNA under 
T7 promoter was transfected into CRFK cells infected with MVAT7. The absence of  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20. Isolation of FCV sgRNA and the effect on its translation during RNAi 
mediated knockdown of PTB. (a.) In vitro translation of FCV RNA after RNase H digestion using 
an FCV genomic RNA specific DNA oligonucleotide (FP) and a control DNA oligonucleotide (CP). 
Immunoprecipitation with α-major capsid (VP1) from the in vitro translation of FCV RNA after RNase 
H digestion using an FCV genomic RNA specific DNA oligonucleotide (FP) and a control DNA 
oligonucleotide (CP). The proteins were labelled with 35S methionine and the SDS-PAGE analysis was 
exposed to a phosphor imager screen (b.) Western blot for the major capsid protein (VP1) in infected 
CRFK cells, purified virus, produced by transfection of the sgRNA-coding pT7SG+R plasmid in CRFK 
cells after infection with MVAT7, non-transfected CRFK cells, and CRFK cells treated with PTB or 
GFP siRNAs that have been transfected with FCV RNA digested with RNase H using an FCV specific 
DNA oligonucleotide (c.) Illustration of the specific digestion of the FCV genomic RNA using the 
IGRDG54 oligonucleotide complementary to p76-coding region (primer) and RNase H. (LC=leader 
capsid, C=capsid, NS=non specific) 
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LC could indicate a possible residual presence of p76 in the cells as a consequence of 
a small proportion of genomic RNA that possibly remained uncleaved after RNase H 
treatment. However, p76 could not be detected by western blot in the same cell lysates 
(data not shown). 
 
3.12. PTB translocates from the nucleus to the cytoplasm during 
FCV infection 
 
To examine the localisation of PTB during FCV infection confocal 
microscopy was used. Infected CRFK cells were probed for PTB and the viral 
polymerase, p76, as a marker for the viral replication complexes. The localisation of 
PTB is normally nuclear, unless the cell undergoes cell division (Fig. 3.21.1). During 
FCV infection of CRFK cells at 37 oC PTB remained predominantly nuclear, while in 
a small number of cells a cytoplasmic fraction of PTB was also present (Fig. 3.21.1). 
However, there was no major redistribution of PTB in the vast majority of infected 
cells (data not shown). The situation was different when the infection was carried out 
at 32 oC. At 32 oC the levels of PTB in the nucleus of the infected cells showed an 
approximately 70% decrease compared to the non-infected cells (Fig. 3.21.2 and 
3.23). The cytoplasmic portion of PTB, present at low levels in normal cells, showed 
an approximately 10x increase in the infected cells (Fig. 3.22 and 3.23). An 
interesting observation was that increasing levels of the viral polymerase, p76, 
resulted in decreasing levels of nuclear PTB in infected cells (Fig. 3.7), while cells at 
the very late stages of the infection had nearly undetectable levels of PTB (data not  
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Figure 3.21.1 Distribution of PTB in FCV infected cells at 37 oC. CRFK cells were 
infected with FCV for 9 h at 37 oC and at an m.o.i. of 0.5. Infected and control cells were fixed and 
stained for p76 (green) and PTB (DH17 monoclonal) (red). DAPI was used for nuclei (blue) staining. 
The cells were observed using confocal microscopy.  
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Figure 3.21.2 FCV infected cells have reduced levels of PTB in the nucleus at 32 oC. 
CRFK cells were infected with FCV for 16 h at 32 oC and at an m.o.i. of 0.5. Infected and control cells 
were fixed and stained for p76 (green) and PTB (DH17 monoclonal) (red). DAPI was used for nuclei 
(blue) staining. The cells were observed using confocal microscopy.  
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Figure 3.22. FCV infected cells have increased levels of PTB in the cytoplasm. CRFK 
cells were infected with FCV for 16 h at 32 oC and at an m.o.i. of 0.5. Infected and control cells were 
fixed and stained for p76 (green) and PTB (DH17 monoclonal) (red). DAPI was used for nuclei (blue) 
staining. The cells were observed using confocal microscopy.  The white arrow indicates the cell with 
high levels of p76 
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Figure 3.23. FCV infected cells have increased levels of PTB in the cytoplasm and 
decreased levels in the nucleus. CRFK cells were infected with FCV for 16 h at 32 oC and at an 
m.o.i. of 0.5. Infected and control cells were fixed and stained for p76 and PTB (DH17 monoclonal). 
The cells were observed using confocal microscopy and the intensity of cytoplasmic and nuclear PTB 
staining was determined using the ImageQuant 5.0 software. (a.) The density of PTB in the cytoplasm 
of infected and non-infected cells. (b.) The density of PTB in the nucleus of infected and non-infected 
cells. The density is measured in ImageQuant density arbitrary units per area unit. 
PTB in the cytoplasm PTB in the nucleus 
Figure 3.24. Correlation between p76 levels and the levels of PTB in the nucleus in 
FCV infected cells. CRFK cells were infected with FCV for 16 h at 32 oC and at an m.o.i. of 0.5. 
Infected and control cells were fixed and stained for p76 and PTB (DH17 monoclonal). The cells were 
observed using confocal microscopy and the intensity of p76 and nuclear PTB staining was determined 
using the ImageQuant 5.0 software. The intensity of p76 staining in the cell was plotted against the 
intensity of PTB staining in the nucleus. The intensity is measured in ImageQuant density arbitrary 
units. 
(a.)                                                         (b.) 
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shown). Thus, during the infection of CRFK cells with FCV, PTB demonstrated  
redistribution from the nucleus to the cytoplasm but also a reduction in total levels of 
the protein as the reduction of the nuclear fraction did not match the increase of the 
cytoplasmic fraction (Fig. 3.23 and 3.24). This overall decrease of PTB levels in FCV 
infected cells can be easily observed in Figure 3.21.2. More detailed pictures of FCV 
infected cells demonstated some overlap of the p76 and PTB signals and in some 
cases PTB staining was peripherally associated with p76 containing replication 
complexes (Fig. 3.25). 
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Figure 3.25. Localisation of PTB in the cytoplasm of FCV infected CRFK cells. CRFK 
cells were infected with FCV for 16 h at 32 oC and at an m.o.i. of 0.5. Infected and control cells were 
fixed and stained for p76 (green) and PTB (DH17 monoclonal) (red). DAPI was used for nuclei (blue) 
staining. The cells were observed using confocal microscopy.   
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3.13. Discussion 
 
In general, the 5' and 3' extremities of viral RNA genomes must fold into 
defined three-dimensional structures in order to adopt a functional state. As a result of 
structural promiscuity and an abundance of intramolecular interactions, alternative 
non-functional conformations are also adopted, significantly slowing the appearance 
of a functional conformation (Treiber & Williamson, 2001). As a consequence, it has 
been suggested that RNA folding requires the aid of proteins with chaperone activity 
that possibly trap or resolve misfolded structures (Herschlag, 1995). 
 
The interaction of host-cell nucleic acid-binding proteins with the genomes of 
positive-stranded RNA viruses is known to play a role in many aspects of the virus 
life cycle. The majority of these proteins are predicted to function as RNA 
chaperones, allowing the viral RNA to adopt a functional conformation. In the case of 
cellular or viral IRES elements, the binding of host-cell proteins to RNA is thought to 
lead to structural rearrangements, usually in close proximity to the protein-binding 
site, resulting in the formation of a conformation suitable for translation initiation 
(Martinez-Salas et al., 2001, Pickering et al., 2004). These proteins, known as IRES 
trans-acting factors (ITAFs), include PTB isoforms, poly(rC)-binding protein, La, 
hnRNP K, unr (upstream of N-ras), nucleolin and many others (reviewed by Stoneley 
& Willis, 2004). 
 
In the present study PTB was identified as a host-cell protein required for 
efficient calicivirus replication in a temperature-dependent manner. A more important 
role for PTB at temperatures above and below 37 °C would agree with the hypothesis 
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that PTB functions as an RNA chaperone, aiding in the correct folding of viral RNA. 
The lack of a significant effect of PTB siRNAs on FCV replication at 37 °C, the 
temperature at which the virus has been repeatedly passaged, is intriguing. Although 
viral RNA polymerase levels were reduced to 65 % of the levels observed in control 
siRNA-treated cells (Fig. 3.11), no effect on virus titre was observed. It is possible 
that the RNA chaperone activity of PTB is only required in conditions where non-
functional RNA structures are stabilized (e.g. temperatures <37 °C) or functional 
structures are destabilized (e.g. temperatures >37 °C). It is important to note that 
although RNA interference-mediated knockdown of PTB significantly reduced PTB 
levels, detectable PTB remained (Fig. 3.7). Hence, the PTB remaining after siRNA-
mediated knockdown may be sufficient for correct RNA folding at 37 °C, but 
increased levels are required to maintain a functional conformation at non-favourable 
temperatures or in circumstances where other RNA chaperone factors are absent. 
Previous studies on EMCV IRES-mediated translation have demonstrated that 
although a wild-type IRES directing EMCV polyprotein synthesis does not require 
PTB for efficient translation, an IRES with an enlarged A-rich bulge is highly 
dependent on PTB (Kaminski & Jackson, 1998). As a result, it was presumed that 
PTB plays a significant role in maintaining an appropriate higher order structure for 
translation initiation only when non-functional conformations are apparent (Kaminski 
& Jackson, 1998). This observation would fit with our hypothesis that the function of 
PTB in the calicivirus life cycle is only required under ‘unfavourable’ conditions. 
 
An additional factor that may affect the relative requirement of RNA for a 
particular RNA chaperone is the expression levels of other interacting host-cell 
factors. The relative expression levels of such factors may be significantly different in 
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primary tissues compared to the levels observed in immortalized cell lines. The 
temperature of the environment in which the virus replicates is also likely to be a 
determining factor in the relative contribution of PTB to the virus life cycle. Given 
that feline body core temperature ranges from 38 to 39 °C and can rise to 41.5 °C 
during FCV infection (Poulet et al., 2005), we would predict PTB plays a functional 
role in FCV replication in vivo.  
 
Similar temperature sensitivity of the RNA chaperone activity of PTB has also 
been highlighted during trans-splicing of the thymidylate synthase group 1 intron 
(Belisova et al., 2005). Whereas trans-splicing occurs in a protein-independent 
manner at 55 °C, the reaction is significantly reduced at 37 °C due to an inability of 
the RNA to fold into a splicing-competent conformation. PTB was found to stimulate 
the rate of trans-splicing at 37 °C by threefold (Belisova et al., 2005). This increased 
requirement for PTB at reduced temperature was due to stabilization of RNA 
structures that were non-functional for splicing. 
 
Previous studies have highlighted that the primary role for PTB in the life 
cycle of many positive-stranded RNA viruses is at the level of viral translation 
(Belsham & Sonenberg, 2000, Pilipenko et al., 2001). The only available means for 
the study of FCV translation is the in vitro RRL translation system (Goodfellow et al., 
2005). In this system PTB acted as negative regulator of FCV translation in a specific 
manner as the effect on FMDV IRES and cap-dependent translation was insignificant 
and at high concentrations non-specific to PTB. (Fig. 3.17 and 3.18). An observation 
that is important to be clarified is the limited increase of the FMDV translation upon 
addition of PTB as it is well known that FMDV IRES function is dependent on PTB. 
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During the original investigation of the involvement of PTB in FMDV translation, the 
dependence on PTB was observed only in RRLs depleted of PTB (Niepmann et al., 
1997). Indeed, previous work on PTB depleted RRLs showed that absence of PTB did 
not affect FCV translation, while FMDV translation was significantly inhibited (data 
not shown). The temperature dependent effect of PTB on FCV in vitro translation was 
in agreement with a similar temperature dependent requirement for the virus 
replication in tissue culture and provided additional evidence towards the RNA 
chaperone activity of PTB (Fig. 3.19).  
 
A major difference between the in vitro translation and the replication of the 
virus in tissue culture was that during the viral infection the knockdown of PTB was 
responsible for the reduction of the viral yield, while in the in vitro translation system 
a reduction of viral translation was observed upon addition of recombinant PTB. How 
can a virus benefit by the reduction of its translation? Positive strand RNA viruses use 
their RNA as template for both translation and replication. At the initial stages of 
infection it is crucial for the virus to transform the intracellular environment in order 
to achieve its replication (Green et al., 2002, Schwartz et al., 2004). This can only 
happen by intensive translation from the viral RNA to produce the proteins required 
for the rearrangement of the cell membranous structures which lead to the formation 
of the replication complexes (van Kuppeveld et al., 1997). As the microenvironment 
of each replication complex becomes saturated with viral proteins, translation is 
decelerated to favour the production of new viral RNAs. This switch between 
translation and replication must occur as the RdRp proceeds in a direction opposite to 
the ribosome during negative-strand RNA synthesis. The involvement of PCBP2 in 
the switch between translation and replication in polioviruses signified the importance 
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of host-cell RNA binding proteins in this process. It is possible that PTB, through 
interaction with the calicivirus RNA (possibly as part of a larger RNP complex) 
decreases the translation rate by sequestration of the 5’extremity from the 
translational machinery, thereby promoting higher rates of replication at later stages 
of the virus life cycle.  
 
An attempt to verify the role of PTB as a negative regulator of FCV translation 
in tissue culture was made by selective digestion of the genomic RNA in the mixture 
of viral RNAs using RNase H. The inactivation of the genomic RNA allowed 
translation from only the subgenomic RNA that, in the absence of polymerase, cannot 
be replicated. The translation of the subgenomic RNA in CRFK cells was 
significantly increased under low levels PTB that indicated again a repression role for 
PTB on viral translation. However, the observed processing of the LC into mature 
major capsid protein indicated the presence of either a cellular or viral protease, 
capable of capsid cleavage. It has been reported previously that caspase mediated 
cleavage of capsid protein occurs during FCV infection (Al-Molawi et al., 2003). The 
caspase cleavage of the 62 kDa mature capsid protein resulted in a product of 
apparent size of 40 kDa, but the cleavage site on the protein was not mapped (Al-
Molawi et al., 2003). If the cleavage occurred closer to the C terminus the deletion 
from the 67 kDa LC of about 22 kDa would result in a 55 kDa protein6, similar in size 
with the mature capsid. The cationic lipid transfection reagents such as Lipofectamine 
used in this study for the transfection of the viral RNA into cells induce apoptosis 
activating the caspase cascade that could result in the cleavage of the LC during the 
overnight exposure to caspases (Iwaoka et al., 2006). Another possibility could be that 
                                                 
6 The apparent weight as determined by SDS-PAGE. The actual molecular weight could be different. 
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other cellular proteases induce the capsid maturation as it has been reported 
previously (Geissler et al., 1999). However, in that study such maturation of FCV 
capsid did not occur in CRFK cells (Geissler et al., 1999), a result verified in the 
present study by the expression of LC from the subgenomic RNA construct (Fig. 
3.20). It is not known if specific proteases are upregulated during transfection of 
dsRNA that could explain the occurrence of maturation only in the cell transfected 
with RNA. A final possibility could be, even if p76 could not be detected by western 
blot, that undetectable amounts of the viral protease could induce the cleavage of the 
leader peptide from LC.  
 
To further investigate the role of PTB during FCV infection the binding of 
PTB was mapped on the 5’ extremity of the virus. PTB was not restricted on a 
specific binding site rather it interacted with a variety of pyrimidine stretches on the 
RNA (Fig. 3.15). The presence of four RRMs on PTB is responsible for its 
complicated binding properties that have been thoroughly dissected for FMDV IRES 
(Song et al., 2005). A strong PTB-binding site is present in the second domain of the 
IRES, where a number of pyrimidines in the domain contribute to the interaction with 
PTB (Luz & Beck, 1991). Additional binding sites for PTB have been identified in 
several parts of the fourth and fifth RNA domain further downstream on FMDV IRES 
(Luz & Beck, 1991, Kolupaeva et al., 1996).  
 
Production of viruses that encompassed mutations in the binding sites of PTB 
was achieved using the FCV reverse genetics system (Sosnovtsev & Green, 1995). 
However, the mutant viruses (even the double mutant virus) demonstrated no defect 
during their replication in CRFK cells compared to the wild-type FCV. It has been 
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well documented that such RNA-protein interactions affect virus replication often in a 
cell-type specific manner (Chang et al., 1993, Guest et al., 2004, Merrill et al., 2006). 
For example, the attenuated vaccine strain of poliovirus type 3 (Sabin 3) is able to 
grow to high titres in the traditional tissue culture cell lines, but is attenuated during 
the infection of neuronal cells (Guest et al., 2004). This attenuation was attributed to 
the reduced binding of PTB caused by the alteration of the secondary structure by a 
single mutation close to one of the PTB binding sites on the poliovirus IRES. The 
effect of the mutation on the binding of PTB on the Sabin type 3 IRES in combination 
with the significantly reduced levels of PTB in the neuronal cells conferred a 2.5 to 4 
fold decrease in the viral translation compared to the wild-type poliovirus type 3 virus 
(Leon) (Guest et al., 2004). It is possible that the kidney-origin of the CRFK cell line 
that has been traditionally used for the study of FCV replication is not representative 
of the conditions during a normal FCV infection of the upper respiratory tract target 
cells. Another possibility could be that PTB is affecting FCV replication via 
interaction with a different region of the viral RNA. A well documented equivalent is 
the involvement of PTB in HCV life cycle. As discussed previously in Chapter 1, 
PTB was shown to interact with a variety of regions (IRES, core and 3’UTR) of HCV 
RNA, while the functional data concerning the involvement of the different RNA 
domains in the regulation network till recently remained rather contradictory (Song et 
al., 2006). Such a region could be the sgRNA in which translation and/or replication 
could be affected through PTB binding to its 5’ extremity (Fig. 3.3). Furthermore this 
interaction has been evolutionally conserved in the MNV genome as the 5’extremity 
of the MNV sgRNA demonstrated a good affinity for PTB, while the MNV 5’ 
genomic extremity demonstrated only residual binding (Fig. 3.3).  
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An important aspect of PTB behaviour during FCV infection is its localisation. 
If PTB remained nuclear during the infection, as it does in non-infected cells, the 
ensuing discussion of an interaction between PTB and the viral genome in the virus 
life cycle would be of less significance. The observation by confocal microscopy of 
CRFK cells infected with FCV, demonstrated that PTB translocated during the 
infection from the nucleus to the cytoplasm, while the total staining of PTB showed a 
dramatic decrease. This effect had been observed when the infection was carried out 
at 37 oC, but was more obvious when the infections were incubated at 32 oC. The 
more apparent translocation of PTB at 32 oC could provide an additional explanation 
for the temperature dependent effect of PTB knockdown in FCV replication. Nuclear 
factors important for viral replication, such as PTB, have been demonstrated to 
translocate from the nucleus to the cytoplasm during poliovirus (Gustin & Sarnow, 
2001) and rhinovirus (Gustin & Sarnow, 2002) infection. Disruption of the 
nucleopores and the proteolytic cleavage or phosphorylation of PTB are factors that 
induce the movement of PTB to the cytoplasm (Kamath et al., 2001, Xie et al., 2003). 
The limited co-localisation between PTB and the viral polymerase, p76, could 
possibly indicate that PTB may be associated only with a particular form of RNA (e.g. 
dsRNA intermediate) or that the epitope of the monoclonal antibody used for the 
confocal microscopy was masked when PTB was in the replication complexes. The 
translocation of PTB to the cytoplasm was followed by an apparent decrease in the 
levels of the protein in the cell that was more obvious at 32 oC than at 37 oC. During 
the study of the effect of PTB knockdown in the viral replication the levels of PTB in 
the control cells (GFP siRNA, Fig. 3.8) did not alter during the course of the 
infection, while in the same cells when the infection was carried out at 32 oC PTB 
levels demonstrated a decrease (Fig. 3.11). This observation signified a possible 
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downregulation of PTB during FCV infection or proteolytic cleavage of the protein 
that could not be detected by western blot (Fig. 3.11). The role of such a 
downregulation of PTB is not known, however, it is known that PTB is cleaved by 
caspases during apoptosis (Back et al., 2002b) and apoptosis is induced during FCV 
infection (Sosnovtsev et al., 2003). PTB is also cleaved by poliovirus protease 3CD 
during poliovirus infection, but such an activity has not been observed for the FCV 
analog, p76 (Back et al., 2002a). 
 
In light of these data, PTB seems to play a key role in the calicivirus life cycle 
possibly as component of the switch between translation and replication giving further 
insight in this important for the virus process. However, further evidence is required 
to support this role, particularly with use of a wide range of cell lines or the in vivo 
animal model.  
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Chapter 4. 
Functional analysis of RNA 
structures in the MNV genome 
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4.1. Introduction 
 
 The identification of functional RNA elements in an mRNA or a vRNA 
provides an alternative to the protein based approach already described for the study 
of RNA-protein interactions. These functional elements often interact with proteins 
that constitute or regulate the translation or replication machinery of a virus. Thus the 
identification of functional RNA structures involved in the major aspects of viral 
replication is crucial for the understanding of the life cycle of positive stranded RNA 
viruses such as caliciviruses. During the course of my studies on the role of RNA-
protein interactions in FCV life cycle, an alternative model system for the study of 
calicivirus biology became available, namely murine norovirus (MNV), a newly 
identified member of the norovirus genus, which can be propagated in tissue culture 
(Wobus et al., 2004). As such, this is also a more representative model for the study of 
human caliciviruses. However, the lack of a reverse genetics system for MNV to 
allow the study of the effect of mutations on viral phenotype, as was readily available 
for FCV, had kept the focus of my studies on FCV. Such a system was successfully 
developed by my colleagues in October 2006 (Chaudhry et al., 2007) and provided a 
powerful tool for the study of MNV. The need for a reverse genetics system was so 
great that soon after the first report another group published an additional method for 
the production of genetically defined MNV (Ward et al., 2007).  
 
 The aim of the work presented in this chapter was to take advantage of this 
newly developed MNV reverse genetics system and use it to identify functional RNA 
elements in murine norovirus genome. Characterisation of the mutant viruses would 
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demonstrate the requirement for a certain RNA structure or sequences while it could 
also indicate the process of the viral life cycle in which this structure is involved.  
 
4.2. Prediction of higher order RNA structures in the MNV genome   
  
 Large scale computational thermodynamic analysis and suppression of 
synonymous site variation analysis7  of the MNV genome showed regions of highly 
structured RNA at the 5’ and 3’ extremities of the viral genome (Fig. 4.1b). In 
addition, a region overlapping the start of the subgenomic RNA region was also 
predicted to have higher order RNA structures (Fig. 4.1b). Using a variety of free 
energy minimisation algorithms, such as mfold (Zuker, 2003) and pfold (Knudsen & 
Hein, 2003), thermodynamically stable RNA structures were predicted for these 
regions (Fig. 4.1a). The regions predicted to form these RNA structures are highly 
conserved among different MNV strains and in most cases the identity reaches 100 % 
(data not shown). Such low variability regions in an mRNA have a high possibility of 
accommodating functional RNA structures. This finding, combined with low p-
number (P-Num) values, which represent the number of different base pairs a specific 
base can form in a set of potential structures predicted for a given RNA sequence, can 
give a good indication towards the prediction of a stable RNA secondary structure 
(Zuker, 2003).  
 
 
 
                                                 
7 A computational method that determines the evolutional variation of a codon in a coding region. 
When a region of an RNA contains an essential RNA structure, its conservation limits the variation of 
the nucleotides in the triplet. This codon variation suppression is forced by the combined need for a 
conserved RNA structure and amino-acid sequence. This analysis was conducted in collaboration with 
Prof. Peter Simmonds (University of Edinburgh)  
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Figure 4.1. Predicted RNA structures in the MNV genome. (a.) RNA structures predicted 
using energy minimisation algorithms. Highlighted in the black circles are the nucleotides mutated to 
the nucleotides presented into the white circles. (b.) Suppression of synonymous site variation (SSSV) 
analysis for the MNV genome (courtesy Prof. Peter Simmonds, University of Edinburgh). Low values 
of variation represent a high possibility of conserved RNA structure and vice-versa. The MNV genome 
is presented under the SSSV graph and shows the position of the predicted stem-loops and the 
respective mutations. The suppression mutations (grey circle) that reverted the lethal phenotype of m53 
and m54 are highlighted in a box, (nts = nucleotides) 
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Two of the predicted stem loops were situated at the 5’extremity of the MNV 
genomic RNA just after the short 5’UTR. The first predicted stem loop is situated 8 
nucleotides from the 5’ end and consists of a 9 base pair stem, terminated by a three 
nucleotide loop (SL8, Fig. 4.1a). Such a stem loop can be predicted for all known 
caliciviruses, however without any similarity in either primary sequence or stem size 
(data not shown). In order to assess the importance of this structure in MNV 
replication, a set of mutations were introduced that destabilised the stem by braking 3 
A-U and 3 G-C base pairs (m50, Fig. 4.1a). The introduction of mutations was limited 
by the fact that the stem accommodates nucleotides which form part of the first open 
reading frame of the virus (ORF1). Such a limitation usually allows the change of the 
most degenerate in the genetic code third base of a triplet, hence only nucleotide 
changes that did not alter the amino-acid sequence were introduced. However, in the 
case of m50 the protein sequence contained two serines that are represented in the 
genetic code by 6 different codons, giving more flexibility in the choice of 
nucleotides.  
 
The second stem loop of the 5’ extremity was situated just after the first stem 
loop at position 29 of the MNV genome (SL29). An internal bulge separated a 4-
nucleotide bottom and a 7-nucleotide top stem (Fig. 4.1a). The mutations for the 
disruption of this stem loop were focused on the longer 7-nuclotide top stem (m51, 
Fig. 4.1a). In contrast to the m50 mutant, the amino-acid sequence restrictions in m51 
allowed the alteration of only 3 nucleotides which, according to mfold predictions 
were enough to destabilise the structure. As the altered bases were located at the third 
base position of the respective ORF1 codon, the introduced nucleotides were selected 
according to their ability to reform a stable stem by subsequent changes of the 
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downstream nucleotides, which constituted the 3’ partners of the stem base pairs. 
Such a second 5’ extremity stem loop structure can also be predicted for other 
noroviruses and several other caliciviruses (data not shown). 
 
Another region that showed a computationally high possibility of 
accommodating functional RNA structures was the junction between ORF1 and 
ORF2. This junction is also the start of the region which represents the sequence of 
the MNV subgenomic RNA (sgRNA). The hypothesis was that structures downstream 
of the junction would represent the 5’ extremity of the subgenomic RNA and such 
structures may regulate sgRNA translation and replication. The sequences upstream 
of the junction could form part of a promoter required for the initiation of subgenomic 
RNA synthesis. This hypothesis was supported by a study on RHDV which 
demonstrated a requirement for 60 nts upstream of the start of the subgenomic RNA 
for the in vitro synthesis of a subgenomic RNA from a negative sense genomic RNA 
template by the viral RdRp (Morales et al., 2004). As the sequence downstream of 
MNV ORF1-ORF2 junction has been predicted to accommodate an alternative ORF 
(ORF4), alterations in RNA structures of this region are rather limited by the 
requirement to maintain two overlapping protein sequences. So, the computational 
predictions focused on the sequence upstream of the sgRNA initiation site. A stem 
loop structure was predicted in this region, however, based on the mean free energy 
difference, it was predicted to form with a slightly higher probability in the negative 
sense RNA than the positive sense. This fact led us to draw the structure in its 
negative sense form (SLa5045, Fig. 4.1a). Such a stem loop could be predicted for all 
caliciviruses and was invariably situated 6 nucleotides upstream of the start of the 
sgRNA (Fig. 4.2). Three nucleotide changes that were permitted by the conservation 
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of amino acid sequence were introduced in the lower 7-nucleotide stem in order to 
destabilise the structure (m53, Fig. 4.1a). Unfortunately, due to the limited choices of 
alternative synonymous nucleotides, rather than complete disruption of base pairing, 
the introduced mutations led to the formation of three wobble G•U base pairs. In each 
case however, these mutations were predicted to lower the likelihood of structure, as 
the G•U pairs are thermodynamically less stable than A-U or G-C pairs which they 
replaced. As in the case of m51, the introduced mutations were designed in such a 
way that compensatory mutations could restore the stem without affecting the amino-
acid sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. A stem loop structure upstream of the subgenomic RNA start is predicted 
for a variety of representative caliciviruses. The structure of the stem loop structure is drawn in 
the negative sense orientation. The framed nucleotides represent the template of the subgenomic RNA, 
while the C at the beginning is the template for the first nucleotide of the subgenomic RNA. The 6 
nucleotides between the start of the subgenomic RNA template and the predicted stem-loop are 
highlighted. (GI and GII are to genogroups of human noroviruses; GI, GII, GIV and GV are genogroups 
of sapoviruses. The initiation codons (AUG) are highlighted in black 
Vesivirus 
Lagovirus 
   GV      GI 
Sapovirus 
                GI 
Human norovirus 
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GII/IV
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The last region to show a potential to form higher order RNA secondary 
structures was the 3’ UTR. A stable stem loop structure was predicted at the 3’ end of 
MNV 3’UTR (SL7330, Fig. 4.1a). As shown in Figure 4.3 the sequence in the region 
that corresponded to the two stems was conserved among MNV strains, while the 
region that corresponded to the loop was highly variable. This fact increased the 
“predictability” of the stem loop structure, especially in alignment based RNA 
structure prediction algorithms such as p-fold. In order to assess the requirement of 
this 3’ end stem loop 6 mutations were introduced in the top stem (m54, Fig. 4.1a). 
The fact that in the 3’ UTR, the sequence of the RNA was not limited by a 
requirement to conserve the amino-acid sequence, meant that there was greater 
flexibility in the changes which could be introduced, compared to m50, m51 and m53 
which are all coding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Alignment of the 3’ end stem loop of MNV RNA. ClustalW alignment of all 
the MNV strains available in GenBank (NCBI) for the last 70 nts of the MNV1 genome. Highlighted in 
black are the nucleotides that form the three stems of the 3’ end stem loop. The innermost bracket   
encompasses the highly variable polypyrimidine hairpin loop. The sequence of the MNV1 infectious 
cDNA clone used in all the experiments is highlighted in the dotted box.    
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4.3. Specific RNA structures are required for the MNV replication   
  
 The mutations in the RNA structures mentioned above were cloned into the 
full length MNV-1 infectious clone (pT7MNV:3’RZ). The mutated clones were tested 
for their ability to produce virus after transfection in BSRT7 cells infected with a fowl 
pox virus expressing T7 RNA polymerase (FPVT7) (Chaudhry et al., 2007). The 
viruses produced after 24 h in this reverse genetics system represent a single 
replication cycle as although MNV can replicate in BSRT7 cells, it cannot infect them 
(Chaudhry et al., 2007). The SL8 disrupting mutations in m50 resulted in a 
significantly reduced viral titre (approximately 20 times lower than the wild type 
virus) while the recovered virus also produced a small plaque phenotype (Fig. 4.4). 
The recovery of the viral clone which contained mutations in SL29 (m51) yielded 
about 16 times less virus than the wild type, while no alteration to the plaque 
phenotype was observed (Fig. 4.4). Considering the conservation of the region where 
both m50 and m51 mutations are situated it was rather surprising to see such a small 
effect on virus replication. In the m50 mutant the virus showed limited but not 
absolute dependence on the stability of the first 5’ end stem loop, SL8. The mutations 
in the second 5’ end stem loop (SL29 as disrupted in m51), demonstrated either that 
there is a limited requirement of this region for the efficient recovery of virus, or that 
the introduced mutations were not able to efficiently disrupt the stem loop in vivo.  
 
A more profound effect was observed for the m53 mutant that disrupted the 
stem loop upstream of ORF1-ORF2 junction (SLa5045). The introduced mutations 
resulted in a lethal phenotype signifying that the mutated RNA structure is important 
for viral replication (Fig. 4.4). A lethal phenotype was also produced by the mutations 
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in the 3’ UTR stem loop (SL7330), again demonstrating a dependence of this region 
for virus replication (Fig. 4.4). An important observation was that one of MNV strain 
isolated from Rag1–/– IFN-γR–/–  laboratory mice lacked two of the nucleotides 
mutated in m54 (nts 7366 and 7367) (Fig. 4.3) (Thackray et al., 2007). Therefore it is 
possible that the observed lethal phenotype was caused by one or more of the other 
introduced mutations or that at least some of the base pairing is required for the 
formation of a functional structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NS7 
   -        wt    m50    m51   m53   m54 
wt m50 m51 m53 m54
Figure 4.4. Phenotypes of the mutated viruses recovered by reverse genetics. (a.) The 
titres of the viruses produced during the recovery procedure after transfection of the mutated viral 
cDNA clones into BSRT7 cells infected with FPVT7 virus. (b.) Western blot for the NS7 protein for all 
different mutant cDNA clones that shows the ability of all the cDNA clones to produce and process the 
viral polyprotein. (c.) Plaques formed by the recovered mutant viruses on a monolayer of RAW 264.7 
cells. Recovery and plaque phenotype are evaluated by comparison to the wild-type (wt) virus recovery. 
Error bars represent the standard deviation determined by 5 experiments and the limit of detection was 
60 TCID50/ml. 
                      (a.) 
  
 
 
 
 
 
                      (b.) 
 
 
    (c.) 
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In order to exclude the possibility that additional spurious mutations arose, 
outside of the manipulated region which was subsequently fully sequenced, every 
mutated MNV genome was represented by at least two independent clones. 
Furthermore, lysates of the cells infected with FPVT7 and transfected with the virus 
mutant MNV clones were probed for the NS7 protein (Fig. 4.4). The NS7 Western 
blot demonstrated that the mutant clones produced NS7 levels similar to wild-type 
clone during the recovery and served as a good indication that every clone had the 
same potential for the production of virus.  
 
4.4. Deletion of the MNV 3’ UTR polypyrimidine hairpin loop does 
not affect viral replication in tissue culture. 
 
During the preliminary computational analysis of the predicted RNA 
structures in the 3’ UTR of the MNV genome, a region which corresponded to the 
loop region of SL7330 was observed to be highly variable between different MNV 
strains (Fig. 4.3). The conservation of a poly(U/C) context appeared to be the only 
restriction in the changes observed. Furthermore, a specific motif, similar to the PTB 
consensus binding sequence of UCUU, was present in a variable number of repeats. 
The conservation of such a motif signified a potential involvement of the loop in the 
regulation of some aspect of the virus life cycle. To assess this hypothesis the 
polypyrimidine tract was substituted by a GNRA tetraloop which is well known to 
stabilise stem-loop structures (Correll & Swinger, 2003). This motif was introduced in 
order to minimise any disruption of the secondary structure which may have been 
caused by a full deletion of the poly(U/C) loop (Fig. 4.5). The mutated region was 
subsequently cloned into the MNV-1 full length clone to generate the mutant m52. 
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2.45 x 104        1.58 x 104 
wt                   m52 
Figure 4.5. Phenotype of the 3’ 
polypyrimidine loop-deletion virus after 
reverse genetics recovery. (a.) The 
predicted structure of the wild-type (wt) SL7330 
stem-loop structure and the structure of the 
same stem loop after substitution of the loop by 
a GNRA motif (m52). (b.) Plaques formed by 
the recovered m52 virus on a monolayer of 
RAW 264.7 cells. Recovery and plaque 
phenotype are evaluated by comparison to the 
wt virus recovery. 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
 
The m52 mutated virus recovered at 
similar to wild-type titres while the 
plaque phenotype was also 
indistinguishable to wild-type. The 
kinetics of m52 replication was tested in 
high (4) and low (0.01) multiplicity of 
infection in comparison to the wild-type 
virus (Fig. 4.6a,b). While the titre of the 
virus yield was approximately the same 
for every time point of the growth 
curves, western blot analysis 
reproducibly demonstrated significantly 
higher levels of NS7 and VP1 proteins 
were produced in the m52 infected cells 
(Fig. 4.6c,d). The fact that the effect was 
not amplified when the virus was 
allowed to go through multiple 
replication cycles signified that the 
observed increase in protein levels did 
not affect the replication efficiency or 
the production of infectious virus. The 
increased protein levels of the m52 virus 
may indicate that either the poly(U/C) 
SL7330 
                                   142
tract of 3’ UTR acts as a repressor of translation or that the inserted GNRA motif 
further stabilises SL7330, which is crucial for viral growth (as shown by the 
mutational analysis of this region).  
 
As has been stated previously in Chapter 3, the stability of RNA structures is 
greatly altered by variations in the temperature at which they fold. For this reason the 
growth of the m52 mutant virus was examined across a temperature gradient (Fig. 
4.6e). At high temperatures (39 oC) the mutant virus produced more NS7 protein than 
the wild-type, while the same was observed at the normal culture temperature of 37 
oC. However, at low temperatures (32 oC) the positive effect of the mutation 
disappeared and the two viruses produced similar levels of NS7 protein. A possible 
explanation could be that the stabilisation of the stem loop by the GNRA tetraloop 
was more obvious at high temperatures as the destabilising effect of a large hairpin 
loop may be much greater than at lower temperatures, where RNA structures are 
stabilised. In other words, at lower temperatures the stabilisation of the RNA structure 
might be efficient enough that the additional thermodynamic stability conferred by the 
GNRA is less apparent.  
 
Further study of the SL7330 stem-loop in Chapter 5 demonstrated that RNA-
binding proteins such as PTB and PCBP2 interact with the polypyrimidine loop of 
this RNA structure. The interaction was severely reduced when the loop was 
substituted by the GNRA motif used for the construction of the m52 mutant.   
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Figure 4.6. Growth kinetics and temperature sensitivity analysis of the 3’ end 
polypyrimidine loop deletion virus (m52). (a.) Virus yield (in TCID50/ml) during the infection 
of RAW 264.7 cells with a low m.o.i. (0.01) of m52 and wt virus. (b.) Virus yield (in TCID50/ml) 
during the infection of RAW 264.7 cells with a high m.o.i. (4.0) of m52 and wt virus. (c. and d.) 
Probing for NS7 (polymerase), VP1 (major capsid protein) and GAPDH (control) of infected lysates at 
different time points of the viral growth at a low (c.) and high (d.) m.o.i. (e.) Western blot for NS7 
(polymerase) and GAPDH (control) showing the NS7 levels produced during the replication of the m52 
virus compared to wild-type virus (wt) in RAW 264.7 cells across a temperature gradient 
m.o.i. 0.01                                               m.o.i. 4.0 
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4.5. Characterisation of naturally revertant viruses  
 
 Reverse genetics systems which are based on T7 RNA polymerase activity 
show an increased probability of introducing mutations into newly transcribed RNA  
as T7 polymerase is a highly error prone polymerase (Huang et al., 2000, Nesser et 
al., 2006). Indeed, in one of the attempts to recover the m53 mutant virus, a viable 
strain was produced. Sequencing of the full genome of the virus revealed that the 
initially introduced mutations in SLa5045 were still present, even after a third passage 
of the virus in cell culture (Fig. 4.7a). However, an additional mutation had been 
introduced which changed nucleotide 4922 from C to U (Fig. 4.7a). This position was 
97 nucleotides upstream of the initial mutations in SLa5045 and lay within the NS7 
coding region, however the alteration has no effect on the sequence of NS7 (Fig. 
4.7a). To verify that this was the only mutation required for the suppression of the 
lethal phenotype, the corresponding region was cloned into the m53 full length cDNA 
clone. The recovery of the virus from this new clone (m53RevA) produced 
approximately 50 times less virus than the wild type clone (Fig. 4.8a). In addition, 
plaque assay performed using the recovered m53RevA virus demonstrated a small 
plaque phenotype (Fig. 4.8a), while the virus growth during a multistep growth curve 
was significantly reduced (Fig. 4.8b). The mutation which resulted in the suppressor 
phenotype (T4922C) is predicted not to participate in any of the predicted (optimal 
and suboptimal) RNA structures and the mechanism of the reversion remains to be 
revealed. Considering that the suppression nucleotide change was so far upstream the 
initial mutations, it seems likely that the predicted stem loop is part of a larger 
secondary (or maybe tertiary) structure that altogether forms a functional RNA 
domain, probably involved in the initiation of sgRNA synthesis. 
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         T  V  A  S           D  A  E  T 
MNV1    ACTGTGGCTTCC- 90nts -GATGCTGAGACC 
m53RevA ACTGTGGCCTCC- 90nts -GACGCCGAAACC 
        ******** ***         ** ** ** *** 
               
              4922         5018  5021  5024 
A  C  G C  C  G  A  A  A  C  C  C  C  G  C  A  G  G  A  A  C  G  T  T  C 
R 
C  T  G T G G C C T  C C C  G  T  G 
R 
         D  A  E  T  P  Q  E  R  S 
MNV1    GATGCTGAGACCCCGCAGGAACGCTCA 
m53RevB GACGCCGAAACCCCGCAGGAACGTTCA 
        ** ** ** ************** *** 
               
     5018  5021  5024         5039 
C  T  G  C  T   T  T  T  A  T  G  A  C A  G  T   T   T  C  G  T  G  C 
Deletion 
site 
MNV1    ACTGCTTTCTTTTCTTTGTGGTAGTTAGAT 
m54RevA ACTGCTTT--------TATGACAGTTTCGT 
        ********        * **  ****   * 
           
            7354-61  7363 7366-7 7372-4 
Figure 4.7. Reversion determinants of naturally revertant viruses. Sequencing of the 
viruses that showed reversion of the lethal phenotype caused by mutations m53 and m54 (a., b., c.) 
Alignments of the m53RevA (a) m53RevB (b) and m54RevA (c) virus sequence compared to wild-type 
MNV1. The nucleotide position numbers in bold highlight the mutations that were found in the 
revertant viruses, while the remaining are the mutations originally introduced. Over the alignments the 
respective amino-acid sequences (when applicable) are presented. Each alignment is followed by a 
chromatogram of the respective sequencing reaction shows the absence of major quasispecies in the 
initial (↓) and supression (R↓) mutations. The dashed arrow points at the site where the deletion of the 
polypyrimidine stretch occurred in m54RevA.  
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
 
 
 
 
 
 
 
 
 
 
 
 
(c.) 
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m53RevA                   wt 
Figure 4.8. Phenotype of the m53RevA 
revertant of the m53 lethal phenotype. 
(a.) Titre of the m53RevA virus produced after 
transfection of the mutated viral cDNA clone 
into BSRT7 cells infected with FPVT7 and 
plaques formed by the recovered m53RevA 
virus on a monolayer of RAW 264.7 cells. 
Recovery and plaque phenotype are evaluated 
by comparison to the wild-type (wt) virus 
recovery. (b.) Kinetics of the m53RevA growth 
at an m.o.i. of 0.01 in RAW 264.7 cells. 
 2.52 x 102               1.42 x 104  
± 8.99 x 101                 ± 5.05 x 103 
(a.) 
 
 
 
 
 
 
 
 
 
 
(b.) 
 
 A second reversion of the m53 
lethal phenotype was identified from an 
independent set of virus recoveries. In 
this instance, blind passage was required 
to obtain full cytopathic effect. Five 
clonal isolates from the revertant virus 
stock (m53RevB) were isolated by 
limiting dilution and partially sequenced. 
In addition to the originally introduced 
mutations in m53, all five isolates had a 
common nucleotide change, compared to 
the wild-type, (Fig. 4.7b). The observed 
C to U substitution in position 5039 was 
a synonymous nucleotide change that 
resulted in a partial reformation of the 
disrupted stem loop (Fig. 4.1). The 
G5024A or C5024U mutations in 
positive (+) or negative (-) strand RNA 
respectively in the m53 mutant led to the 
disruption of the wild-type G5024-C5039 (+) or C5024-G5039 (-) base pair. The C5039U 
alteration, generated by natural selection, reformed the base paring between the two 
nucleotide positions: A5024-U5039 (+) or U5024-A5039 (-). This reversion verified the 
dependence of viral replication on the formation of SLa5045 upstream of the 
subgenomic RNA start. 
 
                                   147
 Another intriguing suppression mutation was observed during the recovery 
attempts of the m54 mutant. A phenotypically reverted virus (m54RevA) was isolated 
by limiting dilutions of the population after blind passage and was partially sequenced 
in the 3’ UTR region. Much to our surprise we found that the originally introduced 
m54 mutations were conserved in the m54RevA virus, while a large region of the 
polypyrimidine hairpin loop had also been deleted (7354-7361 nts, Fig. 4.7b). A 
possible explanation of the effect of such a deletion could be that by deleting the 
polypyrimidine tract the lower stem can reform (Fig. 4.9b). An indication that 
replication might be dependent on the lower stem is supported by the observation that 
the interruption of the bottommost base pair by a U to C mutation is lethal (Chaudhry 
et al., 2007). By re-evaluating the 3’UTR structure using the Kinefold algorithm 
which can predict the formation of pseudoknots (Xayaphoummine et al., 2005), a 
thermodynamically stable pseudoknot was predicted to form between the 
polypyrimidine tract nucleotides and a G/A rich tract just upstream of SL7330 (Fig. 
4.9a). The question that arose after the identification of this new element was its 
involvement in a possible explanation of the observed reverted phenotype in 
m54RevA. Upon disruption of the upper stem of SL7330, the pseudoknot which 
conferred a δG = -12.5 kcal/mol in the free energy of the molecule, competed with the 
lower stem of SL7330 that conferred only a δG = -5.9 kcal/mol. The significantly 
lower free energy of the pseudoknot base stacking favoured an alternative structure 
presented in Figure 4.9b. When a structure is changed so dramatically, it is likely that 
there will be a dramatic effect on the functionality of the respective RNA domain. It is 
now intelligible why the disruption of such a dominating misfold by the deletion of 
the polypyrimidine tract in m54RevA was able to reverse the lethal phenotype of the 
original m54 mutant, as this deletion possibly favoured the formation of the lower 
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stem of the wild-type SL7330 (Fig. 4.9c) or reversed a possible negative effect of the 
stem formed between the poly(U/C) and the GA rich tracts (Fig. 4.9b). Due to the 
lack of time I was unable to confirm that the mutations in 53RevB and 54RevA were 
responsible for the revertant phenotype by the procedure followed for 53RevA, which 
would involve full genome sequencing and cloning of the mutated region back into 
the original m53 and m54 mutants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Thermodynamically 
predicted secondary structures involved 
in the reversion of the m54 lethal 
phenotype. (a.) Kinefold Predicted structure of 
the 3’ end stem loop of MNV including a 
pseudoknot between the polypyrimidine stretch 
and a GA rich sequence upstream the stem loop. 
(b.) The structure of the 3’ end stem loop of the 
m54 mutant in which the polypyrimidine 
sequence that formed the wild-type pseudoknot 
constitutes the 3’ strand of a stem with the GA 
rich region. The blue dashed-line box highlights 
the part of the polypyrimidine stretch that 
participates in the predicted pseudoknot. (c.) 
Predicted structure of the 3’ end stem loop of the 
m54RevA virus after deletion through natural 
selection of the polypyrimidine stretch.  
wild-type 3’UTR 
m54RevA 3’UTR 
m54 3’UTR 
(a.)        (b.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c.) 
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    3.05 x102                1.42 x103 
± 8.90 x101             ± 5.05 x102
Figure 4.10. Compensation of the stem 
loop upstream of the subgenomic RNA 
start. (a.) Original m53 (circles) and the 
compensatory (boxes) mutations in m53R as 
depicted on the wild-type structure of SLa5045. 
(b.) Plaque phenotype of m53R on a monolayer 
of RAW 264.5 cells compared to the wild-type 
virus (wt). Underneath the plaque assay the 
titres of each virus during the recovery are 
presented. 
SLa5045 
(a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b.) 
4.6. Compensation of the disrupting mutations  
 
 Often to verify the need of an RNA 
secondary structure rather than primary 
sequence, mutations which disrupt its 
formation can be compensated by additional 
mutations that restore the base pairing in a 
stem. A drawback of such an approach is 
that sometimes it is not only a particular 
structure which is required for function but 
also the specific primary sequence within 
the secondary structure. Another problem is 
that in some structures which are located in 
coding regions, the introduction of 
compensatory mutations is prohibited if the 
mutations are not in the same reading frame. 
In simple terms, this means that if both the 
disruptive and compensatory mutation are 
not at third nucleotide positions of a codon, 
in the vast majority of cases the 
compensation is forbidden by the 
conservation of amino-acid sequence.  
  
For mutant m53 compensatory mutations could be introduced in order to 
reform the disrupted stem. The wild-type G5039-C5024 pair was substituted in the m53R 
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MNV clone by an A-U pair, while the U5042-A5021 and U5045-A5018 base pairs were 
substituted by a C-G pair (Fig. 4.10a). The compensatory mutations were introduced 
into the m53 clone and the ability of the new clone, referred to as m53R, to produce 
virus was assessed. The restoring mutations in SLa5045 partially compensated the 
lethal phenotype of m53 (Fig. 4.10b). The yield of the recovered virus was lower than 
the wild-type, while its plaque phenotype had no obvious differences from the wild-
type virus. The nearly total reversion of the viral phenotype upon restoration of the 
stem further verified the notion that the formation of SLa5045 is mandatory for the 
replication of MNV. The fact that the compensatory mutations were able to reform the 
stem loop in both positive and negative sense RNAs, prevents however a conclusion 
being drawn concerning the polarity of the functional structure. 
 
4.7. Discussion 
 
 Nowadays it is common knowledge that all positive strand RNA viruses use a 
plethora of RNA structures to promote and regulate different aspects of their 
replication. Picornaviruses and flaviviruses, which are among the best studied 
mammalian positive strand RNA viruses, provide a good example of the dependence 
of virus replication on such cis-acting RNA elements (cre) (Witwer et al., 2001, 
Goodfellow et al., 2003b, Luo et al., 2003). Picornaviruses and flaviviruses 
accommodate in their extensive 5’UTRs the IRES element required for the viral 
translation (Belsham & Sonenberg, 1996, Kikuchi et al., 2005) and a 5’ proximal 
RNA element that is required for the replication of the virus (Barton et al., 2001, Luo 
et al., 2003). Functional RNA elements are also situated in the 3’UTRs of these 
viruses that are important for the replication (Rohll et al., 1995, Yanagi et al., 1999) 
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and translation (Bradrick et al., 2006) of the viral RNA. Functional RNA elements 
have been also identified in the coding sequence of positive strand RNA viruses such 
as the 2C-cre element of picornaviruses that is required for VPg uridylation 
(Goodfellow et al., 2003b) and a structure in the NS5B region of HCV that is required 
for the replication of the virus (You et al., 2004).  
 
 To date our understanding of the RNA structures or sequences required for 
calicivirus translation and replication has been very limited due to the problems in 
cultivating human caliciviruses. The identification and propagation in tissue culture of 
the murine norovirus created the best model for the replication of human noroviruses 
(Wobus et al., 2004, Wobus et al., 2006). The development of a reverse genetics 
system for MNV provided a powerful tool which for the first time allowed the 
introduction of mutations in the norovirus genome (Chaudhry et al., 2007). In the 
present study, norovirus mutants were created taking advantage of this reverse 
genetics system. The mutations aimed at the disruption of certain RNA elements that 
were predicted by bioinformatics analysis. This analysis included the identification of 
regions in the viral RNA that presented a low free energy (thermodynamics RNA 
structure prediction algorithms) and a low variation in codon usage (suppression of 
synonymous site variation analysis) both of which are characteristics of conserved 
RNA elements.   
 
Calicivirus genomes in contrast to other related viruses such as picornaviruses 
have short 5’ UTRs (5 and 4 nucleotides in the case of the MNV genomic and 
sgRNAs respectively) and so any functional RNA elements are likely to be situated in 
the coding region. Also, it is known that calicivirus translation is not driven by an 
                                   152
IRES structure but rather by the VPg protein that is linked to the 5’end of the viral 
genomic and subgenomic RNA (Goodfellow et al., 2005). However, due to the unique 
nature of this translation mechanism, interestingly shared only between caliciviruses 
and a family of plant viruses, potyviruses (Leonard et al., 2000) it is not known 
whether any RNA elements at the 5’end of the viral genome are required for the 
translation initiation or its regulation. Mutagenesis of two conserved RNA elements at 
the 5’ extremity of the viral genome (SL8, m50 and SL29, m51) showed a rather 
small contribution of these structures to viral replication in tissue culture. It is possible 
that the stem-loop sequences within the 5’ end of the coding region contribute to viral 
translation through interactions with either canonical or non-canonical translation 
initiation factors (as discussed in Chapter 3)  to direct ribosome assembly and 
translation initiation. It is also possible that the VPg protein is mainly responsible for 
the translation initiation and that the downstream RNA sequences have only 
regulatory role and so their importance in viral translation is either limited or cell type 
specific. The small plaque phenotype that was observed for the virus with a disrupted 
SL8 (m50) and the fact the initiation codon of ORF1 is situated within the 5’ proximal 
stem loop of MNV (Fig. 4.1a) indicated a possible involvement of this structure in the 
regulation of MNV translation. Further studies would be required to examine this 
hypothesis 
 
Many eukaryotic positive-strand RNA viruses regulate their gene expression 
by the synthesis of smaller subgenomic RNAs (sgRNAs) which can be translated and 
often replicated by the viral RdRp (van der Most et al., 1994, Morales et al., 2004, van 
den Born et al., 2005). Caliciviruses are among the viruses which produce a single 
subgenomic RNA that codes for the major and minor capsid proteins. It is believed 
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that the calicivirus subgenomic RNA is produced by internal initiation by the RdRp 
on the negative-strand genomic RNA. The process is thought to involve a promoter 
that by in vitro polymerase assays was identified to be located upstream of the 
subgenomic RNA region (Morales et al., 2004). In the search of such a subgenomic 
RNA synthesis promoter in the MNV genome, a conserved RNA structure upstream 
of the subgenomic RNA start (SLa5045) was disrupted. The lethal phenotype of the 
mutant virus confirmed the dependence of virus replication on this region. A lethal 
phenotype fitted with the hypothesis that this region formed part of a subgenomic 
RNA promoter as the loss of such an element would lead to the loss of capsid protein 
production. The occurrence of a suppression mutation within the SLa5045 
(m53RevB) and the compensation of the m53 by the stem restoring mutations in 
m53R confirmed the requirement of the SLa5045 structure for virus replication.  
 
Such RNA elements have been characterised in other positive strand RNA-
viruses. In arteriviruses a similar stem-loop structure has been identified upstream of 
the sgRNA and serves as a promoter for the initiation of the sgRNA synthesis (van 
den Born et al., 2005). Also, in cucumber mosaic virus (CMV) a hairpin 5 nucleotides 
upstream of the sgRNA is required for the in-vitro synthesis of the sgRNA by the 
viral RdRp (Chen et al., 2000). A hairpin structure at the same region as SLa5045 was 
predicted for all caliciviruses. Interestingly in all cases the hairpin was 6 nucleotides 
upstream of the subgenomic RNA start site which may indicate a conserved 
mechanism among caliciviruses and a possible similarity with the mechanism 
described for sgRNA synthesis of CMV. The requirement of a region upstream of 
SLa5045 was also apparent as a suppressor mutation was identified ~100 nucleotides 
upstream of the stem-loop in the phenotypically revertant m53RevA. It is known that 
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in other positive strand RNA viruses sequences even 1000 bases upstream of the 
sgRNA start site are required for function of the sgRNA promoter through long-range 
RNA-RNA interactions (Zhang et al., 1999). Further studies are required to identify 
the role of the region in which m53RevA suppressor mutation is located.  
 
The 3’extremity of the positive strand RNA viruses usually accommodate 
RNA elements that are required for the initiation of negative strand RNA synthesis or 
RNA elements that regulate the viral translation. However, in contrast to the rest of 
functional RNA structures, the role of 3’ end structures is often controversial. For 
example the role of the 3’UTR of HCV in IRES function is still debated as HCV 
3’UTR functions in a cell-type specific manner (Song et al., 2006). Similarly, a cell 
specific phenotype was observed with a poliovirus that lacked the 3’UTR as its 
requirement was obvious only in a neuroblastoma cell line (Brown et al., 2004). Thus, 
it is not surprising that the m52 MNV mutant that lacked the SL7330 polypyrimidine 
loop showed no defect in BSRT7 (baby-hamster kidney cells, modified BHK-21 cells) 
and RAW 264.7 cells (mouse leukemic macrophage cell line). It is possible that this 
region regulates an aspect of the virus life cycle upon interaction with a cell-type 
specific RNA binding protein (discussed in more details in Chapter 5). In contrast to 
the loop of SL7330, the importance of the stem was more apparent as the SL7330 
disruption mutant (m54) showed a lethal phenotype. The fact that the lethal phenotype 
was reverted by the deletion of the polypyrimidine tract raised the question of the 
involvement of an extended pseudoknot, formed between the SL7330 loop and a GA-
rich sequence upstream of the stem-loop. A strikingly similar pseudoknot structure 
has been characterised in the arterivirus 3’ UTR, in which the 3’end-most hairpin loop 
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interacts with a sequence just upstream of the hairpin possibly regulating the negative 
strand RNA-synthesis (Beerens & Snijder, 2007).  
 
The identification of functional RNA structures in a positive-strand RNA 
genome is the first step in understanding the mechanism by which an RNA self-
regulates its replication through interaction with viral and cellular factors. In this 
study at least three important RNA elements were identified, however, their specific 
role remains to be elucidated in the future.  
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Chapter 5. 
Characterisation of the 
Interaction of PCBPs and 
La with calicivirus RNA 
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5.1. Introduction  
 
 The majority of the ribonucleoprotein (RNP) complexes formed on an mRNA 
involve a large number of proteins. These proteins may function synergistically to 
perform a specific function on the particular RNA domain. For example, PCBP2 and 
PTB proteins cooperate for the formation of a functional IRES by binding to the 5’ 
UTR of the Bag-1 mRNA (Pickering et al., 2004). In other cases, proteins recruited on 
an mRNA have antagonistic functions, for example the recruitment of the TIA-1 
protein on Fas mRNA promotes exon exclusion, while binding of PTB acts 
antagonistically by hindering the formation of the spliceosome and thereby promoting 
exon skipping (Izquierdo et al., 2005). Furthermore, alteration of the expression levels 
or localisation of RNA-binding proteins is often part of the regulatory network 
controlling the function of such RNPs. A similar network of RNA binding proteins 
seems to apply to the regulation of positive strand RNA virus replication. A variety of 
proteins have been shown to form large RNP complexes on the 5’ and 3’ extremities 
of many positive sense RNA viruses. The RNP complex formed on the 5’ UTR of 
picornavirus genome has been demonstrated to accommodate the translation initiation 
factors eIF4G, eIF4A and eIF4B while the ITAFs: PTB, PCBP2, La and unr proteins 
have also been extensively studied for their roles in this RNP. Proteomics analysis of 
the RNP complex formed on the HCV IRES identified more than 30 proteins that 
interact with the IRES (Lu et al., 2004). Among them there were proteins such as 
PTB, La, PCBP2, hnRNP U, nucleolin and eIF3, the only translation initiation factor 
which interacts with the HCV IRES. Whether or not all the identified proteins are part 
of the functional RNP complex in vivo is not known.  
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The aim of this part of the study was to identify additional proteins that 
interact with the calicivirus RNA and characterise the properties of their binding. The 
identification of additional protein components of the RNPs formed on the viral RNA 
can shed more light in the regulatory network of calicivirus replication.   
 
5.2. The MNV 5’ genomic and 5’ subgenomic RNA extremities 
interact with poly(C)-binding proteins 
 
 Bioinformatics analysis of the MNV 5’ genomic RNA extremity identified at 
least four polypyrimidine tracts, most of which were predicted to be single stranded 
(Fig. 5.1). In contrast to the respective region in FCV, these polypyrimidine tracts 
(BS2-5) also had a substantially higher amount of cytosines (Fig. 5.1) that indicated a 
potential interaction with another important group of RNA-binding proteins, the 
poly(C)-binding proteins (PCBPs). PCBP1 and PCBP2 are arguably the most 
important representatives of this group and have been demonstrated to play a vital 
role in picornavirus translation and replication (Discussed in Chapter 1).  
 
Recombinant PCBP1 and PCBP28 were expressed and purified then their 
ability to interact with the MNV 5’G1-250 RNA examined using EMSA (Fig. 5.2). 
Both proteins showed a high affinity for the 5’G1-250 RNA (Fig. 5.2a). The ability of 
PCBPs to bind to the 5’ extremity of the subgenomic RNA (nts 1-200) was also 
assessed by titration of both PCBP1 and PCBP2 on the 5’SG1-200 RNA probe. Both 
proteins were also able to bind the 5’SG1-200 RNA probe, but with a lower affinity 
than the 5’ genomic extremity (Fig. 5.3).  
                                                 
8 The PCBP data was generated in collaboration with Lillian Chung as part of her master’s project. 
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Figure 5.1. Bioinfomatically predicted secondary structure of the MNV 5’G1-250. The 
potential binding sites (BS1-5) of PTB and PCBPs are highlighted. Dashed arrows indicate the 
nucleotide positions that constituted the terminal nucleotides of the 3’ end truncations of the MNV 
5’G1-250 RNA or the first nucleotide of the 5’ end truncations of the MNV 5’G1-250 RNA 
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Figure 5.2. Interaction of PCBP1 and PCBP2 with the MNV  5’G1-250 and 5’SG1-200 
RNAs. (a.) EMSA analysis examining the ability of PCBP1 and PCBP2 to interact with the 5’ 
extremity of the MNV genome. RNA probes representing nts 1-250 and 1-172 of the genomic RNA 
were incubated with increasing concentrations of protein and the reactions separated on an 4 % native 
acrylamide gel. (b.) Chart that shows the affinity of the truncations tested for the binding of PCBP1 and 
PCBP2 relative to 5’G1-250. PCBP1 and PCBP2 demonstrated similar binding characteristics (c.) EMSA 
analysis examining the ability of PCBP1 and PCBP2 to interact with the 5’ extremity of the MNV 
subgenomic RNA. RNA probes representing nts 1-200 of the of MNV subgenomic RNA were 
incubated with increasing concentrations of protein and the reactions separated on an 4 % native 
acrylamide gel., CI and CII = complex I and II of PCBP1 or PCBP2 with the MNV 5’SG1-200, P=free 
probe, PA=probe alone, *= alternative conformation of the probe or probe dimer)  
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Figure 5.3. Comparison of the interaction of 
PCBP1 and PCBP2 with the MNV  5’G1-250 and 
5’SG1-200 RNAs. Plot of the fraction (%) of the probe in 
complex with PCBP1 or PCBP2 with the MNV 5’G1-250 
and 5’SG1-200 RNA probes from the respective EMSAs of 
Fig. 5.2  
 
 
 
 
 
 
 
 
 
 
 
 
In order to identify the binding site(s) of PCBPs on the 5’ end of the MNV 
genomic RNA, truncations of the original 5’G1-250 RNA were produced by T7 
promoter driven  in vitro transcription of different size PCR fragments representing 
various regions of the 5’G1-250 RNA. The distribution of the potential binding sites 
and the thermodynamically predicted RNA structure were taken into account during 
the design of the truncated transcripts as explained more extensively in Chapter 3. 
PCBP1 and PCBP2 demonstrated similar binding patterns and seemed to bind equally 
well to all the examined RNAs. Truncations from the 3’ end of the 5’G1-250 RNA 
demonstrated that potential binding sites BS1 and BS2 did not contribute to PCBP 
binding as the transcripts that contained only BS1 (5’G1-73) or BS1 and BS2 together 
(5’G1-146) did not demonstrate any PCBP binding affinity (Fig. 5.2a). Addition of the 
sequence containing the potential binding site BS3 (5’G1-172) demonstrated limited 
affinity to PCBP, signifying a small contribution of this region to PCBP binding (Fig. 
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5.2b). Truncations from the 5’ end of the 5’G1-250 RNA demonstrated that deletion of 
the region which included BS1 (5’G73-250) did not lead to any reduction in the affinity 
of the RNA for PCBP. Deletion of the region which contained BS2 (5’G146-250), 
however, had a profound effect on PCBP binding, signifying a role for this region in 
the interaction. Further deletion of the BS3 region (5’G172-250) resulted in the 
abolishment of PCBP binding, highlighting again the importance of the sequence that 
contained BS3. As the deletion analysis demonstrated that BS2 and BS3 were 
important for the interaction between 5’G1-250 and the PCBPs, an RNA transcript 
which contained only the regions containing BS2 and BS3 was examined for its 
ability to bind the PCBPs. This 5’G73-172 RNA demonstrated no affinity for PCBPs 
(Fig. 5.2b). From the above deletion analysis it was obvious that more than one 
binding sites on the MNV 5’extremity were required for the efficient interaction with 
the PCBPs.   
 
 
5.3. The MNV 3’ UTR interacts with PTB and PCBP2 
 
Sequence analysis identified a pyrimidine rich region in the 3’ UTR of MNV 
which localised to the loop region of the 3’ stem-loop. Further analysis indicated that 
it had the potential to form a pseudoknot with upstream sequences (Chapter 4, Fig. 
4.9a). Such a pyrimidine rich context was an obvious potential binding site for PTB 
and PCBP, hence this was characterised further. Such stretches of variable length 
have been identified in the 3’UTR of other viruses such as HCV and are well known 
to interact with PTB and PCBPs. EMSAs using an RNA probe representing the 3’ 
extremity of MNV genome (nts 7133-7382) demonstrated that the region had a high 
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affinity for PTB and PCBP2 protein (Fig. 5.4a,b). The specificity of the interaction 
between PTB and the 3’extremity was assessed using a competition EMSA. Non-
radiolabeled homologous transcripts representing the 3’extremity of the MNV 
genomic RNA and MNV 5’G1-250 were able to inhibit complex formation. FCV 3’ 
extremity had some effect on the complex formation. However, this was insignificant 
as even 5’MNV that demonstrated residual binding for PTB inhibited better even at 
10 times smaller concentration. This competition analysis confirmed that the 
interaction between PTB and the MNV 3’ extremity was specific (Fig. 5.5).  
 
In order to confirm that the region responsible for the binding was the 
pyrimidine rich loop of the 3’ extremity of the MNV genome, the polypyrimidine 
tract was substituted by a GNRA tetranucleotide to generate the MNV mutant m52. 
The replication characteristics of this virus were identical to WT MNV and have 
already been described in Chapter 4. The mutated 3’ extremity was used as an RNA 
probe in EMSA reactions, where it demonstrated that the removal of the 
polypyrimidine tract had a dramatic effect on PCBP2 and PTB binding (Fig. 5.4c,d).  
 
 
 
 
 
 
 
 
 
                                   164
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. PCBP2 and PTB interact with the 3’ extremity of the MNV genome. (a., b., 
c., d.,) EMSA analysis examining the ability  of PCBP2 and PTB to interact with  the 3’ extremity of 
the MNV genome. RNA probes encompassing nts 7133-7382 from either the wild-type virus or the 
m52 mutant lacking the polypyrimidine tract, were incubated with increasing concentrations of protein 
and the reactions separated on an 4 % native acrylamide gel. (e., f.) Plot of the fraction of wt and 
mutated (m52) 3’ extremity probe in complex with the PTB or PCBP2 under increasing amounts of 
protein. (C = complex of PCBP and the MNV 3’extremity, CI, CII and CIII = complex I, II, III of PTB 
and the MNV 3’ extremity, P=free probe, PA=probe alone)  
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5.4. The La protein interacts with the 5’ extremity of FCV genomic 
RNA 
 
A protein that has been demonstrated to participate in RNP complexes which 
also contain PTB is La autoantigen. The poliovirus 5’ IRES RNA structure is one site 
of such an RNP complex (Svitkin et al., 1994), while the two proteins have also been 
identified to form a complex on the 3’ UTR of Dengue 4 virus RNA (De Nova-
5’FCV      3’MNV 
PA    N    NS1                                  NS2
0.75 μg La 
Figure 5.5. PTB interacts specifically 
with the 3’ extremity of the MNV 
genome. The formation of a complex 
between an RNA probe encompassing nts 
7133-7382 of the MNV 3’ extremity and 
PTB is challenged by the addition of non-
labelled 3’extremity homologous RNA 
(3’ext), 5’G1-250 RNA (5’GMNV) and the 3’ 
extremity of FCV (nts 7493-7683, NS). (PA 
= probe alone, N = no competitor, NS = non-
specific competitor, CI and CII the two 
complexes between PTB and the MNV 3’ 
extremity.)  
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Figure 5.6. La protein interacts specifically 
with the 5’ end of the FCV genomic RNA. 
(a.) EMSA analysis examining the ability of La to 
interact with the 5’ extremity (5’G1-245) of FCV 
genome. RNA probes encompassing nts 1-245 of 
FCV genomic RNA were incubated with increasing 
amounts of protein and the reactions separated on a 
4 % native acrylamide gel. (b.) Competition EMSA 
in which the formation of complex between FCV 
5’G1-245 and La protein is challenged with 
homologous FCV 5’G1-245 (5’FCV) MNV 3’ 
extremity (nts 7133-7382, 3’MNV), poliovirus 2C-
Cre (NS1) and FCV 3’ extremity (nts 7493-7683, 
NS2). (C=complex, P= free probe, PA=probe alone, 
N=no competitor, *=complex of La with a smaller 
RNA fragment.)  
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Ocampo et al., 2002). Similarly, PTB and La are part of the RNP complexes formed 
at the 5’ and 3’ extremities of Norwalk virus RNA (Gutierrez-Escolano et al., 2000, 
Gutierrez-Escolano et al., 2003). To address if similar PTB and La containing 
complexes can form on the genomes of other caliciviruses, purified recombinant La 
protein was first examined for its ability to bind on the 5’ extremity of FCV. In 
EMSA reactions that contained the FCV 5’G1-245 RNA probe, La protein was found to 
form a stable complex with the FCV 5’G extremity (Fig. 5.6a). Titration of unlabelled 
RNA transcripts encompassing nts 1-245 of the FCV genomic RNA, homologous to 
the probe, into EMSA reactions inhibited complex formation (Fig. 5.6b). The same 
effect was also observed with RNA transcripts that represented the MNV 3’UTR, 
while the poliovirus 2C-cre (NS1) and the FCV 3’ extremity (NS2) did not inhibit 
complex formation (Fig. 5.6b). This competition assay verified the specificity of the 
interaction between La and the FCV 5’G1-245 RNA probe. Furthermore, the specific 
inhibition of the complex by the MNV 3’UTR revealed another potential binding site 
of this host-cell factor.  
 
5.5 La protein assists PTB binding to the 5’ extremity of the FCV 
genomic RNA 
 
 Often proteins that form one component of a RNP complex may facilitate the 
binding of other components of the complex to the RNA, usually by helping the RNA 
adopt a more favourable conformation for binding. An example of such activity is the 
induction of PCBP2 binding on the 5’ cloverleaf structure of the poliovirus genome, 
which occurs as a consequence of 3CD binding on the same structure (Parsley et al., 
1997). A combined La and PTB EMSA analysis was performed in order to reveal any 
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potential cooperativity in binding between the two proteins. Recombinant La protein 
was titrated into reactions containing a standard amount of PTB in a series of EMSA 
reactions using the FCV 5’G1-245 RNA probe. Increasing amounts of La resulted in an 
increased intensity of the band corresponding to the complex formed by PTB and 
5’G1-245 RNA in the absence of La (PTB CI, Fig. 5.7a). A low amount of PTB (0.25 
μg) was used in the binding assays to  allow any increase in complex formation, 
which might occur as a result of La binding, to be observed. When PTB was titrated 
on top of a standard amount of La protein, increasing amounts of PTB resulted in the 
reduction of the intensity of the band that corresponded to the complex between La 
and the 5’G1-245 RNA in the absence of PTB (La C, Fig. 5.7b). This observation 
demonstrated that PTB either displaced La from its binding site on the 5’G1-245 or that 
both proteins formed a complex that had a mobility very similar to the mobility of the 
PTB-5’G1-245 complex. One fact that was clear from these EMSA reactions was that 
upon addition of La protein, the binding of PTB to the 5’G1-245 RNA was more 
favoured.  
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Figure 5.7. La assists PTB binding on the 5’ end of the FCV genomic RNA. EMSA 
analysis of combined interaction of La and PTB with the 5’ extremity (5’G1-245) of FCV genome. (a.) 
RNA probes encompassing nts 1-245 of FCV genomic RNA with a constant amount of PTB were 
incubated with increasing amounts of La and the reactions separated on an 4 % native acrylamide gel. 
(b.) RNA probes encompassing nts 1-245 of FCV genomic RNA with a constant amount of La were 
incubated with increasing amounts of PTB and the reactions separated on an 4 % native acrylamide gel. 
(c.) Plot of the % increase in the complex between PTB and the 5’G1-245 probe upon addition of 
increasing amounts of La. (d.) Plot of the fraction (%) of 5’G1-245probe in complex with La upon 
addition of increasing amounts of PTB. (PTB CI CII CIII = complex I II and III of PTB with the 5’G1-245, 
La C = complex of La with the 5’G1-245, P=free probe, PA=probe alone)  
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5.6 Discussion 
 
Cooperative assembly of RNP complexes is a conserved mechanism for the 
regulation of many cellular processes. RNA viruses and especially positive strand 
RNA viruses take advantage of the abundance of host RNA-binding proteins for the 
regulation of their own translation and replication processes. During this part of the 
study the interaction of a number of host RNA-binding proteins with the calicivirus 
RNA was examined in order to identify additional components of the viral RNPs.  
 
Poly(C)-binding proteins (PCBPs) are a large group of RNA-binding proteins 
that are involved in the regulation of translation and replication of a number of 
positive strand RNA viruses. In poliovirus, PCBPs play a dual role as they are 
required for the efficient IRES-mediated translation, while through interaction with a 
5’ extremity cis-replication element (cloverleaf) they also regulate poliovirus 
replication (Gamarnik & Andino, 1998). PCBP1 and PCBP2 were demonstrated to 
interact with the 5’ extremity of the MNV genomic RNA and an attempt to roughly 
map their binding site(s) on the RNA was made. According to the deletion analysis, 
potential binding sites BS2 and BS3 on the MNV 5’ extremity contributed greatly to 
the binding of the PCBPs. However, BS2 and BS3 were not sufficient for PCBP 
binding. It is highly possible structural rearrangements in the truncated RNA masked 
or altered the tertiary positions of the pyrimidine tracts inhibiting PCBP binding. For 
example, it is known that the alteration of the secondary structure of the poliovirus 
type 3 IRES and not the actual alteration of its binding site due to a mutation present 
in Sabin type 3 vaccine strain is probably responsible for the inefficient binding of 
PTB (Guest et al., 2004). Mutational analysis of BS2 and BS3 binding sites would 
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elucidate their involvement in the interaction between MNV 5’G1-250 and the PCBPs, 
but time constrains did not allow further study of PCBP binding to the MNV 5’ 
genomic extremity. Nevertheless, it was clear that PCBP binding involved more than 
one region of the RNA.  
 
The interaction of PCBPs with additional regions of the MNV genomic RNA 
was assessed by EMSAs that contained the 5’ extremity of the subgenomic RNA and 
the 3’ extremity of the MNV genome. Both regions demonstrated some affinity for 
the PCBPs, while the pyrimidine rich loop of the 3’end stem-loop was the major 
binding determinant of the 3’ extremity for both PCBP2 and PTB. The simultaneous 
high affinity interaction of PCBP2 with both the MNV 5’ and 3’ extremities also 
suggested a possible role of PCBP2 in the formation of a protein bridge between the 
two ends of the viral RNA. Such an interaction has been demonstrated to be important 
for the efficient translation and/or replication of all the extensively studied 
mammalian positive strand RNA viruses. An interaction between PABP, that binds 
the 3’ end poly(A) tail and PCBP, which binds the poliovirus IRES, is a well studied 
example of viral RNA circularisation that has been demonstrated to enhance the viral 
translation (Herold & Andino, 2001). In rotaviruses the 3’ end partner, PABP, has 
been substituted by the virally encoded protein NSP3, which binds to a conserved 
sequence at the 3′ end (UGUGACC-3’OH) of all six segments of the rotavirus RNA 
genome (Vende et al., 2000). The fact that PCBP2 was recently demonstrated by X-
ray crystallography and NMR to form a dimer through interaction between two KH1 
domains or a KH1 and a KH2 domain (Du et al., 2007) indicated a PCBP2-PCBP2 
interaction might be a potential bridge between the two extremities of the MNV viral 
RNA. Further studies are required to support this hypothesis. 
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Amongst the proteins that were identified to be part of the Norwalk virus 
5’end RNP was the La autoantigen (Gutierrez-Escolano et al., 2000). However, after 
the initial finding, the interactions were not characterised either biochemically or 
functionally. During this study, La protein was demonstrated to interact specifically 
with the 5’ extremity of the FCV genomic RNA, while in combination with PTB, the 
La protein demonstrated an assisting role in PTB binding. In the presence of the La 
protein, the viral RNA demonstrated an increased affinity for PTB. Enhancement of 
such an interaction could either signify that a direct interaction between La and PTB 
assisted the formation of a tripartite complex with the RNA or that La acted as an 
RNA chaperone, allosterically altering the conformation of the RNA which facilitated 
the binding of PTB. A direct interaction between La and PTB has never been 
reported, despite the fact that these proteins have been found together in several 
RNPs. On the other hand, La protein is well known for its RNA chaperone activity by 
inducing conformational changes of the RNA during mRNA cis-splicing (Belisova et 
al., 2005), while it has also been found to promote the correct folding of several pre-
tRNAs (Wolin & Wurtmann, 2006). An allosterically assisted binding of a protein to 
RNA has been previously described during the study of RNP complex assembly on 
the 16S ribosomal RNA (Recht & Williamson, 2004). In the presence of the 
ribosomal protein S15, the affinity of the 16S RNA for the S6/S18 heterodimer was 
significantly enhanced, while it is believed that the conformational change induced by 
the S15 is the cause of this shift in the affinity (Recht & Williamson, 2004). 
 
Identification of the components of the viral RNPs is the first step in the 
elucidation of the regulatory network that controls calicivirus translation and 
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replication. Future demonstration of the functional role of these interactions will 
reveal the mechanism by which the above regulation takes place. 
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Chapter 6. 
Conclusion and future work 
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RNA performs essential functions within the cell, regulating a wide range of 
processes though interaction with RNA-binding proteins (Ciesla, 2006, Rodriguez-
Trelles et al., 2006). Viruses taking advantage of this regulatory network use cellular 
RNA-binding proteins for their own translation and replication (Belsham & 
Sonenberg, 2000). The study of these interactions can offer insights in the 
mechanisms that regulate the virus life cycle. 
 
The study of RNA-protein interactions and RNA structures in caliciviruses 
and most importantly in human caliciviruses was particularly difficult due to the lack 
of a tissue culture system to support human norovirus infection. Recently, a research 
group managed to apply a 3D-culture system in which cells could differentiate 
mimicking the small intestinal epithelium that could support the growth of human 
noroviruses (Straub et al., 2007). However, this system is difficult to establish as the 
cells need at least a month of preparation for every infectivity assay and although this 
finding was a breakthrough in the study of human noroviruses, in practice the FCV 
and MNV model systems remain the best for the study of calicivirus replication.  
 
Throughout this project a number of RNP complexes formed on the calicivirus 
RNA were dissected to allow the identification of the RNA-binding proteins that 
constitute the viral RNP complexes. Host-cell RNA binding proteins such as PTB, the 
PCBPs and La were demonstrated to interact with the extremities of the FCV and 
MNV genomic and subgenomic RNAs (Table 6.1). PTB protein had an intriguingly 
diverse affinity for the extremities of the FCV and MNV genomic RNA. The 5’ 
extremity of the FCV genome could interact with PTB while its 3’ extremity did not 
demonstrate any affinity. The opposite was observed for the MNV genomic RNA, 
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which had residual binding affinity for PTB at the 5’ extremity, while the 3’ extremity 
demonstrated a good binding affinity for PTB. The opposite polarity of PTB binding 
on the FCV and MNV genomic RNA could indicate a possible alternative regulation 
of FCV and MNV replication by PTB. It is has been already demonstrated that FCV 
and MNV may have different mechanisms for the regulation of their gene expression 
as they differ in their requirements for canonical translation initiation factors 
(Chaudhry et al., 2006). In contrast to PTB, PCBPs could interact with both 
extremities of the MNV genome indicating a possible role in the circularisation of the 
viral RNA that has been shown to be important for other positive strand RNA viruses 
(Edgil & Harris, 2006). The attribution of such a role to PCBPs, however, requires 
additional study that will demonstrate the formation of such a protein bridge between 
the two ends of the viral RNA in vitro and also the requirement of such an interaction 
in viral replication.  
 
 
 
 
 
 
 
 
 
The interaction of PTB with the FCV RNA was thoroughly studied during this 
project and PTB demonstrated a potential RNA chaperone activity in the regulation of 
FCV translation. The negative regulation of FCV translation by PTB was the first 
                    Protein 
Viral RNA PTB PCBPs La 
FCV 5’G extremity ++++ ? Yes 
FCV 5’SG extremity ++++ ? ? 
FCV 3’extremity - ? No 
MNV 5’G extremity + ++++ Yes 
MNV 5’SG extremity ++++ +++ ? 
MNV 3’extremity +++++ +++++ Yes 
 
†                       ‡                ¶ 
Table 6.1. RNA-protein interactions in FCV and MNV 
† ++++ = relative affinity of PTB for FCV 5’G1-245 
‡ ++++ = relative affinity of PCBPs for MNV 5’G1-250 
¶ the lack of comparative study for La binding limited the designation to    
   Yes for some affinity and No for no affinity 
? = not assayed, - = no affinity 
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functional analysis for an RNA-binding protein in the life cycle of any calicivirus.  It 
is hypothesised that translation of viral proteins causes PTB to move out of the 
nucleus late in the infection to down-regulate translation in order to facilitate the 
assembly of the replication machinery (Fig. 6.1). The hypothesis that PTB may be 
part of the switch between translation and replication requires additional study in 
isolated active replication complexes (Green et al., 2002) and in cell culture. The 
assistance of PTB recruitment on the 5’ extremity by La protein added another 
component in the RNP complex that possibly regulates the translation of FCV RNA 
(Fig. 6.2).  
 
 The identification of functional RNA structures in the viral genomes has been 
a well known alternative path for the elucidation of the role of viral RNP complexes. 
The poliovirus 2C-Cre structure is an example of an RNA element that was identified 
by computational analysis of the poliovirus genome (Goodfellow et al., 2000) and was 
subsequently demonstrated to be crucial for poliovirus replication (Goodfellow et al., 
2003a). Functional RNA structures were identified in the MNV genome by 
computational and mutational analysis using the recently described MNV reverse 
genetics system (Chaudhry et al., 2007). This study revealed a potential subgenomic 
RNA synthesis promoter upstream of the subgenomic RNA start site. In vitro studies 
of subgenomic RNA synthesis initiation by the viral RdRp (Morales et al., 2004) on 
wild-type and mutated (m53, Chapter 4) negative strand RNA templates would 
elucidate the role of this important MNV RNA element. Moreover, further study of 
the phenotypically reventant viruses (m53RevA and m53RevB, Chapter 4) could aid 
the dissection of the mechanism that lies behind the subgenomic RNA synthesis in 
MNV.  
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Figure 6.2. The RNP complex that regulates FCV translation. The canonical translation 
initiation factors eIF4E, eIF4G and eIF4A that are recruited on the 5’ end of the FCV RNA through 
interaction with VPg and possibly with the viral RNA (Chaudhry et al., 2006). PTB and possibly La 
protein interact with the viral RNA for the regulation of the translation. 
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Figure 6.1. The hypothesis for the regulation of FCV replication by PTB. The viral RNA 
is translated producing the viral proteins. The viral proteins later during the infection inhibit the 
shuttling of PTB to the nucleus either directly or indirectly and promote the translocation of PTB to the 
cytoplasm. PTB inhibits the recruitment of the ribosomes at the 5’ end of the positive strand viral RNA 
and the RNA-dependent RNA polymerase can produce the negative strand RNA. 
nucleopore 
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MNV replication demonstrated a dependence on RNA elements situated in the 
5’ and 3’ extremities of the MNV genome. The dependence of MNV replication on 5’ 
end RNA structures was less apparent than the requirement of RNA elements in the 
3’extremity. The unique translation initiation mechanism of caliciviruses has 
potentially resulted in the reduction of the regulatory role of the 5’ extremity 
structures during the evolution, as the extremely short 5’ UTR would indicate. In 
contrast the 3’ extremity stem-loop (SL7330, Chapter 4) is required for the 
production of viable viruses. If the conserved motifs that form the polypyrimidine 
loop of this structure are required for the replication of the virus in the in vivo mouse 
model, then strains such as m54RevA could serve as candidates for live-attenuated 
vaccine. 
 
The identification of RNA-binding proteins that regulate calicivirus translation 
and replication may reveal new targets for the production of drugs against human 
caliciviruses. Finally, the construction of attenuated mutant viruses, which are 
defective in the interaction of their RNA with a cellular protein, could lead to the 
production of a vaccine strain for a disease that affects millions of people worldwide. 
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